BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Castro MC, David DS, David-Neto E, Bagnasco SM, Cendales LC, Cornell LD, Demetris AJ, Drachenberg CB, Farver CF, Farris AB 3rd, Gibson IW, Kraus E, Liapis H, Loupy A, Nickeleit V, Randhawa P, Rodriguez ER, Rush D, Smith RN, Tan CD, Wallace WD, Mengel M; Banff meeting report writing committee. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 2014;14:272-83. [PMID: 24472190 DOI: 10.1111/ajt.12590] [Cited by in Crossref: 977] [Cited by in F6Publishing: 865] [Article Influence: 139.6] [Reference Citation Analysis]
Number Citing Articles
1 Jobert A, Rao N, Deayton S, Bennett GD, Brealey J, Nolan J, Carroll RP, Dragun D, Coates PT. Angiotensin II type 1 receptor antibody precipitating acute vascular rejection in kidney transplantation. Nephrology (Carlton) 2015;20 Suppl 1:10-2. [PMID: 25807851 DOI: 10.1111/nep.12421] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
2 Gill RG, Lin CM. Linking innate immunity and chronic antibody-mediated allograft rejection. Curr Opin Organ Transplant 2019;24:694-8. [PMID: 31599762 DOI: 10.1097/MOT.0000000000000708] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Michel K, Santella R, Steers J, Sahajpal A, Downey FX, Thohan V, Oaks M. Many de novo donor-specific antibodies recognize β2 -microglobulin-free, but not intact HLA heterodimers. HLA 2016;87:356-66. [PMID: 27060279 DOI: 10.1111/tan.12775] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
4 Toki D, Inui M, Ishida H, Okumi M, Shimizu T, Shirakawa H, Omoto K, Unagami K, Setoguchi K, Koike J, Honda K, Yamaguchi Y, Tanabe K. Interstitial fibrosis is the critical determinant of impaired renal function in transplant glomerulopathy. Nephrology (Carlton) 2016;21 Suppl 1:20-5. [PMID: 26970313 DOI: 10.1111/nep.12765] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
5 Couzi L, Manook M, Perera R, Shaw O, Ahmed Z, Kessaris N, Dorling A, Mamode N. Difference in outcomes after antibody-mediated rejection between abo-incompatible and positive cross-match transplantations. Transpl Int. 2015;28:1205-1215. [PMID: 26095452 DOI: 10.1111/tri.12621] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
6 Matas AJ, Fieberg A, Mannon RB, Leduc R, Grande J, Kasiske BL, Cecka M, Gaston R, Hunsicker L, Connett J, Cosio F, Gourishankar S, Rush D. Long-term follow-up of the DeKAF cross-sectional cohort study. Am J Transplant 2019;19:1432-43. [PMID: 30506642 DOI: 10.1111/ajt.15204] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
7 Muduma G, Odeyemi I, Smith-palmer J, Pollock RF. Review of the Clinical and Economic Burden of Antibody-Mediated Rejection in Renal Transplant Recipients. Adv Ther 2016;33:345-56. [DOI: 10.1007/s12325-016-0292-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
8 Orandi BJ, Lonze BE, Jackson A, Terezakis S, Kraus ES, Alachkar N, Bagnasco SM, Segev DL, Orens JB, Montgomery RA. Splenic Irradiation for the Treatment of Severe Antibody-Mediated Rejection. Am J Transplant 2016;16:3041-5. [DOI: 10.1111/ajt.13882] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
9 Huang E, Gillespie M, Ammerman N, Vo A, Lim K, Peng A, Najjar R, Sethi S, Jordan SC, Mirocha J, Haas M. Donor-derived Cell-free DNA Combined With Histology Improves Prediction of Estimated Glomerular Filtration Rate Over Time in Kidney Transplant Recipients Compared With Histology Alone. Transplant Direct 2020;6:e580. [PMID: 33134504 DOI: 10.1097/TXD.0000000000001027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Kulkarni HS, Bemiss BC, Hachem RR. Antibody-mediated Rejection in Lung Transplantation. Curr Transplant Rep 2015;2:316-23. [PMID: 27896040 DOI: 10.1007/s40472-015-0074-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
11 Sablik KA, Clahsen-van Groningen MC, Looman CWN, Damman J, Roelen DL, van Agteren M, Betjes MGH. Chronic-active antibody-mediated rejection with or without donor-specific antibodies has similar histomorphology and clinical outcome - a retrospective study. Transpl Int 2018;31:900-8. [PMID: 29570868 DOI: 10.1111/tri.13154] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
12 Mikhail D, Chan E, Sharma H, Kleinsteuber D, Wei J, Rim C, Henein M, Sener A, Jevnikar AM, Gabril M, Moussa M, Luke PP. Clinical Significance of Isolated V1 Arteritis in Renal Transplantation. Transplant Proc 2021;53:1570-5. [PMID: 33994184 DOI: 10.1016/j.transproceed.2021.03.027] [Reference Citation Analysis]
13 Blydt-Hansen TD, Sharma A, Gibson IW, Wiebe C, Sharma AP, Langlois V, Teoh CW, Rush D, Nickerson P, Wishart D, Ho J. Validity and utility of urinary CXCL10/Cr immune monitoring in pediatric kidney transplant recipients. Am J Transplant 2021;21:1545-55. [PMID: 33034126 DOI: 10.1111/ajt.16336] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Barisoni L, Troost JP, Nast C, Bagnasco S, Avila-Casado C, Hodgin J, Palmer M, Rosenberg A, Gasim A, Liensziewski C, Merlino L, Chien HP, Chang A, Meehan SM, Gaut J, Song P, Holzman L, Gibson D, Kretzler M, Gillespie BW, Hewitt SM. Reproducibility of the NEPTUNE descriptor-based scoring system on whole-slide images and histologic and ultrastructural digital images. Mod Pathol 2016;29:671-84. [PMID: 27102348 DOI: 10.1038/modpathol.2016.58] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
15 Kozakowski N, Eskandary F, Herkner H, Bond G, Oberbauer R, Regele H, Böhmig GA, Kikić Ž. Diffuse Extent of Peritubular Capillaritis in Late Antibody-Mediated Rejection: Associations With Levels of Donor-Specific Antibodies and Chronic Allograft Injury. Transplantation 2017;101:e178-87. [PMID: 28252564 DOI: 10.1097/TP.0000000000001707] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
16 Ortiz MA, Álvarez CM, Arrunátegui AM, Arias YR, Villegas A. Immunological follow-up of patients with renal transplants: A proposal for clinical practice in Colombia. Biomedica 2020;40:479-86. [PMID: 33030826 DOI: 10.7705/biomedica.5092] [Reference Citation Analysis]
17 de Graav GN, Baan CC, Clahsen-van Groningen MC, Kraaijeveld R, Dieterich M, Verschoor W, von der Thusen JH, Roelen DL, Cadogan M, van de Wetering J, van Rosmalen J, Weimar W, Hesselink DA. A Randomized Controlled Clinical Trial Comparing Belatacept With Tacrolimus After De Novo Kidney Transplantation. Transplantation. 2017;101:2571-2581. [PMID: 28403127 DOI: 10.1097/tp.0000000000001755] [Cited by in Crossref: 37] [Cited by in F6Publishing: 14] [Article Influence: 7.4] [Reference Citation Analysis]
18 Kizilbash S, Claes D, Ashoor I, Chen A, Jandeska S, Matar RB, Misurac J, Sherbotie J, Twombley K, Verghese P. Bortezomib in the treatment of antibody-mediated rejection in pediatric kidney transplant recipients: A multicenter Midwest Pediatric Nephrology Consortium study. Pediatr Transplant 2017;21. [PMID: 28092129 DOI: 10.1111/petr.12873] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
19 Yamamoto T, Watarai Y, Takeda A, Tsujita M, Hiramitsu T, Goto N, Narumi S, Katayama A, Morozumi K, Uchida K, Kobayashi T. De Novo Anti-HLA DSA Characteristics and Subclinical Antibody-Mediated Kidney Allograft Injury. Transplantation 2016;100:2194-202. [PMID: 26636737 DOI: 10.1097/TP.0000000000001012] [Cited by in Crossref: 47] [Cited by in F6Publishing: 17] [Article Influence: 9.4] [Reference Citation Analysis]
20 Salvadé I, Aubert V, Venetz JP, Golshayan D, Saouli AC, Matter M, Rotman S, Pantaleo G, Pascual M. Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation. Hum Immunol 2016;77:483-9. [PMID: 27085791 DOI: 10.1016/j.humimm.2016.04.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
21 Gu Y, Koh RWK, Lai ML, Pochinco D, Teo RZC, Chan M, Murali TM, Liew CW, Wong YH, Gascoigne NRJ, Wood KJ, Lescar J, Nickerson P, MacAry PA, Vathsala A. Defining the structural basis for human leukocyte antigen reactivity in clinical transplantation. Sci Rep 2020;10:18397. [PMID: 33110123 DOI: 10.1038/s41598-020-75355-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Einecke G, Reeve J, Halloran PF. A molecular biopsy test based on arteriolar under-hyalinosis reflects increased probability of rejection related to under-immunosuppression. Am J Transplant 2018;18:821-31. [DOI: 10.1111/ajt.14532] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
23 Béland S, Vallin P, Désy O, Lévesque E, De Serres SA. Effects of alloantibodies to human leukocyte antigen on endothelial expression and serum levels of thrombomodulin. J Thromb Haemost 2017;15:1020-31. [PMID: 28239987 DOI: 10.1111/jth.13661] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
24 Budding K, van de Graaf E, Otten H. Humoral immunity and complement effector mechanisms after lung transplantation. Transplant Immunology 2014;31:260-5. [DOI: 10.1016/j.trim.2014.08.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
25 Lefaucheur C, Viglietti D, Hidalgo LG, Ratner LE, Bagnasco SM, Batal I, Aubert O, Orandi BJ, Oppenheimer F, Bestard O, Rigotti P, Reisaeter AV, Kamar N, Lebranchu Y, Duong Van Huyen JP, Bruneval P, Glotz D, Legendre C, Empana JP, Jouven X, Segev DL, Montgomery RA, Zeevi A, Halloran PF, Loupy A. Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment. J Am Soc Nephrol 2018;29:620-35. [PMID: 29042454 DOI: 10.1681/ASN.2017050589] [Cited by in Crossref: 62] [Cited by in F6Publishing: 21] [Article Influence: 12.4] [Reference Citation Analysis]
26 Velidedeoglu E, Cavaillé-Coll MW, Bala S, Belen OA, Wang Y, Albrecht R. Summary of 2017 FDA Public Workshop: Antibody-mediated Rejection in Kidney Transplantation. Transplantation 2018;102:e257-64. [PMID: 29470345 DOI: 10.1097/TP.0000000000002141] [Cited by in Crossref: 29] [Cited by in F6Publishing: 7] [Article Influence: 9.7] [Reference Citation Analysis]
27 Gielis EM, Beirnaert C, Dendooven A, Meysman P, Laukens K, De Schrijver J, Van Laecke S, Van Biesen W, Emonds MP, De Winter BY, Bosmans JL, Del Favero J, Abramowicz D, Ledeganck KJ. Plasma donor-derived cell-free DNA kinetics after kidney transplantation using a single tube multiplex PCR assay. PLoS One. 2018;13:e0208207. [PMID: 30521549 DOI: 10.1371/journal.pone.0208207] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
28 Dutra RS, Fabreti-Oliveira RA, Lasmar MF, Araujo SA, Nascimento E. Impact of the immunotherapy induction on allograft outcome and survival in kidney transplant patients with donor-specific antibodies to HLA-DQB1. Transpl Immunol 2021;66:101390. [PMID: 33838296 DOI: 10.1016/j.trim.2021.101390] [Reference Citation Analysis]
29 Kildey K, Francis RS, Hultin S, Harfield M, Giuliani K, Law BMP, Wang X, See EJ, John G, Ungerer J, Wilkinson R, Kassianos AJ, Healy H. Specialized Roles of Human Natural Killer Cell Subsets in Kidney Transplant Rejection. Front Immunol 2019;10:1877. [PMID: 31440252 DOI: 10.3389/fimmu.2019.01877] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
30 Go RS, Winters JL, Leung N, Murray DL, Willrich MA, Abraham RS, Amer H, Hogan WJ, Marshall AL, Sethi S, Tran CL, Chen D, Pruthi RK, Ashrani AA, Fervenza FC, Cramer CH 2nd, Rodriguez V, Wolanskyj AP, Thomé SD, Hook CC; Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy Disease-Oriented Group. Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented Group. Mayo Clin Proc 2016;91:1189-211. [PMID: 27497856 DOI: 10.1016/j.mayocp.2016.05.015] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
31 Arias-Cabrales C, Redondo-Pachón D, Pérez-Sáez MJ, Gimeno J, Sánchez-Güerri I, Bermejo S, Sierra A, Burballa C, Mir M, Crespo M, Pascual J. Renal graft survival according to Banff 2013 classification in indication biopsies. Nefrologia 2016;36:660-6. [PMID: 27595515 DOI: 10.1016/j.nefro.2016.05.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
32 Horneland R, Paulsen V, Lindahl JP, Grzyb K, Eide TJ, Lundin K, Aabakken L, Jenssen T, Aandahl EM, Foss A, Øyen O. Pancreas transplantation with enteroanastomosis to native duodenum poses technical challenges--but offers improved endoscopic access for scheduled biopsies and therapeutic interventions. Am J Transplant 2015;15:242-50. [PMID: 25394773 DOI: 10.1111/ajt.12953] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
33 Ventura CG, Whisenant T, Gelbart T, David DSR, Agena F, Salomon DR, David-Neto E, Kurian SM. Discovery and cross-validation of peripheral blood and renal biopsy gene expression signatures from ethnically diverse kidney transplant populations. Am J Transplant 2019;19:3356-66. [PMID: 31152474 DOI: 10.1111/ajt.15482] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
34 Hasanzamani B, Hami M, Zolfaghari V, Torkamani M, Ghorban Sabagh M, Ahmadi Simab S. The effect of cytomegalovirus infection on acute rejection in kidney transplanted patients. J Renal Inj Prev 2016;5:85-8. [PMID: 27471740 DOI: 10.15171/jrip.2016.18] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
35 Nowańska K, Donizy P, Kościelska-Kasprzak K, Kamińska D, Krajewska M, Mazanowska O, Madziarska K, Zmonarski S, Chudoba P, Małkiewicz B, Hałoń A, Klinger M, Banasik M. Endothelin A Receptors Expressed in Renal Blood Vessels of Renal Transplant Patients Are Connected With Acute Tubular Necrosis or Antibody-Mediated Rejection. Transplant Proc 2018;50:1760-4. [PMID: 30056896 DOI: 10.1016/j.transproceed.2018.05.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
36 Gan CC, Jalalonmuhali M, Nordin NZ, Abdul Wahab MZ, Yahya R, Ng KP, Tan SY, Lim SK. ABO-Incompatible Living-Donor Kidney Transplantation in a Developing Country: A Multicenter Experience in Malaysia. Transplant Proc 2021;53:856-64. [PMID: 33487455 DOI: 10.1016/j.transproceed.2020.10.038] [Reference Citation Analysis]
37 Höcker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B, Oh J, Zirngibl M, Dello Strologo L, Büscher A, Weber LT, Awan A, Pohl M, Bald M, Printza N, Rusai K, Peruzzi L, Topaloglu R, Fichtner A, Krupka K, Köster L, Bruckner T, Schnitzler P, Hirsch HH, Tönshoff B. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study. Transplantation 2019;103:1224-33. [PMID: 30130322 DOI: 10.1097/TP.0000000000002414] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 9.5] [Reference Citation Analysis]
38 Halloran PF, Merino Lopez M, Barreto Pereira A. Identifying Subphenotypes of Antibody-Mediated Rejection in Kidney Transplants. Am J Transplant 2016;16:908-20. [PMID: 26743766 DOI: 10.1111/ajt.13551] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 7.5] [Reference Citation Analysis]
39 Uva PD, Quevedo A, Roses J, Toniolo MF, Pilotti R, Chuluyan E, Casadei DH. Anti-Hla donor-specific antibody monitoring in pancreas transplantation: Role of protocol biopsies. Clin Transplant 2020;34:e13998. [PMID: 32492226 DOI: 10.1111/ctr.13998] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Ulloa CE, Anglicheau D, Snanoudj R, Scemla A, Martinez F, Timsit MO, Legendre C, Sberro-Soussan R. Conversion From Calcineurin Inhibitors to Belatacept in HLA-sensitized Kidney Transplant Recipients With Low-level Donor-specific Antibodies. Transplantation 2019;103:2150-6. [PMID: 30720681 DOI: 10.1097/TP.0000000000002592] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
41 Sharbafi MH, Assadiasl S, Pour‐reza‐gholi F, Barzegari S, Mohammadi Torbati P, Samavat S, Nicknam MH, Amirzargar A. TLR‐2, TLR‐4 and MyD88 genes expression in renal transplant acute and chronic rejections. Int J Immunogenet 2019;46:427-36. [DOI: 10.1111/iji.12446] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
42 Sánchez-Fructuoso AI, Pérez-Flores I, Valero R, Moreno MA, Fernandez-Arquero M, Urcelay E, Fernández-Pérez C, Santiago JL. The Polymorphism -308G/A of Tumor Necrosis Factor-α Gene Modulates the Effect of Immunosuppressive Treatment in First Kidney Transplant Subjects Who Suffer an Acute Rejection. J Immunol Res 2016;2016:2197595. [PMID: 27777962 DOI: 10.1155/2016/2197595] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
43 de Graav GN, Dieterich M, Hesselink DA, Boer K, Clahsen-van Groningen MC, Kraaijeveld R, Litjens NH, Bouamar R, Vanderlocht J, Tilanus M, Houba I, Boonstra A, Roelen DL, Claas FH, Betjes MG, Weimar W, Baan CC. Follicular T helper cells and humoral reactivity in kidney transplant patients. Clin Exp Immunol 2015;180:329-40. [PMID: 25557528 DOI: 10.1111/cei.12576] [Cited by in Crossref: 73] [Cited by in F6Publishing: 71] [Article Influence: 10.4] [Reference Citation Analysis]
44 Loupy A, Vernerey D, Tinel C, Aubert O, Duong van Huyen JP, Rabant M, Verine J, Nochy D, Empana JP, Martinez F, Glotz D, Jouven X, Legendre C, Lefaucheur C. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts. J Am Soc Nephrol 2015;26:1721-31. [PMID: 25556173 DOI: 10.1681/ASN.2014040399] [Cited by in Crossref: 177] [Cited by in F6Publishing: 67] [Article Influence: 25.3] [Reference Citation Analysis]
45 Kwun J, Page E, Hong JJ, Gibby A, Yoon J, Farris AB, Villinger F, Knechtle S. Neutralizing BAFF/APRIL with atacicept prevents early DSA formation and AMR development in T cell depletion induced nonhuman primate AMR model. Am J Transplant 2015;15:815-22. [PMID: 25675879 DOI: 10.1111/ajt.13045] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 6.1] [Reference Citation Analysis]
46 Giannis D, Moris D, Cendales LC. Costimulation Blockade in Vascularized Composite Allotransplantation. Front Immunol 2020;11:544186. [PMID: 33042138 DOI: 10.3389/fimmu.2020.544186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Cherukuri A, Salama AD, Mehta R, Mohib K, Zheng L, Magee C, Harber M, Stauss H, Baker RJ, Tevar A, Landsittel D, Lakkis FG, Hariharan S, Rothstein DM. Transitional B cell cytokines predict renal allograft outcomes. Sci Transl Med 2021;13:eabe4929. [PMID: 33627487 DOI: 10.1126/scitranslmed.abe4929] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
48 Wallace WD, Weigt SS, Farver CF. Update on pathology of antibody-mediated rejection in the lung allograft. Current Opinion in Organ Transplantation 2014;19:303-8. [DOI: 10.1097/mot.0000000000000079] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
49 Brakemeier S, Kannenkeril D, Dürr M, Braun T, Bachmann F, Schmidt D, Wiesener M, Budde K. Experience with belatacept rescue therapy in kidney transplant recipients. Transpl Int 2016;29:1184-95. [PMID: 27514317 DOI: 10.1111/tri.12822] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
50 Reeve J, Chang J, Salazar IDR, Lopez MM, Halloran PF. Using Molecular Phenotyping to Guide Improvements in the Histologic Diagnosis of T Cell-Mediated Rejection: Improved Diagnosis of T Cell-Mediated Rejection. Am J Transplant 2016;16:1183-92. [DOI: 10.1111/ajt.13572] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
51 Fischman C, Fribourg M, Fabrizio G, Cioni M, Comoli P, Nocera A, Cardillo M, Cantarelli C, Gallon L, Petrosyan A, Da Sacco S, Perin L, Cravedi P. Circulating B Cells With Memory and Antibody-Secreting Phenotypes Are Detectable in Pediatric Kidney Transplant Recipients Before the Development of Antibody-Mediated Rejection. Transplant Direct 2019;5:e481. [PMID: 31579809 DOI: 10.1097/TXD.0000000000000914] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
52 Böhmig GA, Kikic Z, Wahrmann M, Eskandary F, Aliabadi AZ, Zlabinger GJ, Regele H, Feucht HE. Detection of alloantibody-mediated complement activation: A diagnostic advance in monitoring kidney transplant rejection? Clin Biochem 2016;49:394-403. [PMID: 26118475 DOI: 10.1016/j.clinbiochem.2015.05.024] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
53 Carey BS, Boswijk K, Mabrok M, Rowe PA, Connor A, Saif I, Poles A. A reliable method for avoiding false negative results with Luminex single antigen beads; evidence of the prozone effect. Transpl Immunol 2016;37:23-7. [PMID: 27109036 DOI: 10.1016/j.trim.2016.04.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
54 Bettinotti MP, Zachary AA, Leffell MS. Clinically relevant interpretation of solid phase assays for HLA antibody. Curr Opin Organ Transplant 2016;21:453-8. [PMID: 27200498 DOI: 10.1097/MOT.0000000000000326] [Cited by in Crossref: 17] [Cited by in F6Publishing: 1] [Article Influence: 3.4] [Reference Citation Analysis]
55 Mincham CM, Gibson IW, Sharma A, Wiebe C, Mandal R, Rush D, Nickerson P, Ho J, Wishart DS, Blydt-Hansen TD. Evolution of renal function and urinary biomarker indicators of inflammation on serial kidney biopsies in pediatric kidney transplant recipients with and without rejection. Pediatr Transplant 2018;22:e13202. [PMID: 29696778 DOI: 10.1111/petr.13202] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
56 Caillard S, Becmeur C, Gautier-vargas G, Olagne J, Muller C, Cognard N, Perrin P, Braun L, Heibel F, Lefebre F, Renner V, Gachet C, Moulin B, Parissiadis A. Pre-existing donor-specific antibodies are detrimental to kidney allograft only when persistent after transplantation. Transpl Int 2017;30:29-40. [DOI: 10.1111/tri.12864] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
57 Sahutoglu T, Akgul S, Caliskan Y, Yazici H, Demir E, Kara E, Temurhan S, Savran F, Turkmen A. Tac-MMF Versus CsA-MMF/CsA-AZA–Based Regimens in Development of De Novo Complement-Binding Anti-HLA Antibodies After Kidney Transplantation. Transplantation Proceedings 2017;49:454-9. [DOI: 10.1016/j.transproceed.2017.01.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
58 Vo AA, Sinha A, Haas M, Choi J, Mirocha J, Kahwaji J, Peng A, Villicana R, Jordan SC. Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization. Transplantation 2015;99:1423-30. [PMID: 25606792 DOI: 10.1097/TP.0000000000000525] [Cited by in Crossref: 49] [Cited by in F6Publishing: 18] [Article Influence: 8.2] [Reference Citation Analysis]
59 Treat E, Baskin A, Lin A, Cohen N, Del Rosario C, Gritsch HA. Use of Polyethylene Glycol Electrolyte Solution Expedites Return of Bowel Function and Facilitates Early Discharge after Kidney Transplantation. J Am Coll Surg 2016;222:798-804. [PMID: 27016901 DOI: 10.1016/j.jamcollsurg.2016.01.058] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
60 Jouve T, Rostaing L, Malvezzi P. New formulations of tacrolimus and prevention of acute and chronic rejections in adult kidney-transplant recipients. Expert Opinion on Drug Safety 2017;16:845-55. [DOI: 10.1080/14740338.2017.1328051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
61 Gandolfini I, Crespo E, Baweja M, Jarque M, Donadei C, Luque S, Montero N, Allesina A, Perin L, Maggiore U, Cravedi P, Bestard O. Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation. PLoS One 2018;13:e0200696. [PMID: 30059561 DOI: 10.1371/journal.pone.0200696] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
62 Jadoul A, Lovinfosse P, Weekers L, Delanaye P, Krzesinski JM, Hustinx R, Jouret F. The Uptake of 18F-FDG by Renal Allograft in Kidney Transplant Recipients Is Not Influenced by Renal Function. Clin Nucl Med 2016;41:683-7. [PMID: 27405040 DOI: 10.1097/RLU.0000000000001298] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
63 Toyoda M, Shin BH, Ge S, Mirocha J, Thomas D, Chu M, Rodriguez E, Chao C, Petrosyan A, Galera OA, Vo A, Choi J, Peng A, Kahwaji J, Jordan SC. Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients. J Immunol Res 2017;2017:5672523. [PMID: 28265581 DOI: 10.1155/2017/5672523] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
64 Lamarche C, Orio J, Collette S, Senécal L, Hébert MJ, Renoult É, Tibbles LA, Delisle JS. BK Polyomavirus and the Transplanted Kidney: Immunopathology and Therapeutic Approaches. Transplantation 2016;100:2276-87. [PMID: 27391196 DOI: 10.1097/TP.0000000000001333] [Cited by in Crossref: 50] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
65 Maier M, Takano T, Sapir-Pichhadze R. Changing Paradigms in the Management of Rejection in Kidney Transplantation: Evolving From Protocol-Based Care to the Era of P4 Medicine. Can J Kidney Health Dis 2017;4:2054358116688227. [PMID: 28270929 DOI: 10.1177/2054358116688227] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
66 Bachelet T, Nodimar C, Taupin JL, Lepreux S, Moreau K, Morel D, Guidicelli G, Couzi L, Merville P. Intravenous immunoglobulins and rituximab therapy for severe transplant glomerulopathy in chronic antibody-mediated rejection: a pilot study. Clin Transplant 2015;29:439-46. [PMID: 25739833 DOI: 10.1111/ctr.12535] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
67 Garg N, Samaniego MD, Clark D, Djamali A. Defining the phenotype of antibody-mediated rejection in kidney transplantation: Advances in diagnosis of antibody injury. Transplant Rev (Orlando) 2017;31:257-67. [PMID: 28882367 DOI: 10.1016/j.trre.2017.08.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
68 Lee JY, Song SH, Kim YS, Lim BJ, Kim SI, Kim MS, Jeong HJ. Tubuloreticular inclusions in peritubular capillaries of renal allografts. Pathology - Research and Practice 2017;213:1185-90. [DOI: 10.1016/j.prp.2017.06.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
69 Fischer S, Lee TC, Krezdorn N, Alhefzi M, Kueckelhaus M, Bueno EM, Pomahac B. First Lower Two-Thirds Osteomyocutaneous Facial Allograft Perfused by a Unilateral Facial Artery: Outcomes and Vascularization at 1 Year after Transplantation. Plastic and Reconstructive Surgery 2017;139:1175e-83e. [DOI: 10.1097/prs.0000000000003288] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 2.2] [Reference Citation Analysis]
70 Memarnejadian A, Meilleur CE, Mazzuca DM, Welch ID, Haeryfar SM. Quantification of Alloantibody-Mediated Cytotoxicity In Vivo. Transplantation 2016;100:1041-51. [PMID: 26985743 DOI: 10.1097/TP.0000000000001154] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
71 Odum JD, Kats A, VanSickle JS, Chadha V, Brewer B, Staggs VS, Warady BA. Characterizing the frequency of modifiable histological changes observed on surveillance biopsies in pediatric kidney allograft recipients. Pediatr Nephrol 2020;35:2173-82. [PMID: 32556543 DOI: 10.1007/s00467-020-04624-1] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Valenzuela NM, Reed EF. Antibodies to HLA Molecules Mimic Agonistic Stimulation to Trigger Vascular Cell Changes and Induce Allograft Injury. Curr Transplant Rep 2015;2:222-32. [PMID: 28344919 DOI: 10.1007/s40472-015-0065-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
73 Nakamura T, Yoshimura N, Akioka K, Shirouzu T, Kawai S, Imanishi Y, Matsuyama T, Harada S, Nobori S, Ushigome H. Clearance of Intra-graft Donor Specific Anti-HLA Antibodies in the Early Stage of Antibody-Mediated Rejection Following Rituximab and Apheresis Therapy in Renal Transplantation. Transplant Proc 2019;51:1365-70. [PMID: 31056246 DOI: 10.1016/j.transproceed.2019.01.126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
74 Lemoine M, Titeca Beauport D, Lobbedez T, Choukroun G, Hurault de Ligny B, Hazzan M, Guerrot D, Bertrand D. Risk Factors for Early Graft Failure and Death After Kidney Transplantation in Recipients Older Than 70 Years. Kidney Int Rep 2019;4:656-66. [PMID: 31080920 DOI: 10.1016/j.ekir.2019.01.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
75 Iwasaki K, Yamamoto T, Inanaga Y, Hiramitsu T, Miwa Y, Murotani K, Narumi S, Watarai Y, Katayama A, Uchida K. MiR-142-5p and miR-486-5p as biomarkers for early detection of chronic antibody-mediated rejection in kidney transplantation. Biomarkers. 2017;22:45-54. [PMID: 27323802 DOI: 10.1080/1354750x.2016.1204000] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
76 Nishida S, Hidaka Y, Toyoda M, Kinoshita K, Tanaka K, Kawabata C, Hamanoue S, Inadome A, Yokomizo H, Takeda A, Uekihara S, Yamanaga S. Factors related to suboptimal recovery of renal function after living donor nephrectomy: a retrospective study. BMC Nephrol 2019;20:403. [PMID: 31703636 DOI: 10.1186/s12882-019-1588-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
77 Varnell CD Jr, Rich KL, Zhang B, Carle AC, Pai ALH, Modi AC, Hooper DK. Predicting acute rejection in children, adolescents, and young adults with a kidney transplant by assessing barriers to taking medication. Pediatr Nephrol 2021;36:2453-61. [PMID: 33501558 DOI: 10.1007/s00467-021-04946-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Cai Q, Moore SA, Hendricks AR, Torrealba JR. Upregulation of Endothelial HLA Class II is a Marker of Antibody-Mediated Rejection in Heart Allograft Biopsies. Transplant Proc 2020;52:1192-7. [PMID: 32197864 DOI: 10.1016/j.transproceed.2020.01.049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
79 Lemerle M, Garnier AS, Planchais M, Brilland B, Subra JF, Blanchet O, Blanchard S, Croue A, Duveau A, Augusto JF. CD45RC Expression of Circulating CD8+ T Cells Predicts Acute Allograft Rejection: A Cohort Study of 128 Kidney Transplant Patients. J Clin Med 2019;8:E1147. [PMID: 31374966 DOI: 10.3390/jcm8081147] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
80 Jung HY, Kim YJ, Choi JY, Cho JH, Park SH, Kim YL, Kim HK, Huh S, Won DI, Kim CD. Increased Circulating T Lymphocytes Expressing HLA-DR in Kidney Transplant Recipients with Microcirculation Inflammation. J Korean Med Sci 2017;32:908-18. [PMID: 28480647 DOI: 10.3346/jkms.2017.32.6.908] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
81 Blydt-Hansen TD, Sharma A, Gibson IW, Wishart DS, Mandal R, Ho J, Nickerson P, Rush D. Urinary Metabolomics for Noninvasive Detection of Antibody-Mediated Rejection in Children After Kidney Transplantation. Transplantation 2017;101:2553-61. [PMID: 28121909 DOI: 10.1097/TP.0000000000001662] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 3.2] [Reference Citation Analysis]
82 Kobashigawa JA. Continuing the pursuit of heart transplant antibody-mediated rejection. J Heart Lung Transplant 2015;34:1134-5. [PMID: 26169668 DOI: 10.1016/j.healun.2015.05.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
83 Salazar ID, Merino López M, Chang J, Halloran PF. Reassessing the Significance of Intimal Arteritis in Kidney Transplant Biopsy Specimens. J Am Soc Nephrol 2015;26:3190-8. [PMID: 25918035 DOI: 10.1681/ASN.2014111064] [Cited by in Crossref: 34] [Cited by in F6Publishing: 8] [Article Influence: 4.9] [Reference Citation Analysis]
84 See SB, Aubert O, Loupy A, Veras Y, Lebreton X, Gao B, Legendre C, Anglicheau D, Zorn E. Post-Transplant Natural Antibodies Associate with Kidney Allograft Injury and Reduced Long-Term Survival. J Am Soc Nephrol 2018;29:1761-70. [PMID: 29602833 DOI: 10.1681/ASN.2017111157] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
85 Drachenberg CB, Papadimitriou JC, Chaudhry MR, Ugarte R, Mavanur M, Thomas B, Cangro C, Costa N, Ramos E, Weir MR, Haririan A. Histological Evolution of BK Virus-Associated Nephropathy: Importance of Integrating Clinical and Pathological Findings. Am J Transplant 2017;17:2078-91. [PMID: 28422412 DOI: 10.1111/ajt.14314] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 8.8] [Reference Citation Analysis]
86 Kaufman CL, Kanitakis J, Weissenbacher A, Brandacher G, Mehra MR, Amer H, Zelger BG, Zelger B, Pomahac B, McDiarmid S, Cendales L, Morelon E. Defining chronic rejection in vascularized composite allotransplantation-The American Society of Reconstructive Transplantation and International Society of Vascularized Composite Allotransplantation chronic rejection working group: 2018 American Society of Reconstructive Transplantation meeting report and white paper Research goals in defining chronic rejection in vascularized composite allotransplantation. SAGE Open Med 2020;8:2050312120940421. [PMID: 32704373 DOI: 10.1177/2050312120940421] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
87 Dürr M, Lachmann N, Zukunft B, Schmidt D, Budde K, Brakemeier S. Late Conversion to Belatacept After Kidney Transplantation: Outcome and Prognostic Factors. Transplantation Proceedings 2017;49:1747-1756.e1. [DOI: 10.1016/j.transproceed.2017.05.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
88 Garnier AS, Planchais M, Riou J, Jacquemin C, Ordonez L, Saint-André JP, Croue A, Saoudi A, Delneste Y, Devys A, Boutin I, Subra JF, Duveau A, Augusto JF. Pre-transplant CD45RC expression on blood T cells differentiates patients with cancer and rejection after kidney transplantation. PLoS One 2019;14:e0214321. [PMID: 30925186 DOI: 10.1371/journal.pone.0214321] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
89 Landsberg A, Sharma A, Gibson IW, Rush D, Wishart DS, Blydt-hansen TD. Non-invasive staging of chronic kidney allograft damage using urine metabolomic profiling. Pediatr Transplantation 2018;22:e13226. [DOI: 10.1111/petr.13226] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
90 Ma MK, Law HK, Tse KS, Chan KW, Chan GC, Yap DY, Mok MM, Kwan LP, Tang SC, Choy BY, Chan TM. Non-invasive assessment of kidney allograft fibrosis with shear wave elastography: A radiological-pathological correlation analysis. Int J Urol 2018;25:450-5. [PMID: 29444550 DOI: 10.1111/iju.13536] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
91 Yan Q, Jiang H, Wang B, Sui W, Zhou H, Zou G. Expression and Significance of RANTES and MCP-1 in Renal Tissue With Chronic Renal Allograft Dysfunction. Transplantation Proceedings 2016;48:2034-9. [DOI: 10.1016/j.transproceed.2016.05.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
92 Caliskan Y, Karahan G, Akgul SU, Mirioglu S, Ozluk Y, Yazici H, Demir E, Dirim AB, Turkmen A, Edwards J, Savran FO, Sever MS, Kiryluk K, Gharavi A, Lentine KL. LIMS1 Risk Genotype and T-Cell Mediated Rejection in Kidney Transplant Recipients. Nephrol Dial Transplant 2021:gfab168. [PMID: 33909908 DOI: 10.1093/ndt/gfab168] [Reference Citation Analysis]
93 3C Study Collaborative Group, Haynes R, Harden P, Judge P, Blackwell L, Emberson J, Landray MJ, Baigent C, Friend PJ. Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial. Lancet. 2014;384:1684-1690. [PMID: 25078310 DOI: 10.1016/s0140-6736(14)61095-3] [Cited by in Crossref: 94] [Cited by in F6Publishing: 32] [Article Influence: 11.8] [Reference Citation Analysis]
94 Adam B, Afzali B, Dominy KM, Chapman E, Gill R, Hidalgo LG, Roufosse C, Sis B, Mengel M. Multiplexed color-coded probe-based gene expression assessment for clinical molecular diagnostics in formalin-fixed paraffin-embedded human renal allograft tissue. Clin Transplant 2016;30:295-305. [DOI: 10.1111/ctr.12689] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
95 Koenig A, Mezaache S, Callemeyn J, Barba T, Mathias V, Sicard A, Charreau B, Rabeyrin M, Dijoud F, Picard C, Meas-Yedid V, Olivo-Marin JC, Morelon E, Naesens M, Dubois V, Thaunat O. Missing Self-Induced Activation of NK Cells Combines with Non-Complement-Fixing Donor-Specific Antibodies to Accelerate Kidney Transplant Loss in Chronic Antibody-Mediated Rejection. J Am Soc Nephrol 2021;32:479-94. [PMID: 33239394 DOI: 10.1681/ASN.2020040433] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
96 Tsuji T, Yanai M, Itami H, Ishii Y, Akimoto M, Fukuzawa N, Harada H, Fukasawa Y. Microvascular inflammation in early protocol biopsies of renal allografts in cases of chronic active antibody-mediated rejection. Nephrology (Carlton) 2015;20 Suppl 2:26-30. [PMID: 26031582 DOI: 10.1111/nep.12450] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
97 Gautier Vargas G, Olagne J, Parissiadis A, Joly M, Cognard N, Perrin P, Froelich N, Guntz P, Gachet C, Moulin B, Caillard S. Does a Useful Test Exist to Properly Evaluate the Pathogenicity of Donor-specific Antibodies? Lessons From a Comprehensive Analysis in a Well-studied Single-center Kidney Transplant Cohort. Transplantation 2020;104:2148-57. [PMID: 31895344 DOI: 10.1097/TP.0000000000003080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
98 Schinstock CA, Sapir-Pichhadze R, Naesens M, Batal I, Bagnasco S, Bow L, Campbell P, Clahsen-van Groningen MC, Cooper M, Cozzi E, Dadhania D, Diekmann F, Budde K, Lower F, Orandi BJ, Rowshani AT, Cornell L, Kraus E. Banff survey on antibody-mediated rejection clinical practices in kidney transplantation: Diagnostic misinterpretation has potential therapeutic implications. Am J Transplant 2019;19:123-31. [PMID: 29935060 DOI: 10.1111/ajt.14979] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
99 Tatapudi VS, Kopchaliiska D, da Gente GJ, Buenaventura OF, Singh M, Laszik Z, Adey DB, Rajalingam R. Solid-Phase C1q/C3d Fixing Readouts Correlate with High Median Fluorescence Intensity (MFI) De Novo Donor-Specific HLA Antibodies and C4d⁺ Antibody-Mediated Rejection in Kidney Transplant Recipients. Ann Transplant 2021;26:e934175. [PMID: 34848674 DOI: 10.12659/AOT.934175] [Reference Citation Analysis]
100 Bestard O, Sarwal MM. Antibody-mediated rejection in young kidney transplant recipients: the dilemma of noncompliance and insufficient immunosuppression. Pediatr Nephrol 2015;30:397-403. [DOI: 10.1007/s00467-014-3020-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
101 Langhorst C, Ganner A, Schneider J, Prager EP, Walz G, Pisarski P, Jänigen B, Zschiedrich S. Long-term Follow-up of ABO-Incompatible Kidney Transplantation in Freiburg, Germany: A Single-Center Outcome Report. Transplant Proc 2021;53:848-55. [PMID: 33041078 DOI: 10.1016/j.transproceed.2020.09.001] [Reference Citation Analysis]
102 Jackson KR, Chen J, Kraus E, Desai N, Segev DL, Alachkar N. Outcomes of cPRA 100% deceased donor kidney transplant recipients under the new Kidney Allocation System: A single-center cohort study. Am J Transplant 2020;20:2890-8. [PMID: 32342630 DOI: 10.1111/ajt.15956] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
103 Rocchetti MT, Rascio F, Castellano G, Fiorentino M, Netti GS, Spadaccino F, Ranieri E, Gallone A, Gesualdo L, Stallone G, Pontrelli P, Grandaliano G. Altered Phosphorylation of Cytoskeleton Proteins in Peripheral Blood Mononuclear Cells Characterizes Chronic Antibody-Mediated Rejection in Kidney Transplantation. Int J Mol Sci 2020;21:E6509. [PMID: 32899575 DOI: 10.3390/ijms21186509] [Reference Citation Analysis]
104 Adam B, Mengel M. Molecular nephropathology: ready for prime time? Am J Physiol Renal Physiol 2015;309:F185-8. [PMID: 26017976 DOI: 10.1152/ajprenal.00153.2015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
105 Haas M, Loupy A, Lefaucheur C, Roufosse C, Glotz D, Seron D, Nankivell BJ, Halloran PF, Colvin RB, Akalin E, Alachkar N, Bagnasco S, Bouatou Y, Becker JU, Cornell LD, Duong van Huyen JP, Gibson IW, Kraus ES, Mannon RB, Naesens M, Nickeleit V, Nickerson P, Segev DL, Singh HK, Stegall M, Randhawa P, Racusen L, Solez K, Mengel M. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am J Transplant. 2018;18:293-307. [PMID: 29243394 DOI: 10.1111/ajt.14625] [Cited by in Crossref: 463] [Cited by in F6Publishing: 426] [Article Influence: 115.8] [Reference Citation Analysis]
106 Bagnasco SM, Kraus ES. Intimal arteritis in renal allografts: new takes on an old lesion. Curr Opin Organ Transplant 2015;20:343-7. [PMID: 25944226 DOI: 10.1097/MOT.0000000000000186] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
107 Stites E, Le Quintrec M, Thurman JM. The Complement System and Antibody-Mediated Transplant Rejection. J Immunol 2015;195:5525-31. [PMID: 26637661 DOI: 10.4049/jimmunol.1501686] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
108 Okabe Y, Noguchi H, Miyamoto K, Kaku K, Tsuchimoto A, Masutani K, Nakamura M. Preformed C1q-binding Donor-specific Anti-HLA Antibodies and Graft Function After Kidney Transplantation. Transplantation Proceedings 2018;50:3460-6. [DOI: 10.1016/j.transproceed.2018.07.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
109 Sicard A, Meas-yedid V, Rabeyrin M, Koenig A, Ducreux S, Dijoud F, Hervieu V, Badet L, Morelon E, Olivo-marin JC, Dubois V, Thaunat O. Computer-assisted topological analysis of renal allograft inflammation adds to risk evaluation at diagnosis of humoral rejection. Kidney International 2017;92:214-26. [DOI: 10.1016/j.kint.2017.01.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
110 Gibier J, Hémon B, Fanchon M, Gaudelot K, Pottier N, Ringot B, Van Seuningen I, Glowacki F, Cauffiez C, Blum D, Copin M, Perrais M, Gnemmi V. Dual role of MUC1 mucin in kidney ischemia-reperfusion injury: Nephroprotector in early phase, but pro-fibrotic in late phase. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2017;1863:1336-49. [DOI: 10.1016/j.bbadis.2017.03.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
111 Dragun D, Catar R, Philippe A. Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity. Kidney Int 2016;90:280-8. [PMID: 27188505 DOI: 10.1016/j.kint.2016.03.019] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 9.2] [Reference Citation Analysis]
112 Becker LE, Morath C, Suesal C. Immune mechanisms of acute and chronic rejection. Clin Biochem 2016;49:320-3. [PMID: 26851348 DOI: 10.1016/j.clinbiochem.2016.02.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
113 Yoshiyasu N, Sato M. Chronic lung allograft dysfunction post-lung transplantation: The era of bronchiolitis obliterans syndrome and restrictive allograft syndrome. World J Transplant 2020; 10(5): 104-116 [PMID: 32864356 DOI: 10.5500/wjt.v10.i5.104] [Reference Citation Analysis]
114 Goldberg RJ, Weng FL, Kandula P. Acute and Chronic Allograft Dysfunction in Kidney Transplant Recipients. Medical Clinics of North America 2016;100:487-503. [DOI: 10.1016/j.mcna.2016.01.002] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
115 Matignon M, Aissat A, Canoui-Poitrine F, Grondin C, Pilon C, Desvaux D, Saadoun D, Barathon Q, Garrido M, Audard V. Th-17 Alloimmune Responses in Renal Allograft Biopsies From Recipients of Kidney Transplants Using Extended Criteria Donors During Acute T Cell-Mediated Rejection. Am J Transplant. 2015;15:2718-2725. [PMID: 25989263 DOI: 10.1111/ajt.13304] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
116 Halloran PF, Venner JM, Famulski KS. Comprehensive Analysis of Transcript Changes Associated With Allograft Rejection: Combining Universal and Selective Features. Am J Transplant 2017;17:1754-69. [PMID: 28101959 DOI: 10.1111/ajt.14200] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 7.4] [Reference Citation Analysis]
117 González-Molina M, Ruiz-Esteban P, Caballero A, Burgos D, Cabello M, Leon M, Fuentes L, Hernandez D. Immune response and histology of humoral rejection in kidney transplantation. Nefrologia 2016;36:354-67. [PMID: 27267916 DOI: 10.1016/j.nefro.2016.03.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
118 Sethi S, Najjar R, Peng A, Choi J, Lim K, Vo A, Jordan SC, Huang E. Outcomes of Conversion From Calcineurin Inhibitor to Belatacept-based Immunosuppression in HLA-sensitized Kidney Transplant Recipients. Transplantation 2020;104:1500-7. [DOI: 10.1097/tp.0000000000002976] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
119 Kauke T, Kneidinger N, Martin B, Dick A, Schneider C, Schramm R, Meimarakis G, Preissler G, Eickelberg O, von Dossow V, Behr J, Hatz R, Neurohr C, Winter H. Bronchiolitis obliterans syndrome due to donor-specific HLA-antibodies. Tissue Antigens 2015;86:178-85. [PMID: 26204790 DOI: 10.1111/tan.12626] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
120 Cheungpasitporn W, Kremers WK, Lorenz E, Amer H, Cosio FG, Stegall MD, Gandhi MJ, Schinstock CA. De novo donor-specific antibody following BK nephropathy: The incidence and association with antibody-mediated rejection. Clin Transplant 2018;32:e13194. [PMID: 29315820 DOI: 10.1111/ctr.13194] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
121 Madariaga ML, Michel SG, La Muraglia GM, Sekijima M, Villani V, Leonard DA, Powell HJ, Kurtz JM, Farkash EA, Colvin RB. Kidney-Induced Cardiac Allograft Tolerance in Miniature Swine is Dependent on MHC-Matching of Donor Cardiac and Renal Parenchyma. Am J Transplant. 2015;15:1580-1590. [PMID: 25824550 DOI: 10.1111/ajt.13131] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
122 Yang C, Wu S, Yang P, Shang G, Qi R, Xu M, Rong R, Zhu T, He W. Prediction of renal allograft chronic rejection using a model based on contrast-enhanced ultrasonography. Microcirculation. 2019;26:e12544. [PMID: 30887637 DOI: 10.1111/micc.12544] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
123 Rose EM, Kennedy SE, Mackie FE. Surveillance biopsies after paediatric kidney transplantation: A review. Pediatr Transplantation 2016;20:748-55. [DOI: 10.1111/petr.12733] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
124 Grupper A, Grupper A, Daly RC, Pereira NL, Hathcock MA, Kremers WK, Cosio FG, Edwards BS, Kushwaha SS. Kidney transplantation as a therapeutic option for end-stage renal disease developing after heart transplantation. J Heart Lung Transplant 2017;36:297-304. [PMID: 27642059 DOI: 10.1016/j.healun.2016.08.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
125 Haas M, Rastaldi MP, Fervenza F. The authors reply:. Kidney Int 2014;86:1059-60. [PMID: 25360501 DOI: 10.1038/ki.2014.250] [Reference Citation Analysis]
126 Einecke G, Reeve J, Halloran PF. Hyalinosis Lesions in Renal Transplant Biopsies: Time-Dependent Complexity of Interpretation. Am J Transplant 2017;17:1346-57. [PMID: 27873464 DOI: 10.1111/ajt.14136] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
127 Cornell LD, Schinstock CA, Gandhi MJ, Kremers WK, Stegall MD. Positive crossmatch kidney transplant recipients treated with eculizumab: outcomes beyond 1 year. Am J Transplant. 2015;15:1293-1302. [PMID: 25731800 DOI: 10.1111/ajt.13168] [Cited by in Crossref: 134] [Cited by in F6Publishing: 111] [Article Influence: 19.1] [Reference Citation Analysis]
128 Kim KW, Kim BM, Doh KC, Kim CD, Jeong KH, Lee SH, Yang CW, Chung BH. Clinical significance of CD161+CD4+ T cells in the development of chronic antibody-mediated rejection in kidney transplant recipients. PLoS One 2018;13:e0200631. [PMID: 30011312 DOI: 10.1371/journal.pone.0200631] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
129 Moreso F, Crespo M, Ruiz JC, Torres A, Gutierrez-Dalmau A, Osuna A, Perelló M, Pascual J, Torres IB, Redondo-Pachón D, Rodrigo E, Lopez-Hoyos M, Seron D. Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial. Am J Transplant 2018;18:927-35. [PMID: 28949089 DOI: 10.1111/ajt.14520] [Cited by in Crossref: 74] [Cited by in F6Publishing: 65] [Article Influence: 14.8] [Reference Citation Analysis]
130 Jeong HS, Kim DG, Lee ST, Huh KH, Kim YS, Jeong HJ, Lim BJ. Clinical Significance of Revised Banff Criteria in the Diagnosis of Antibody-Mediated Rejection. Transplant Proc 2019;51:1488-90. [PMID: 31053345 DOI: 10.1016/j.transproceed.2019.03.012] [Reference Citation Analysis]
131 Filippone EJ, McCue PA, Farber JL. Transplant glomerulopathy. Mod Pathol 2018;31:235-52. [PMID: 29027535 DOI: 10.1038/modpathol.2017.123] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
132 Nickerson PW. What have we learned about how to prevent and treat antibody‐mediated rejection in kidney transplantation? Am J Transplant 2020;20:12-22. [DOI: 10.1111/ajt.15859] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
133 Tatapudi VS, Montgomery RA. Pharmacologic Complement Inhibition in Clinical Transplantation. Curr Transplant Rep 2017;4:91-100. [PMID: 29214126 DOI: 10.1007/s40472-017-0148-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
134 Dale LA, Brennan C, Batal I, Morris H, Jain NG, Valeri A, Husain SA, King K, Tsapepas D, Cohen D, Mohan S. Treatment of borderline infiltrates with minimal inflammation in kidney transplant recipients has no effect on allograft or patient outcomes. Clin Transplant 2020;34:e14019. [PMID: 32573811 DOI: 10.1111/ctr.14019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
135 Chancharoenthana W, Leelahavanichkul A, Ariyanon W, Vadcharavivad S, Phumratanaprapin W. Comparative Long-Term Renal Allograft Outcomes of Recurrent Immunoglobulin A with Severe Activity in Kidney Transplant Recipients with and without Rituximab: An Observational Cohort Study. J Clin Med 2021;10:3939. [PMID: 34501386 DOI: 10.3390/jcm10173939] [Reference Citation Analysis]
136 Tavernier Q, Tinel C, Rabant M, Morin L, Anglicheau D, Pallet N. A Comparative Study of the Predictive Values of Urinary Acute Kidney Injury Markers Angiogenin and Kidney Injury Molecule 1 for the Outcomes of Kidney Allografts. Transplant Direct 2017;3:e204. [PMID: 28979926 DOI: 10.1097/TXD.0000000000000720] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
137 McGregor SM, Chon WJ, Kim L, Chang A, Meehan SM. Clinical and pathological features of kidney transplant patients with concurrent polyomavirus nephropathy and rejection-associated endarteritis. World J Transplant 2015; 5(4): 292-299 [PMID: 26722657 DOI: 10.5500/wjt.v5.i4.292] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
138 Baker RJ, Mark PB, Patel RK, Stevens KK, Palmer N. Renal association clinical practice guideline in post-operative care in the kidney transplant recipient. BMC Nephrol. 2017;18:174. [PMID: 28571571 DOI: 10.1186/s12882-017-0553-2] [Cited by in Crossref: 57] [Cited by in F6Publishing: 39] [Article Influence: 11.4] [Reference Citation Analysis]
139 Jordan SC. Donor-Specific HLA Antibody IgG Subclasses Are Associated with Phenotypes of Antibody-Mediated Rejection in Sensitized Renal Allograft Recipients. J Am Soc Nephrol 2016;27:6-8. [PMID: 26293823 DOI: 10.1681/ASN.2015060608] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
140 Sekulic M, Crary GS, Herrera Hernandez LP. BK Polyomavirus Tubulointerstitial Nephritis With Urothelial Hyperplasia in a Kidney Transplant. Am J Kidney Dis 2016;68:307-11. [PMID: 26992480 DOI: 10.1053/j.ajkd.2016.01.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
141 Sapir-pichhadze R, Tinckam K, Quach K, Logan A, Laupacis A, John R, Beyene J, Kim S. HLA-DR and -DQ Eplet Mismatches and Transplant Glomerulopathy: A Nested Case-Control Study: HLA-DR + DQ Eplet Mismatches and TG. American Journal of Transplantation 2015;15:137-48. [DOI: 10.1111/ajt.12968] [Cited by in Crossref: 84] [Cited by in F6Publishing: 77] [Article Influence: 10.5] [Reference Citation Analysis]
142 Choi BH, Han DJ. Ongoing higher infection rate in ABO-incompatible kidney transplant recipient: is it a serious problem? A single-center experience. Ann Surg Treat Res 2016;91:37-44. [PMID: 27433463 DOI: 10.4174/astr.2016.91.1.37] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
143 Baek JH, Zeng R, Weinmann-Menke J, Valerius MT, Wada Y, Ajay AK, Colonna M, Kelley VR. IL-34 mediates acute kidney injury and worsens subsequent chronic kidney disease. J Clin Invest 2015;125:3198-214. [PMID: 26121749 DOI: 10.1172/JCI81166] [Cited by in Crossref: 72] [Cited by in F6Publishing: 43] [Article Influence: 10.3] [Reference Citation Analysis]
144 Crespo E, Cravedi P, Martorell J, Luque S, Melilli E, Cruzado JM, Jarque M, Meneghini M, Manonelles A, Donadei C, Lloberas N, Gomà M, Grinyó JM, Heeger P, Bestard O. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients. Kidney Int 2017;92:201-13. [PMID: 28274484 DOI: 10.1016/j.kint.2016.12.024] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
145 Banham GD, Clatworthy MR. B-cell biomarkers in transplantation - from genes to therapy: B-cell biomarkers in transplantation. Tissue Antigens 2015;85:82-92. [DOI: 10.1111/tan.12520] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
146 Kitamura M, Hisano S, Kurobe Y, Abe S, Ota Y, Sawayama Y, Uramatsu T, Obata Y, Fukuoka J, Miyazaki Y, Mukae H, Nishino T. Membranous Nephropathy with Crescent after Hematopoietic Cell Transplantation. Intern Med 2019;58:91-6. [PMID: 30146584 DOI: 10.2169/internalmedicine.1251-18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
147 Hisadome Y, Noguchi H, Nakafusa Y, Sakihama K, Mei T, Kaku K, Okabe Y, Masutani K, Ohara Y, Ikeda K, Oda Y, Nakamura M. Association of Pretransplant BK Polyomavirus Antibody Status with BK Polyomavirus Infection After Kidney Transplantation: A Prospective Cohort Pilot Study of 47 Transplant Recipients. Transplant Proc 2020;52:1762-8. [PMID: 32611487 DOI: 10.1016/j.transproceed.2020.01.164] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
148 Abuzeineh M, Aala A, Alasfar S, Alachkar N. Angiotensin II receptor 1 antibodies associate with post-transplant focal segmental glomerulosclerosis and proteinuria. BMC Nephrol 2020;21:253. [PMID: 32615995 DOI: 10.1186/s12882-020-01910-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
149 Go H, Shin S, Kim YH, Han DJ, Cho YM. Refinement of the criteria for ultrastructural peritubular capillary basement membrane multilayering in the diagnosis of chronic active/acute antibody-mediated rejection. Transpl Int 2017;30:398-409. [PMID: 28109026 DOI: 10.1111/tri.12921] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
150 Heigl T, Saez-Gimenez B, Van Herck A, Kaes J, Sacreas A, Beeckmans H, Ambrocio GPL, Kwakkel-Van Erp H, Ordies S, Vanstapel A, Verleden SE, Neyrinck AP, Ceulemans LJ, Van Raemdonck DE, Verbeken E, Verleden GM, Vos R, Vanaudenaerde B. Free Airway C4d after Lung Transplantation - A Quantitative Analysis of Bronchoalveolar Lavage Fluid. Transpl Immunol 2021;64:101352. [PMID: 33217540 DOI: 10.1016/j.trim.2020.101352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
151 Gupta G, Raynaud M, Kumar D, Sanghi P, Chang J, Kimball P, Kang L, Levy M, Sharma A, Bhati CS, Kamal L, Yakubu I, Massey HD, Kidd C, King AL, Halloran PF. Impact of belatacept conversion on kidney transplant function, histology, and gene expression - a single-center study. Transpl Int 2020;33:1458-71. [PMID: 32790889 DOI: 10.1111/tri.13718] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
152 Jung HY, Kim SH, Seo MY, Cho SY, Yang Y, Choi JY, Cho JH, Park SH, Kim YL, Kim HK, Huh S, Won DI, Kim CD. Characteristics and Clinical Significance of De Novo Donor-Specific Anti-HLA Antibodies after Kidney Transplantation. J Korean Med Sci 2018;33:e217. [PMID: 30127706 DOI: 10.3346/jkms.2018.33.e217] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
153 Solis M, Velay A, Gantner P, Bausson J, Filipputtu A, Freitag R, Moulin B, Caillard S, Fafi-Kremer S. Torquetenovirus viremia for early prediction of graft rejection after kidney transplantation. J Infect. 2019;79:56-60. [PMID: 31100359 DOI: 10.1016/j.jinf.2019.05.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
154 Sullivan HC, Gebel HM, Bray RA. Understanding solid-phase HLA antibody assays and the value of MFI. Human Immunology 2017;78:471-80. [DOI: 10.1016/j.humimm.2017.05.007] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 7.2] [Reference Citation Analysis]
155 Hammond MEH, Revelo MP, Miller DV, Snow GL, Budge D, Stehlik J, Molina KM, Selzman CH, Drakos SG, Rami A. A, Nativi-nicolau JN, Reid BB, Kfoury AG. ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis. The Journal of Heart and Lung Transplantation 2016;35:320-5. [DOI: 10.1016/j.healun.2015.10.035] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
156 Yakubu I, Ravichandran B, Sparkes T, Barth RN, Haririan A, Masters B. Comparison of Alemtuzumab Versus Basiliximab Induction Therapy in Elderly Kidney Transplant Recipients: A Single-Center Experience. J Pharm Pract 2021;34:199-206. [PMID: 31315501 DOI: 10.1177/0897190019850934] [Reference Citation Analysis]
157 Hueper K, Khalifa AA, Bräsen JH, Vo Chieu VD, Gutberlet M, Wintterle S, Lehner F, Richter N, Peperhove M, Tewes S. Diffusion-Weighted imaging and diffusion tensor imaging detect delayed graft function and correlate with allograft fibrosis in patients early after kidney transplantation. J Magn Reson Imaging. 2016;44:112-121. [PMID: 26778459 DOI: 10.1002/jmri.25158] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 9.7] [Reference Citation Analysis]
158 Utrero-Rico A, Laguna-Goya R, Cano-Romero F, Chivite-Lacaba M, Gonzalez-Cuadrado C, Rodríguez-Sánchez E, Ruiz-Hurtado G, Serrano A, Fernández-Ruiz M, Justo I, González E, Andrés A, Paz-Artal E. Early Posttransplant Mobilization of Monocytic Myeloid-derived Suppressor Cell Correlates With Increase in Soluble Immunosuppressive Factors and Predicts Cancer in Kidney Recipients. Transplantation 2020;104:2599-608. [PMID: 32068661 DOI: 10.1097/TP.0000000000003179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
159 Messner F, Etra JW, Shores JT, Thoburn CJ, Hackl H, Iglesias Lozano M, Fidder SAJ, Guo Y, Kambarashvili K, Alagol K, Kalsi R, Beck SE, Cooney C, Furtmüller GJ, Krapf J, Oh BC, Brandacher G. Noninvasive evaluation of intragraft immune responses in upper extremity transplantation. Transpl Int 2021;34:894-905. [PMID: 33626223 DOI: 10.1111/tri.13854] [Reference Citation Analysis]
160 Grupper A, Grupper A, Daly RC, Pereira NL, Hathcock MA, Kremers WK, Cosio FG, Edwards BS, Kushwaha SS. Renal Allograft Outcome After Simultaneous Heart and Kidney Transplantation. The American Journal of Cardiology 2017;120:494-9. [DOI: 10.1016/j.amjcard.2017.05.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
161 Zeevi A. Chronic antibody-mediated rejection: new diagnostic tools - clinical significance of C4d deposition and improved detection and characterization of human leucocyte antigen antibodies. Clin Exp Immunol 2014;178 Suppl 1:52-3. [PMID: 25546760 DOI: 10.1111/cei.12509] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
162 Kuo HH, Fan R, Dvorina N, Chiesa-Vottero A, Baldwin WM 3rd. Platelets in early antibody-mediated rejection of renal transplants. J Am Soc Nephrol 2015;26:855-63. [PMID: 25145937 DOI: 10.1681/ASN.2013121289] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
163 Naesens M, Anglicheau D. Precision Transplant Medicine: Biomarkers to the Rescue. J Am Soc Nephrol 2018;29:24-34. [PMID: 28993504 DOI: 10.1681/ASN.2017010004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 17] [Article Influence: 6.8] [Reference Citation Analysis]
164 Smith RN. In-silico performance, validation, and modeling of the Nanostring Banff Human Organ transplant gene panel using archival data from human kidney transplants. BMC Med Genomics 2021;14:86. [PMID: 33740956 DOI: 10.1186/s12920-021-00891-5] [Reference Citation Analysis]
165 Townamchai N, Eiam-Ong S. Biomarkers in kidney transplantation: From bench to bedside. World J Nephrol 2015; 4(5): 487-491 [PMID: 26558185 DOI: 10.5527/wjn.v4.i5.487] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
166 Sánchez-escuredo A, Oppenheimer F, Solé M, Revuelta I, Cid J, Lozano M, Blasco M, Esforzado N, Ricart MJ, Cofán F, Torregrosa JV, Paredes D, Musquera M, Ercilla G, Campistol JM, Diekmann F. Borderline rejection in ABO-incompatible kidney transplantation. Clin Transplant 2016;30:872-9. [DOI: 10.1111/ctr.12759] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
167 Willicombe M, Moss J, Moran L, Brookes P, Santos-Nunez E, McLean AG, Cairns T, Taube D, Cook TH, Roufosse C. Tubuloreticular Inclusions in Renal Allografts Associate with Viral Infections and Donor-Specific Antibodies. J Am Soc Nephrol 2016;27:2188-95. [PMID: 26614383 DOI: 10.1681/ASN.2015050478] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
168 Lemke A, Noriega M, Röske AM, Kemper MJ, Nashan B, Falk CS, Koch M. Rat renal transplant model for mixed acute humoral and cellular rejection: Weak correlation of serum cytokines/chemokines with intragraft changes. Transplant Immunology 2015;33:95-102. [DOI: 10.1016/j.trim.2015.08.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
169 Papp G, Boros P, Nakken B, Szodoray P, Zeher M. Regulatory immune cells and functions in autoimmunity and transplantation immunology. Autoimmunity Reviews 2017;16:435-44. [DOI: 10.1016/j.autrev.2017.03.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
170 Legendre C, Sberro-Soussan R, Zuber J, Frémeaux-Bacchi V. The role of complement inhibition in kidney transplantation. Br Med Bull 2017;124:5-17. [PMID: 29069327 DOI: 10.1093/bmb/ldx037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
171 Kim YH, Kim JY, Kim DH, Ko Y, Choi JY, Shin S, Jung JH, Park SK, Kim SH, Kwon H, Han DJ. Pneumocystis pneumonia occurrence and prophylaxis duration in kidney transplant recipients according to perioperative treatment with rituximab. BMC Nephrol 2020;21:93. [PMID: 32160881 DOI: 10.1186/s12882-020-01750-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
172 Amubieya O, Ramsey A, DerHovanessian A, Fishbein GA, Lynch JP 3rd, Belperio JA, Weigt SS. Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies. Semin Respir Crit Care Med 2021;42:392-410. [PMID: 34030202 DOI: 10.1055/s-0041-1729175] [Reference Citation Analysis]
173 Aziz F, Jorgenson MR, Parajuli S, Zhong W, Hidalgo LG, Djamali A, Mandelbrot D, Odorico J, Sollinger H, Astor BC, Mohamed MA. Polyomavirus and cytomegalovirus infections are risk factors for grafts loss in simultaneous pancreas and kidney transplant. Transpl Infect Dis 2020;22:e13272. [PMID: 32112710 DOI: 10.1111/tid.13272] [Reference Citation Analysis]
174 Bischof N, Wehmeier C, Dickenmann M, Hirt-Minkowski P, Amico P, Steiger J, Naegele K, Hirsch HH, Schaub S. Revisiting cytomegalovirus serostatus and replication as risk factors for inferior long-term outcomes in the current era of renal transplantation. Nephrol Dial Transplant 2020;35:346-56. [PMID: 31943075 DOI: 10.1093/ndt/gfz268] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
175 Vonbrunn E, Ries T, Söllner S, Müller-Deile J, Büttner-Herold M, Amann K, Daniel C. Multiplex gene analysis reveals T-cell and antibody-mediated rejection-specific upregulation of complement in renal transplants. Sci Rep 2021;11:15464. [PMID: 34326417 DOI: 10.1038/s41598-021-94954-3] [Reference Citation Analysis]
176 Schinstock CA, Gandhi M, Cheungpasitporn W, Mitema D, Prieto M, Dean P, Cornell L, Cosio F, Stegall M. Kidney Transplant With Low Levels of DSA or Low Positive B-Flow Crossmatch: An Underappreciated Option for Highly Sensitized Transplant Candidates. Transplantation 2017;101:2429-39. [PMID: 28009780 DOI: 10.1097/TP.0000000000001619] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 6.8] [Reference Citation Analysis]
177 Sicard A, Kanitakis J, Dubois V, Morelon E, Thaunat O. Humoral Alloreactivity in VCA Recipients: Should We Learn From Our Experience? Transplantation 2020;104:2003-10. [PMID: 32039965 DOI: 10.1097/TP.0000000000003164] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
178 Panzer SE, Wilson NA, Verhoven BM, Xiang D, Rubinstein CD, Redfield RR, Zhong W, Reese SR. Complete B Cell Deficiency Reduces Allograft Inflammation and Intragraft Macrophages in a Rat Kidney Transplant Model. Transplantation 2018;102:396-405. [PMID: 29215459 DOI: 10.1097/TP.0000000000002010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
179 Eskandary F, Bond G, Kozakowski N, Regele H, Marinova L, Wahrmann M, Kikić Ž, Haslacher H, Rasoul-Rockenschaub S, Kaltenecker CC, König F, Hidalgo LG, Oberbauer R, Halloran PF, Böhmig GA. Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study. Transplantation 2017;101:631-41. [PMID: 27120452 DOI: 10.1097/TP.0000000000001195] [Cited by in Crossref: 40] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
180 Turolo S, Edefonti A, Ghio L, Testa S, Morello W, Montini G. CYP and SXR gene polymorphisms influence in opposite ways acute rejection rate in pediatric patients with renal transplant. BMC Pediatr 2020;20:246. [PMID: 32450827 DOI: 10.1186/s12887-020-02152-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
181 Varnell C Jr, Harshman LA, Smith L, Liu C, Chen S, Al-Akash S, Barletta GM, Belsha C, Brakeman P, Chaudhuri A, Fadakar P, Garro R, Gluck C, Goebel J, Kershaw D, Matossian D, Nailescu C, Patel HP, Pruette C, Ranabothu S, Rodig N, Smith J, Sebestyen VanSickle J, Weng P, Danziger-Isakov L, Hooper DK, Seifert M. COVID-19 in pediatric kidney transplantation: The Improving Renal Outcomes Collaborative. Am J Transplant 2021;21:2740-8. [PMID: 33452854 DOI: 10.1111/ajt.16501] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
182 Zhan P, Li H, Han M, Wang Z, Zhao J, Tu J, Shi X, Fu Y. PSMP Is Discriminative for Chronic Active Antibody-Mediated Rejection and Associate With Intimal Arteritis in Kidney Transplantation. Front Immunol 2021;12:661911. [PMID: 33897709 DOI: 10.3389/fimmu.2021.661911] [Reference Citation Analysis]
183 Torres IB, Salcedo M, Moreso F, Sellarés J, Castellá E, Azancot MA, Perelló M, Cantarell C, Serón D. Comparing transplant glomerulopathy in the absence of C4d deposition and donor-specific antibodies to chronic antibody-mediated rejection. Clin Transplant 2014;28:1148-54. [DOI: 10.1111/ctr.12433] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
184 Tsuchimoto A, Masutani K, Ueki K, Nakagawa K, Matsukuma Y, Tanaka S, Unagami K, Kakuta Y, Okumi M, Noguchi H, Kaku K, Okabe Y, Nakano T, Kitazono T, Nakamura M, Ishida H, Tanabe K; The Japan Academic Consortium of Kidney Transplantation (JACK) Investigators. Effect of renin–angiotensin system blockade on graft survival and cardiovascular disease in kidney transplant recipients: retrospective multicenter study in Japan. Clin Exp Nephrol 2020;24:369-78. [DOI: 10.1007/s10157-019-01827-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
185 Timofeeva OA. Donor-Specific HLA Antibodies as Biomarkers of Transplant Rejection. Clinics in Laboratory Medicine 2019;39:45-60. [DOI: 10.1016/j.cll.2018.10.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
186 Kawamura T, Hamasaki Y, Takahashi Y, Hashimoto J, Kubota M, Muramatu M, Itabashi Y, Hyodo Y, Ohashi Y, Aikawa A, Sakai K, Shishido S. ABO-incompatible pediatric kidney transplantation without antibody removal. Pediatr Nephrol 2020;35:95-102. [DOI: 10.1007/s00467-019-04376-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
187 Tsujita M, Kosugi T, Goto N, Futamura K, Nishihira M, Okada M, Hiramitsu T, Narumi S, Uchida K, Takeda A, Morozumi K, Maruyama S, Watarai Y. The effect of maintaining high hemoglobin levels on long-term kidney function in kidney transplant recipients: a randomized controlled trial. Nephrol Dial Transplant 2019;34:1409-16. [PMID: 30561729 DOI: 10.1093/ndt/gfy365] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
188 Rabant M, Boullenger F, Gnemmi V, Pellé G, Glowacki F, Hertig A, Brocheriou I, Suberbielle C, Taupin JL, Anglicheau D, Legendre C, Duong Van Huyen JP, Buob D. Isolated v-lesion in kidney transplant recipients: Characteristics, association with DSA, and histological follow-up. Am J Transplant 2018;18:972-81. [PMID: 29206350 DOI: 10.1111/ajt.14617] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
189 Loupy A, Lefaucheur C, Vernerey D, Chang J, Hidalgo LG, Beuscart T, Verine J, Aubert O, Dubleumortier S, Duong van Huyen JP, Jouven X, Glotz D, Legendre C, Halloran PF. Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection. J Am Soc Nephrol 2014;25:2267-77. [PMID: 24700874 DOI: 10.1681/ASN.2013111149] [Cited by in Crossref: 92] [Cited by in F6Publishing: 40] [Article Influence: 11.5] [Reference Citation Analysis]
190 Berglund E, Andersen Ljungdahl M, Bogdanović D, Berglund D, Wadström J, Kowalski J, Brandacher G, Kamińska D, Kaufman CL, Talbot SG, Azari K, Landin L, Höhnke C, Dwyer KM, Cavadas PC, Thione A, Clarke B, Kay S, Wilks D, Iyer S, Iglesias M, Özkan Ö, Özkan Ö, Krapf J, Weissenbacher A, Petruzzo P, Schneeberger S. Clinical Significance of Alloantibodies in Hand Transplantation: A Multicenter Study. Transplantation 2019;103:2173-82. [DOI: 10.1097/tp.0000000000002650] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
191 Cosio FG, El Ters M, Cornell LD, Schinstock CA, Stegall MD. Changing Kidney Allograft Histology Early Posttransplant: Prognostic Implications of 1‐Year Protocol Biopsies. American Journal of Transplantation 2015;16:194-203. [DOI: 10.1111/ajt.13423] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
192 Grodsky JD, Craver RD, Ashoor IF. Early identification of transplant glomerulopathy in pediatric kidney transplant biopsies: A single-center experience with electron microscopy analysis. Pediatr Transplant 2019;23:e13459. [PMID: 31062922 DOI: 10.1111/petr.13459] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
193 Marx D, Metzger J, Olagne J, Belczacka I, Faguer S, Colombat M, Husi H, Mullen W, Gwinner W, Caillard S. Proteomics in Kidney Allograft Transplantation—Application of Molecular Pathway Analysis for Kidney Allograft Disease Phenotypic Biomarker Selection. Prot Clin Appl 2019;13:1800091. [DOI: 10.1002/prca.201800091] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
194 Naesens M, Lerut E, Emonds MP, Herelixka A, Evenepoel P, Claes K, Bammens B, Sprangers B, Meijers B, Jochmans I, Monbaliu D, Pirenne J, Kuypers DR. Proteinuria as a Noninvasive Marker for Renal Allograft Histology and Failure: An Observational Cohort Study. J Am Soc Nephrol 2016;27:281-92. [PMID: 26152270 DOI: 10.1681/ASN.2015010062] [Cited by in Crossref: 36] [Cited by in F6Publishing: 19] [Article Influence: 5.1] [Reference Citation Analysis]
195 Kakuta Y, Okumi M, Kanzawa T, Unagami K, Iizuka J, Takagi T, Ishida H, Tanabe K. Impact of donor‐related arteriosclerosis in pretransplant biopsy on long‐term outcome of living‐kidney transplantation: A propensity score‐matched cohort study. Int J Urol 2020;27:423-30. [DOI: 10.1111/iju.14212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
196 Morelon E, Petruzzo P, Kanitakis J. Chronic rejection in vascularized composite allotransplantation. Current Opinion in Organ Transplantation 2018;23:582-91. [DOI: 10.1097/mot.0000000000000571] [Cited by in Crossref: 22] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
197 Zschiedrich S, Jänigen B, Dimova D, Neumann A, Seidl M, Hils S, Geyer M, Emmerich F, Kirste G, Drognitz O, Hopt UT, Walz G, Huber TB, Pisarski P, Kramer-zucker A. One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience. Nephrol Dial Transplant 2016;31:663-71. [DOI: 10.1093/ndt/gfv388] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
198 Liao J, Fu Q, Chen W, Li J, Zhang W, Zhang H, Gao Y, Yang S, Xu B, Huang H, Wang J, Li X, Liu L, Wang C. Plasma Soluble CD146 as a Potential Diagnostic Marker of Acute Rejection in Kidney Transplantation. Front Med (Lausanne) 2020;7:531999. [PMID: 33330520 DOI: 10.3389/fmed.2020.531999] [Reference Citation Analysis]
199 Burghuber CK, Manook M, Ezekian B, Gibby AC, Leopardi FV, Song M, Jenks J, Saccoccio F, Permar S, Farris AB, Iwakoshi NN, Kwun J, Knechtle SJ. Dual targeting: Combining costimulation blockade and bortezomib to permit kidney transplantation in sensitized recipients. Am J Transplant 2019;19:724-36. [PMID: 30102844 DOI: 10.1111/ajt.15067] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 8.3] [Reference Citation Analysis]
200 Eskandary F, Jilma B, Mühlbacher J, Wahrmann M, Regele H, Kozakowski N, Firbas C, Panicker S, Parry GC, Gilbert JC, Halloran PF, Böhmig GA. Anti-C1s monoclonal antibody BIVV009 in late antibody-mediated kidney allograft rejection-results from a first-in-patient phase 1 trial. Am J Transplant 2018;18:916-26. [DOI: 10.1111/ajt.14528] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 7.2] [Reference Citation Analysis]
201 Malheiro J, Martins LS, Tafulo S, Dias L, Fonseca I, Beirão I, Castro-henriques A, Cabrita A. Impact of de novo donor-specific anti-HLA antibodies on grafts outcomes in simultaneous pancreas-kidney transplantation. Transpl Int 2016;29:173-83. [DOI: 10.1111/tri.12687] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
202 Lopategui DM, Lerut E, Naesens M, Van Damme-Lombaerts R, Levtchenko E, Knops N. Rethinking peritubular capillary basement membrane multilayering in renal transplant pathology: a case report. Pediatr Nephrol 2017;32:697-701. [PMID: 27858192 DOI: 10.1007/s00467-016-3541-z] [Reference Citation Analysis]
203 Mengel M, Loupy A, Haas M, Roufosse C, Naesens M, Akalin E, Clahsen-van Groningen MC, Dagobert J, Demetris AJ, Duong van Huyen JP, Gueguen J, Issa F, Robin B, Rosales I, Von der Thüsen JH, Sanchez-Fueyo A, Smith RN, Wood K, Adam B, Colvin RB. Banff 2019 Meeting Report: Molecular diagnostics in solid organ transplantation-Consensus for the Banff Human Organ Transplant (B-HOT) gene panel and open source multicenter validation. Am J Transplant 2020;20:2305-17. [PMID: 32428337 DOI: 10.1111/ajt.16059] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
204 Bamoulid J, Staeck O, Halleck F, Dürr M, Paliege A, Lachmann N, Brakemeier S, Liefeldt L, Budde K. Advances in pharmacotherapy to treat kidney transplant rejection. Expert Opin Pharmacother 2015;16:1627-48. [PMID: 26159444 DOI: 10.1517/14656566.2015.1056734] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
205 Singh HK, Reisner H, Derebail VK, Kozlowski T, Nickeleit V. Polyomavirus nephropathy: quantitative urinary polyomavirus-Haufen testing accurately predicts the degree of intrarenal viral disease. Transplantation 2015;99:609-15. [PMID: 25136849 DOI: 10.1097/TP.0000000000000367] [Cited by in Crossref: 32] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
206 Chen XT, Li J, Deng RH, Yang SC, Chen YY, Chen PS, Wang ZY, Huang Y, Wang CX, Huang G. The therapeutic effect of switching from tacrolimus to low-dose cyclosporine A in renal transplant recipients with BK virus nephropathy. Biosci Rep 2019;39:BSR20182058. [PMID: 30737303 DOI: 10.1042/BSR20182058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
207 Reese PP, Aubert O, Naesens M, Huang E, Potluri V, Kuypers D, Bouquegneau A, Divard G, Raynaud M, Bouatou Y, Vo A, Glotz D, Legendre C, Lefaucheur C, Jordan S, Empana JP, Jouven X, Loupy A. Assessment of the Utility of Kidney Histology as a Basis for Discarding Organs in the United States: A Comparison of International Transplant Practices and Outcomes. J Am Soc Nephrol 2021;32:397-409. [PMID: 33323474 DOI: 10.1681/ASN.2020040464] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
208 Désy O, Béland S, Vallin P, Riopel J, Latulippe E, Wagner E, De Serres SA. Allogeneic dendritic cells stimulated with antibodies against HLA class II polarize naive T cells in a follicular helper phenotype. Sci Rep 2018;8:4025. [PMID: 29507364 DOI: 10.1038/s41598-018-22391-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
209 Mccaffrey J, Shenoy M. Acute rejection and growth outcomes in paediatric kidney allograft recipients treated with a corticosteroid minimisation immunosuppressive protocol. Pediatr Nephrol 2021;36:2463-72. [DOI: 10.1007/s00467-021-04948-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
210 Halloran PF, Chang J, Famulski K, Hidalgo LG, Salazar ID, Merino Lopez M, Matas A, Picton M, de Freitas D, Bromberg J, Serón D, Sellarés J, Einecke G, Reeve J. Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients. J Am Soc Nephrol 2015;26:1711-20. [PMID: 25377077 DOI: 10.1681/ASN.2014060588] [Cited by in Crossref: 96] [Cited by in F6Publishing: 52] [Article Influence: 12.0] [Reference Citation Analysis]
211 Pelletier RP, Balazs I, Adams P, Rajab A, Dipaola NR, Henry ML. Clinical utility of C3d binding donor-specific anti-human leukocyte antigen antibody detection by single antigen beads after kidney transplantation-a retrospective study. Transpl Int 2018;31:424-35. [DOI: 10.1111/tri.13106] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
212 Gumabay FM, Novak M, Bansal A, Mitchell M, Famure O, Kim S, Mucsi I. Pre-transplant history of mental health concerns, non-adherence, and post-transplant outcomes in kidney transplant recipients. Journal of Psychosomatic Research 2018;105:115-24. [DOI: 10.1016/j.jpsychores.2017.12.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
213 Petruzzo P, Kanitakis J, Testelin S, Pialat J, Buron F, Badet L, Thaunat O, Devauchelle B, Morelon E. Clinicopathological Findings of Chronic Rejection in a Face Grafted Patient. Transplantation 2015;99:2644-50. [DOI: 10.1097/tp.0000000000000765] [Cited by in Crossref: 67] [Cited by in F6Publishing: 16] [Article Influence: 9.6] [Reference Citation Analysis]
214 Crespo M, Heidt S, Redondo D, Pascual J. Monitoring B cell subsets and alloreactivity in kidney transplantation. Transplant Rev (Orlando) 2015;29:45-52. [PMID: 25867605 DOI: 10.1016/j.trre.2015.02.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
215 Wu K, Budde K, Schmidt D, Neumayer HH, Lehner L, Bamoulid J, Rudolph B. The inferior impact of antibody-mediated rejection on the clinical outcome of kidney allografts that develop de novo thrombotic microangiopathy. Clin Transplant. 2016;30:105-117. [PMID: 26448478 DOI: 10.1111/ctr.12645] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
216 Ashraf MI, Sarwar A, Kühl AA, Hunger E, Sattler A, Aigner F, Regele H, Sauter M, Klingel K, Schneeberger S, Resch T, Kotsch K. Natural Killer Cells Promote Kidney Graft Rejection Independently of Cyclosporine A Therapy. Front Immunol 2019;10:2279. [PMID: 31616441 DOI: 10.3389/fimmu.2019.02279] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
217 dos Santos DC, Campos EF, Saraiva Câmara NO, David DSR, Malheiros DMAC. Compartment-specific expression of natural killer cell markers in renal transplantation: immune profile in acute rejection. Transpl Int 2016;29:443-52. [DOI: 10.1111/tri.12726] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
218 Remport A, Ivanyi B, Mathe Z, Tinckam K, Mucsi I, Molnar MZ. Better understanding of transplant glomerulopathy secondary to chronic antibody-mediated rejection. Nephrol Dial Transplant 2015;30:1825-33. [PMID: 25473123 DOI: 10.1093/ndt/gfu371] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
219 Min JW, Lee H, Choi BS, Park CW, Yang CW, Kim YS, Choi YJ, Oh EJ, Chung BH. Clinical Impact of Pre-transplant Antibodies Against Angiotensin II Type I Receptor and Major Histocompatibility Complex Class I-Related Chain A in Kidney Transplant Patients. Ann Lab Med 2018;38:450-7. [PMID: 29797816 DOI: 10.3343/alm.2018.38.5.450] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
220 Hachem RR. Acute Rejection and Antibody-Mediated Rejection in Lung Transplantation. Clin Chest Med 2017;38:667-75. [PMID: 29128017 DOI: 10.1016/j.ccm.2017.07.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
221 Hooper DK, Varnell CD Jr, Rich K, Carle A, Huber J, Mostajabi F, Dahale D, Pai ALH, Goebel J, Modi AC. A Medication Adherence Promotion System to Reduce Late Kidney Allograft Rejection: A Quality Improvement Study. Am J Kidney Dis 2021:S0272-6386(21)00768-X. [PMID: 34352285 DOI: 10.1053/j.ajkd.2021.06.021] [Reference Citation Analysis]
222 Hasegawa J, Hatakeyama S, Wakai S, Omoto K, Okumi M, Tanabe K, Mieno M, Shirakawa H. Preemptive anti-cytomegalovirus therapy in high-risk (donor-positive, recipient-negative cytomegalovirus serostatus) kidney transplant recipients. Int J Infect Dis 2017;65:50-6. [PMID: 28986314 DOI: 10.1016/j.ijid.2017.09.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
223 Verghese PS, Reed RC, Lihong B, Matas AJ, Kim Y. The clinical implications of the unique glomerular complement deposition pattern in transplant glomerulopathy. J Nephrol 2018;31:157-64. [PMID: 27848227 DOI: 10.1007/s40620-016-0365-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
224 Einecke G, Bräsen JH, Hanke N, Haller H, Schwarz A. Fatal Pneumococcus Sepsis after Treatment of Late Antibody-Mediated Kidney Graft Rejection. Case Rep Nephrol 2018;2018:1415450. [PMID: 29682370 DOI: 10.1155/2018/1415450] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
225 Böhmig GA, Eskandary F, Doberer K, Halloran PF. The therapeutic challenge of late antibody-mediated kidney allograft rejection. Transpl Int 2019;32:775-88. [PMID: 30955215 DOI: 10.1111/tri.13436] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
226 Kanzelmeyer NK, Zürbig P, Mischak H, Metzger J, Fichtner A, Ruszai KH, Seemann T, Hansen M, Wygoda S, Krupka K, Tönshoff B, Melk A, Pape L. Urinary proteomics to diagnose chronic active antibody-mediated rejection in pediatric kidney transplantation - a pilot study. Transpl Int 2019;32:28-37. [DOI: 10.1111/tri.13363] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
227 Litjens N, Peeters A, Gestel JK, Klepper M, Betjes M. The FCGR3A 158 V/V-genotype is associated with decreased survival of renal allografts with chronic active antibody-mediated rejection. Sci Rep 2021;11:7903. [PMID: 33846428 DOI: 10.1038/s41598-021-86943-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
228 Schrezenmeier E, Müller M, Friedersdorff F, Khadzhynov D, Halleck F, Staeck O, Dürr M, Zhang K, Eckardt KU, Budde K, Lehner LJ. Evaluation of severity of delayed graft function in kidney transplant recipients. Nephrol Dial Transplant 2021:gfab304. [PMID: 34665258 DOI: 10.1093/ndt/gfab304] [Reference Citation Analysis]
229 Rajalingam R. The Impact of HLA Class I-Specific Killer Cell Immunoglobulin-Like Receptors on Antibody-Dependent Natural Killer Cell-Mediated Cytotoxicity and Organ Allograft Rejection. Front Immunol 2016;7:585. [PMID: 28066408 DOI: 10.3389/fimmu.2016.00585] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
230 Phillips S, Kapp M, Crowe D, Garces J, Fogo AB, Giannico GA. Endothelial activation, lymphangiogenesis, and humoral rejection of kidney transplants. Hum Pathol 2016;51:86-95. [PMID: 27067786 DOI: 10.1016/j.humpath.2015.12.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
231 Ho J, Rush DN, Krokhin O, Antonovici M, Gao A, Bestland J, Wiebe C, Hiebert B, Rigatto C, Gibson IW, Wilkins JA, Nickerson PW. Elevated Urinary Matrix Metalloproteinase-7 Detects Underlying Renal Allograft Inflammation and Injury. Transplantation 2016;100:648-54. [DOI: 10.1097/tp.0000000000000867] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
232 Gupta A, Broin PÓ, Bao Y, Pullman J, Kamal L, Ajaimy M, Lubetzky M, Colovai A, Schwartz D, de Boccardo G, Golden A, Akalin E. Clinical and molecular significance of microvascular inflammation in transplant kidney biopsies. Kidney International 2016;89:217-25. [DOI: 10.1038/ki.2015.276] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
233 Traitanon O, Mathew JM, Shetty A, Bontha SV, Maluf DG, El Kassis Y, Park SH, Han J, Ansari MJ, Leventhal JR, Mas V, Gallon L. Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen-Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate Mofetil. PLoS One 2019;14:e0216300. [PMID: 31136582 DOI: 10.1371/journal.pone.0216300] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
234 Buxeda A, Said SM, Nasr SH, Leung N, El Ters M, Cosio FG. Recurrent Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits in Kidney Allografts Treated With Anti-CD20 Antibodies. Transplantation 2019;103:1477-85. [PMID: 30747850 DOI: 10.1097/TP.0000000000002577] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
235 Mannon RB, Armstrong B, Stock PG, Mehta AK, Farris AB, Watson N, Morrison Y, Sarwal M, Sigdel T, Bridges N, Robien M, Newell KA, Larsen CP. Avoidance of CNI and steroids using belatacept-Results of the Clinical Trials in Organ Transplantation 16 trial. Am J Transplant 2020;20:3599-608. [PMID: 32558199 DOI: 10.1111/ajt.16152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
236 Wiebe C, Rush DN, Nevins TE, Birk PE, Blydt-Hansen T, Gibson IW, Goldberg A, Ho J, Karpinski M, Pochinco D, Sharma A, Storsley L, Matas AJ, Nickerson PW. Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development. J Am Soc Nephrol 2017;28:3353-62. [PMID: 28729289 DOI: 10.1681/ASN.2017030287] [Cited by in Crossref: 115] [Cited by in F6Publishing: 48] [Article Influence: 23.0] [Reference Citation Analysis]
237 Abbas K, Mubarak M, Zafar MN, Aziz T, Abbas H, Muzaffar R, Rizvi SA. Plasma cell-rich acute rejections in living-related kidney transplantation: a clinicopathological study of 50 cases. Clin Transplant 2015;29:835-41. [PMID: 26172154 DOI: 10.1111/ctr.12589] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
238 Yang B, Dieudé M, Hamelin K, Hénault-Rondeau M, Patey N, Turgeon J, Lan S, Pomerleau L, Quesnel M, Peng J, Tremblay J, Shi Y, Chan JS, Hébert MJ, Cardinal H. Anti-LG3 Antibodies Aggravate Renal Ischemia-Reperfusion Injury and Long-Term Renal Allograft Dysfunction. Am J Transplant 2016;16:3416-29. [PMID: 27172087 DOI: 10.1111/ajt.13866] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
239 Phupradit A, Vadcharavivad S, Ingsathit A, Kantachuvesiri S, Areepium N, Sra-Ium S, Auamnoy T, Sukasem C, Sumethkul V, Kitiyakara C. Impact of POR and CYP3A5 Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in the Early Post-operative Period Following Kidney Transplantation. Ther Drug Monit 2018;40:549-57. [PMID: 29878980 DOI: 10.1097/FTD.0000000000000542] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
240 Hueper K, Hensen B, Gutberlet M, Chen R, Hartung D, Barrmeyer A, Meier M, Li W, Jang MS, Mengel M, Wacker F, Rong S, Gueler F. Kidney Transplantation: Multiparametric Functional Magnetic Resonance Imaging for Assessment of Renal Allograft Pathophysiology in Mice. Invest Radiol 2016;51:58-65. [PMID: 26371534 DOI: 10.1097/RLI.0000000000000205] [Cited by in Crossref: 37] [Cited by in F6Publishing: 19] [Article Influence: 6.2] [Reference Citation Analysis]
241 Hori S, Ichikawa K, Morizawa Y, Gotoh D, Itami Y, Nakai Y, Miyake M, Yoneda T, Tanaka N, Yoshida K, Fujimoto K. Clinical Significance of Postoperative Nutritional Status as a Prognostic Factor in Kidney Transplant Recipients. Transplant Proc 2019;51:1763-72. [PMID: 31255359 DOI: 10.1016/j.transproceed.2019.04.047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
242 Nickerson PW, Balshaw R, Wiebe C, Ho J, Gibson IW, Bridges ND, Rush DN, Heeger PS. A noninferiority design for a delayed calcineurin inhibitor substitution trial in kidney transplantation. Am J Transplant 2021;21:1503-12. [PMID: 32956576 DOI: 10.1111/ajt.16311] [Reference Citation Analysis]
243 Brakemeier S, Taxeidi S, Zukunft B, Schmidt D, Gaedeke J, Dürr M, Hansen S, Budde K. Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae –Related Urinary Tract Infection in Kidney Transplant Recipients: Risk Factors, Treatment, and Long-Term Outcome. Transplantation Proceedings 2017;49:1757-65. [DOI: 10.1016/j.transproceed.2017.06.033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
244 Manook M, Flores WJ, Schmitz R, Fitch Z, Yoon J, Bae Y, Shaw B, Kirk A, Harnois M, Permar S, Farris AB, Magnani DM, Kwun J, Knechtle S. Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model. Front Immunol 2021;12:660900. [PMID: 34149698 DOI: 10.3389/fimmu.2021.660900] [Reference Citation Analysis]
245 Ali HA, Pavlisko EN, Snyder LD, Frank M, Palmer SM. Complement system in lung transplantation. Clin Transplant 2018;32:e13208. [DOI: 10.1111/ctr.13208] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
246 Visentin J, Bachelet T, Aubert O, Del Bello A, Martinez C, Jambon F, Guidicelli G, Ralazamahaleo M, Bouthemy C, Cargou M, Congy‐jolivet N, Nong T, Lee J, Sberro‐soussan R, Couzi L, Kamar N, Legendre C, Merville P, Taupin J. Reassessment of the clinical impact of preformed donor‐specific anti‐HLA‐Cw antibodies in kidney transplantation. Am J Transplant 2020;20:1365-74. [DOI: 10.1111/ajt.15766] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
247 Osako K, Yazawa M, Terashita M, Imai N, Nakazawa R, Sasaki H, Shibagaki Y. Arteriovenous fistulas after ultrasound-guided needle biopsy of kidney allografts and treatment outcomes after transcatheter embolization: A single-center experience in Japan. Clin Exp Nephrol 2020;24:963-70. [PMID: 32594374 DOI: 10.1007/s10157-020-01922-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
248 Iwami D, Hotta K, Sasaki H, Hirose T, Higuchi H, Takada Y, Shinohara N. Highly Immunogenic DQB1 Mismatch Eplets Are Associated With Development of Chronic Active Antibody-Mediated Rejection: A First Report From Japan. Transplantation Proceedings 2017;49:84-7. [DOI: 10.1016/j.transproceed.2016.10.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
249 Jamshaid F, Froghi S, Di Cocco P, Dor FJ. Novel non-invasive biomarkers diagnostic of acute rejection in renal transplant recipients: A systematic review. Int J Clin Pract. 2018;e13220. [PMID: 30011113 DOI: 10.1111/ijcp.13220] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
250 Carmona-Escamilla MA, Fonseca-Sánchez MÁ, Chávez JP, Pizando LA, Soto V, Hernández-Mendoza SA, García-Covarrubias L, Queipo G. Analyses of Programmed Cell Death Protein 1 in High Immunologic-Risk Transplant Patients. Transplant Proc 2020;52:1132-5. [PMID: 32249055 DOI: 10.1016/j.transproceed.2020.02.019] [Reference Citation Analysis]
251 Crespo M, Yelamos J, Redondo D, Muntasell A, Perez-saéz MJ, López-montañés M, García C, Torio A, Mir M, Hernández JJ, López-botet M, Pascual J. Circulating NK-Cell Subsets in Renal Allograft Recipients With Anti-HLA Donor-Specific Antibodies: NK-Cell Subsets and Donor-Specific Antibodies. American Journal of Transplantation 2015;15:806-14. [DOI: 10.1111/ajt.13010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
252 Noguchi H, Tsuchimoto A, Ueki K, Kaku K, Okabe Y, Nakamura M. One-year Outcome of Everolimus With Standard-dose Tacrolimus Immunosuppression in De Novo ABO-incompatible Living Donor Kidney Transplantation: A Retrospective, Single-center, Propensity Score Matching Comparison With Mycophenolate in 42 Transplants. Transplant Direct 2020;6:e514. [PMID: 32047842 DOI: 10.1097/TXD.0000000000000962] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
253 Weng SC, Shu KH, Wu MJ, Wen MC, Hsieh SL, Chen NJ, Tarng DC. Expression of decoy receptor 3 in kidneys is associated with allograft survival after kidney transplant rejection. Sci Rep 2015;5:12769. [PMID: 26335204 DOI: 10.1038/srep12769] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
254 Pearl MH, Nayak AB, Ettenger RB, Puliyanda D, Palma Diaz MF, Zhang Q, Reed EF, Tsai EW. Bortezomib may stabilize pediatric renal transplant recipients with antibody-mediated rejection. Pediatr Nephrol 2016;31:1341-8. [PMID: 27048228 DOI: 10.1007/s00467-016-3319-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
255 Montgomery RA, Loupy A, Segev DL. Antibody-mediated rejection: New approaches in prevention and management. Am J Transplant. 2018;18 Suppl 3:3-17. [PMID: 29292861 DOI: 10.1111/ajt.14584] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 15.3] [Reference Citation Analysis]
256 Castro-Dopico T, Clatworthy MR. Fcγ Receptors in Solid Organ Transplantation. Curr Transplant Rep 2016;3:284-93. [PMID: 27909648 DOI: 10.1007/s40472-016-0116-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
257 Sai K, Omoto K, Shimizu T, Honda K, Tanabe K. The impact of C4d-negative acute antibody-mediated rejection on short-term prognosis among kidney transplant recipients. Nephrology (Carlton) 2015;20 Suppl 2:16-9. [PMID: 26031580 DOI: 10.1111/nep.12473] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
258 Comoli P, Cioni M, Tagliamacco A, Quartuccio G, Innocente A, Fontana I, Trivelli A, Magnasco A, Nocco A, Klersy C, Rubert L, Ramondetta M, Zecca M, Garibotto G, Ghiggeri GM, Cardillo M, Nocera A, Ginevri F. Acquisition of C3d-Binding Activity by De Novo Donor-Specific HLA Antibodies Correlates With Graft Loss in Nonsensitized Pediatric Kidney Recipients. Am J Transplant 2016;16:2106-16. [PMID: 26725780 DOI: 10.1111/ajt.13700] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 11.0] [Reference Citation Analysis]
259 Landsberg A, Riazy M, Blydt-Hansen TD. Yield and utility of surveillance kidney biopsies in pediatric kidney transplant recipients at various time points post-transplant. Pediatr Transplant 2021;25:e13869. [PMID: 33073499 DOI: 10.1111/petr.13869] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
260 Aghighi M, Pisani L, Theruvath AJ, Muehe AM, Donig J, Khan R, Holdsworth SJ, Kambham N, Concepcion W, Grimm PC, Daldrup-Link HE. Ferumoxytol Is Not Retained in Kidney Allografts in Patients Undergoing Acute Rejection. Mol Imaging Biol 2018;20:139-49. [PMID: 28411307 DOI: 10.1007/s11307-017-1084-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
261 Weissenbacher A, Loupy A, Chandraker A, Schneeberger S. Donor-specific antibodies and antibody-mediated rejection in vascularized composite allotransplantation. Curr Opin Organ Transplant 2016;21:510-5. [PMID: 27517505 DOI: 10.1097/MOT.0000000000000349] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
262 Thurman JM, Panzer SE, Le Quintrec M. The role of complement in antibody mediated transplant rejection. Mol Immunol 2019;112:240-6. [PMID: 31195225 DOI: 10.1016/j.molimm.2019.06.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
263 Senev A, Coemans M, Lerut E, Van Sandt V, Daniëls L, Kuypers D, Sprangers B, Emonds M, Naesens M. Histological picture of antibody‐mediated rejection without donor‐specific anti‐HLA antibodies: Clinical presentation and implications for outcome. Am J Transplant 2019;19:763-80. [DOI: 10.1111/ajt.15074] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
264 Orandi BJ, Alachkar N, Kraus ES, Naqvi F, Lonze BE, Lees L, Van Arendonk KJ, Wickliffe C, Bagnasco SM, Zachary AA, Segev DL, Montgomery RA. Presentation and Outcomes of C4d-Negative Antibody-Mediated Rejection After Kidney Transplantation. Am J Transplant 2016;16:213-20. [PMID: 26317487 DOI: 10.1111/ajt.13434] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
265 Lehner LJ, Öllinger R, Globke B, Naik MG, Budde K, Pratschke J, Eckardt KU, Kahl A, Zhang K, Halleck F. Impact of Early Pancreatic Graft Loss on Outcome after Simultaneous Pancreas-Kidney Transplantation (SPKT)-A Landmark Analysis. J Clin Med 2021;10:3237. [PMID: 34362019 DOI: 10.3390/jcm10153237] [Reference Citation Analysis]
266 Uppin MS, Gudithi S, Taduri G, Prayaga AK, Raju SB. Expanding the antibody-mediated component of plasma cell-rich acute rejection: A case series. Indian J Nephrol 2016;26:176-81. [PMID: 27194831 DOI: 10.4103/0971-4065.159300] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
267 Tabibzadeh N, Glowacki F, Frimat M, Elsermans V, Provôt F, Lionet A, Gnemmi V, Hertig A, Noël C, Hazzan M. Long-term outcome after early cyclosporine withdrawal in kidney transplantation: ten years after. Clin Transplant 2016;30:1480-7. [DOI: 10.1111/ctr.12843] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
268 Xu-Dubois YC, Ahmadpoor P, Brocheriou I, Louis K, Arzouk Snanoudj N, Rouvier P, Taupin JL, Corchia A, Galichon P, Barrou B, Giraud S, Hauet T, Jouanneau C, Rodenas A, Placier S, Niasse A, Ouchelouche S, Naimi BY, Akil E, Hertig A, Buob D, Rondeau E. Microvasculature partial endothelial mesenchymal transition in early posttransplant biopsy with acute tubular necrosis identifies poor recovery renal allografts. Am J Transplant 2020;20:2400-12. [PMID: 32167213 DOI: 10.1111/ajt.15847] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
269 Adam BA, Gebel HM. IgE in Antibody-Mediated Rejection: A Novel Pathogenic Mechanism? Clin J Am Soc Nephrol 2020;15:1392-3. [PMID: 33028604 DOI: 10.2215/CJN.13000820] [Reference Citation Analysis]
270 Kawanishi K, Honda K, Koike J, Hattori M, Fuchinoue S, Tanabe K, Oda H, Nagashima Y. A Preliminary Study Into the Significance of Intrarenal Reflux in BK Virus Nephropathy After Kidney Transplantation. Transplant Direct 2016;2:e64. [PMID: 27500256 DOI: 10.1097/TXD.0000000000000575] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
271 Mező B, Heilos A, Böhmig GA, Eskandary F, Wahrmann M, Bond G, Kozakowski N, Halloran PF, Rusai K, Prohászka Z. Complement Markers in Blood and Urine: No Diagnostic Value in Late Silent Antibody-Mediated Rejection. Transplant Direct 2019;5:e470. [PMID: 31334344 DOI: 10.1097/TXD.0000000000000915] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
272 Racusen LC, Bagnasco SM. Peritubular capillaritis in the renal allograft takes center stage. Kidney Int 2015;88:218-20. [PMID: 26230198 DOI: 10.1038/ki.2015.99] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
273 Chen XT, Wang ZY, Huang Y, Wang JY, Yang SC, Chen WF, Chen PS, Li J, Deng RH, Huang G. Combined detection of urine specific gravity and BK viruria on prediction of BK polyomavirus nephropathy in kidney transplant recipients. Chin Med J (Engl) 2020;133:33-40. [PMID: 31923102 DOI: 10.1097/CM9.0000000000000579] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
274 Dao M, Habès D, Taupin JL, Mussini C, Redon MJ, Suberbielle C, Jacquemin E, Gonzales E, Guettier C. Morphological characterization of chronic antibody-mediated rejection in ABO-identical or ABO-compatible pediatric liver graft recipients. Liver Transpl 2018;24:897-907. [PMID: 29704327 DOI: 10.1002/lt.25187] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
275 Franzin R, Stasi A, Fiorentino M, Stallone G, Cantaluppi V, Gesualdo L, Castellano G. Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage. Front Immunol 2020;11:734. [PMID: 32457738 DOI: 10.3389/fimmu.2020.00734] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
276 Roux A, Bendib Le Lan I, Holifanjaniaina S, Thomas KA, Picard C, Grenet D, De Miranda S, Douvry B, Beaumont-Azuar L, Sage E, Devaquet J, Cuquemelle E, Le Guen M, Suberbielle C, Gautreau C, Stern M, Rossetti M, Hamid AM, Parquin F. Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung Transplantation. Front Med (Lausanne) 2017;4:155. [PMID: 29075627 DOI: 10.3389/fmed.2017.00155] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
277 Hennigar RA, Klein CL. Nephrotic Syndrome Post-Kidney Transplant. Clin J Am Soc Nephrol 2017;12:1347-50. [PMID: 28596417 DOI: 10.2215/CJN.01200117] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
278 Gupta G, Regmi A, Kumar D, Posner S, Posner MP, Sharma A, Cotterell A, Bhati CS, Kimball P, Massey HD, King AL. Safe Conversion From Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients With Allograft Dysfunction: Belatacept in Sensitized Kidney Transplant Patients. American Journal of Transplantation 2015;15:2726-31. [DOI: 10.1111/ajt.13322] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 6.7] [Reference Citation Analysis]
279 Lovinfosse P, Hustinx R. Nuclear medicine techniques in transplantation. Clin Transl Imaging 2017;5:45-62. [DOI: 10.1007/s40336-016-0216-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
280 Biglarnia AR, Huber-Lang M, Mohlin C, Ekdahl KN, Nilsson B. The multifaceted role of complement in kidney transplantation. Nat Rev Nephrol 2018;14:767-81. [PMID: 30367174 DOI: 10.1038/s41581-018-0071-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
281 Lion J, Taflin C, Cross AR, Robledo-sarmiento M, Mariotto E, Savenay A, Carmagnat M, Suberbielle C, Charron D, Haziot A, Glotz D, Mooney N. HLA Class II Antibody Activation of Endothelial Cells Promotes Th17 and Disrupts Regulatory T Lymphocyte Expansion. Am J Transplant 2016;16:1408-20. [DOI: 10.1111/ajt.13644] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
282 Xu X, Han Y, Wang Q, Cai M, Qian Y, Wang X, Huang H, Xu L, Xiao L, Shi B. Characterisation of Tertiary Lymphoid Organs in Explanted Rejected Donor Kidneys. Immunol Invest 2016;45:38-51. [PMID: 26709668 DOI: 10.3109/08820139.2015.1085394] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
283 Oblak M, Mlinšek G, Kojc N, Frelih M, Buturović-Ponikvar J, Arnol M. Spot Urine Protein Excretion in the First Year Following Kidney Transplantation Associates With Allograft Rejection Phenotype at 1-Year Surveillance Biopsies: An Observational National-Cohort Study. Front Med (Lausanne) 2021;8:781195. [PMID: 34869503 DOI: 10.3389/fmed.2021.781195] [Reference Citation Analysis]
284 Mannon RB. The Banff schema for antibody-mediated rejection: Lost in translation? Am J Transplant 2019;19:9-10. [PMID: 30040194 DOI: 10.1111/ajt.15033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
285 de Sousa MV, Gonçalez AC, de Lima Zollner R, Mazzali M. Treatment of Antibody-Mediated Rejection After Kidney Transplantation: Immunological Effects, Clinical Response, and Histological Findings. Ann Transplant 2020;25:e925488. [PMID: 33199675 DOI: 10.12659/AOT.925488] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
286 Prunotto M, Chaykovska L, Bongiovanni M, Frattini M, Cagarelli T, Weibel F, Bruschi M, de Herreros AG, Moll S. Tubular Cytoplasmic Expression of Zinc Finger Protein SNAI1 in Renal Transplant Biopsies: A Sign of Diseased Epithelial Phenotype? Am J Pathol 2017;187:55-69. [PMID: 27863213 DOI: 10.1016/j.ajpath.2016.09.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
287 Barbas AS, Lin L, McRae M, MacDonald AL, Truong T, Yang Y, Brennan TV. Heparan sulfate is a plasma biomarker of acute cellular allograft rejection. PLoS One 2018;13:e0200877. [PMID: 30086133 DOI: 10.1371/journal.pone.0200877] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
288 Nankivell BJ, PNg CH, OConnell PJ, Chapman JR. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras. Transplantation. 2016;100:1723-1731. [PMID: 27306529 DOI: 10.1097/tp.0000000000001243] [Cited by in Crossref: 85] [Cited by in F6Publishing: 37] [Article Influence: 17.0] [Reference Citation Analysis]
289 Cornell LD. Histopathologic Features of Antibody Mediated Rejection: The Banff Classification and Beyond. Front Immunol 2021;12:718122. [PMID: 34646262 DOI: 10.3389/fimmu.2021.718122] [Reference Citation Analysis]
290 Lovinfosse P, Weekers L, Bonvoisin C, Bovy C, Grosch S, Krzesinski JM, Hustinx R, Jouret F. Fluorodeoxyglucose F(18) Positron Emission Tomography Coupled With Computed Tomography in Suspected Acute Renal Allograft Rejection. Am J Transplant. 2016;16:310-316. [PMID: 26302136 DOI: 10.1111/ajt.13429] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
291 Luque S, Lúcia M, Bestard O. Refinement of humoral immune monitoring in kidney transplantation: the role of “hidden” alloreactive memory B cells. Transpl Int 2017;30:955-68. [DOI: 10.1111/tri.13014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
292 Petit L, Rabant M, Canioni D, Suberbielle-boissel C, Goulet O, Chardot C, Lacaille F. Impacts of donor-specific anti-HLA antibodies and antibody-mediated rejection on outcomes after intestinal transplantation in children. Pediatr Transplantation 2017;21:e12847. [DOI: 10.1111/petr.12847] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
293 Bouatou Y, Seyde O, Moll S, Martin PY, Villard J, Ferrari-Lacraz S, Hadaya K. Clinical and histological evolution after de novo donor-specific anti-human leukocyte antigen antibodies: a single centre retrospective study. BMC Nephrol 2018;19:86. [PMID: 29649973 DOI: 10.1186/s12882-018-0886-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
294 Parajuli S, Mandelbrot DA, Muth B, Mohamed M, Garg N, Aziz F, Redfield RR, Zhong W, Astor BC, Djamali A. Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney Transplantation. Transplant Direct 2017;3:e227. [PMID: 29536028 DOI: 10.1097/TXD.0000000000000746] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 4.4] [Reference Citation Analysis]
295 Jackson AM, Wiebe C, Hickey MJ. The role of non-HLA antibodies in solid organ transplantation: a complex deliberation. Curr Opin Organ Transplant 2020;25:536-42. [PMID: 33044346 DOI: 10.1097/MOT.0000000000000811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
296 Viglietti D, Gosset C, Loupy A, Deville L, Verine J, Zeevi A, Glotz D, Lefaucheur C. C1 Inhibitor in Acute Antibody-Mediated Rejection Nonresponsive to Conventional Therapy in Kidney Transplant Recipients: A Pilot Study. Am J Transplant 2016;16:1596-603. [PMID: 26693703 DOI: 10.1111/ajt.13663] [Cited by in Crossref: 75] [Cited by in F6Publishing: 63] [Article Influence: 12.5] [Reference Citation Analysis]
297 Traitanon O, Poggio ED, Fairchild RL. Molecular monitoring of alloimmune-mediated injury in kidney transplant patients. Curr Opin Nephrol Hypertens 2014;23:625-30. [PMID: 25202838 DOI: 10.1097/MNH.0000000000000064] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
298 Mulley WR, Huang LL, Ramessur Chandran S, Longano A, Amos LAR, Polkinghorne KR, Nikolic-paterson DJ, Kanellis J. Long-term graft survival in patients with chronic antibody-mediated rejection with persistent peritubular capillaritis treated with intravenous immunoglobulin and rituximab. Clin Transplant 2017;31:e13037. [DOI: 10.1111/ctr.13037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
299 Lei Y, Ehle B, Kumar SV, Müller S, Moll S, Malone AF, Humphreys BD, Andrassy J, Anders HJ. Cathepsin S and Protease-Activated Receptor-2 Drive Alloimmunity and Immune Regulation in Kidney Allograft Rejection. Front Cell Dev Biol 2020;8:398. [PMID: 32582696 DOI: 10.3389/fcell.2020.00398] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
300 Reischig T, Kacer M, Hes O, Machova J, Nemcova J, Lysak D, Jindra P, Pivovarcikova K, Kormunda S, Bouda M. Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy. Am J Transplant 2019;19:2457-67. [PMID: 31220412 DOI: 10.1111/ajt.15507] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
301 Kueckelhaus M, Fischer S, Seyda M, Bueno EM, Aycart MA, Alhefzi M, ElKhal A, Pomahac B, Tullius SG. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration. Transpl Int 2016;29:655-62. [PMID: 26265179 DOI: 10.1111/tri.12652] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 9.0] [Reference Citation Analysis]
302 Hoffmann U, Neudörfl C, Daemen K, Keil J, Stevanovic-Meyer M, Lehner F, Haller H, Blume C, Falk CS. NK Cells of Kidney Transplant Recipients Display an Activated Phenotype that Is Influenced by Immunosuppression and Pathological Staging. PLoS One 2015;10:e0132484. [PMID: 26147651 DOI: 10.1371/journal.pone.0132484] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
303 Sentís A, Kers J, Yapici U, Claessen N, Roelofs JJ, Bemelman FJ, Ten Berge IJ, Florquin S. The prognostic significance of glomerular infiltrating leukocytes during acute renal allograft rejection. Transpl Immunol 2015;33:168-75. [PMID: 26494157 DOI: 10.1016/j.trim.2015.10.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
304 Parkes MD, Halloran PF, Hidalgo LG. Evidence for CD16a-Mediated NK Cell Stimulation in Antibody-Mediated Kidney Transplant Rejection. Transplantation 2017;101:e102-11. [PMID: 27906829 DOI: 10.1097/TP.0000000000001586] [Cited by in Crossref: 45] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
305 Strassl R, Doberer K, Rasoul-Rockenschaub S, Herkner H, Görzer I, Kläger JP, Schmidt R, Haslacher H, Schiemann M, Eskandary FA, Kikić Ž, Reindl-Schwaighofer R, Puchhammer-Stöckl E, Böhmig GA, Bond G. Torque Teno Virus for Risk Stratification of Acute Biopsy-Proven Alloreactivity in Kidney Transplant Recipients. J Infect Dis 2019;219:1934-9. [PMID: 30668796 DOI: 10.1093/infdis/jiz039] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
306 Tamain M, Sayegh J, Lionet A, Grimbert P, Philipponnet C, Hazzan M, Augusto JF, Büchler M, Merlin E, Kosmadakis G, Tiple A, Pereira B, Garrouste C, Heng AE. Extracorporeal photopheresis for the treatment of graft rejection in 33 adult kidney transplant recipients. Transfus Apher Sci 2019;58:515-24. [PMID: 31383541 DOI: 10.1016/j.transci.2019.06.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
307 Gwinner W, Metzger J, Husi H, Marx D. Proteomics for rejection diagnosis in renal transplant patients: Where are we now? World J Transplant 2016; 6(1): 28-41 [PMID: 27011903 DOI: 10.5500/wjt.v6.i1.28] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
308 Hashimoto J, Oguchi H, Mikami T, Hamasaki Y, Muramatsu M, Yamaguchi Y, Sakai K. Clinicopathological Analysis of Medullary Ray Injury in 1-Year Protocol Paediatric Renal Allograft Biopsies. Nephron 2020;144 Suppl 1:79-85. [PMID: 33221804 DOI: 10.1159/000511917] [Reference Citation Analysis]
309 Yapici Ü, Kers J, Slavujevic-Letic I, Stokman G, Roelofs JJ, van Aalderen MC, Groothoff JW, de Boer OJ, van der Pant KA, Claessen N, Hilbrands LB, Bemelman FJ, Ten Berge IJ, Florquin S. Intragraft Blood Dendritic Cell Antigen-1-Positive Myeloid Dendritic Cells Increase during BK Polyomavirus-Associated Nephropathy. J Am Soc Nephrol 2016;27:2502-10. [PMID: 26701980 DOI: 10.1681/ASN.2015040442] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
310 Bachelet T, Visentin J, Guidicelli G, Merville P, Couzi L, Taupin J. Anti-HLA donor-specific antibodies are not created equally. Don't forget the flow…. Transpl Int 2016;29:508-10. [DOI: 10.1111/tri.12745] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
311 Liao T, Xue Y, Zhao D, Li S, Liu M, Chen J, Brand DD, Zheng H, Zhang Y, Zheng SG, Sun Q. In Vivo Attenuation of Antibody-Mediated Acute Renal Allograft Rejection by Ex Vivo TGF-β-Induced CD4+Foxp3+ Regulatory T Cells. Front Immunol 2017;8:1334. [PMID: 29085374 DOI: 10.3389/fimmu.2017.01334] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
312 Mockler C, Sharma A, Gibson IW, Gao A, Wong A, Ho J, Blydt-Hansen TD. The prognostic value of urinary chemokines at 6 months after pediatric kidney transplantation. Pediatr Transplant 2018;22:e13205. [PMID: 29733487 DOI: 10.1111/petr.13205] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
313 Cioni M, Nocera A, Tagliamacco A, Basso S, Innocente A, Fontana I, Magnasco A, Trivelli A, Klersy C, Gurrado A, Ramondetta M, Boghen S, Catenacci L, Verrina E, Garibotto G, Ghiggeri GM, Cardillo M, Ginevri F, Comoli P. Failure to remove de novo donor-specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody-mediated rejection destined to graft loss - a retrospective study. Transpl Int 2019;32:38-48. [PMID: 30076765 DOI: 10.1111/tri.13325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
314 Pineda S, Sigdel TK, Chen J, Jackson AM, Sirota M, Sarwal MM. Novel Non-Histocompatibility Antigen Mismatched Variants Improve the Ability to Predict Antibody-Mediated Rejection Risk in Kidney Transplant. Front Immunol 2017;8:1687. [PMID: 29259604 DOI: 10.3389/fimmu.2017.01687] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
315 Shiu KY, McLaughlin L, Rebollo-Mesa I, Zhao J, Burton H, Douthwaite H, Wilkinson H, Semik V, Dodd PC, Brookes P, Lechler RI, Hernandez-Fuentes MP, Kemper C, Dorling A. Graft dysfunction in chronic antibody-mediated rejection correlates with B-cell-dependent indirect antidonor alloresponses and autocrine regulation of interferon-γ production by Th1 cells. Kidney Int 2017;91:477-92. [PMID: 27988211 DOI: 10.1016/j.kint.2016.10.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
316 Li GJ, Trac J, Husain S, Famure O, Li Y, Kim SJ. Incidence, Risk Factors, and Outcomes of Clostridium difficile Infections in Kidney Transplant Recipients. Transplantation 2018;102:1576-81. [PMID: 29620613 DOI: 10.1097/TP.0000000000002199] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
317 Haas M. Uncovering the etiology of CINAC, a complex and mysterious renal syndrome: the invaluable role of histopathology and electron microscopy. Kidney Int 2020;97:258-60. [PMID: 31980074 DOI: 10.1016/j.kint.2019.10.005] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
318 Devadass CW, Vanikar AV, Nigam LK, Kanodia KV, Patel RD, Vinay KS, Patel HV. Evaluation of Renal Allograft Biopsies for Graft Dysfunction and Relevance of C4d Staining in Antibody Mediated Rejection. J Clin Diagn Res 2016;10:EC11-5. [PMID: 27134877 DOI: 10.7860/JCDR/2016/16339.7433] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
319 Sakai K, Oguchi H, Muramatsu M, Shishido S. Protocol graft biopsy in kidney transplantation: Protocol graft biopsy in kidney transplant. Nephrology 2018;23:38-44. [DOI: 10.1111/nep.13282] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
320 González-almada A, Arreola-guerra JM, López-sánchez JA, Cuevas E, Vilatoba M, Contreras AG, Morales-buenrostro LE, Alberu J, Uribe-uribe NO. Pretransplant angiotensin II type 1-receptor antibodies point to an increase in renal graft sub-intimal fibrosis in living- donor kidney transplant recipients. Transplant Immunology 2019;54:1-8. [DOI: 10.1016/j.trim.2018.10.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
321 Nakada Y, Yamamoto I, Horita S, Kobayashi A, Mafune A, Katsumata H, Yamakawa T, Katsuma A, Kawabe M, Tanno Y, Ohkido I, Tsuboi N, Yamamoto H, Okumi M, Ishida H, Yokoo T, Tanabe K; Japan Academic Consortium of Kidney Transplantation (JACK). The prognostic values of caveolin-1 immunoreactivity in peritubular capillaries in patients with kidney transplantation. Clin Transplant 2016;30:1417-24. [PMID: 27543925 DOI: 10.1111/ctr.12833] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
322 Lovinfosse P, Hustinx R, Weekers L, Jouret F, Detry O. Re: The role of FDG PET in detecting rejection after liver transplantation. Surgery 2019;165:853-8. [PMID: 30054015 DOI: 10.1016/j.surg.2018.06.014] [Reference Citation Analysis]
323 Aubert O, Higgins S, Bouatou Y, Yoo D, Raynaud M, Viglietti D, Rabant M, Hidalgo L, Glotz D, Legendre C, Delahousse M, Shah N, Sis B, Campbell P, Mengel M, Jouven X, Duong Van Huyen JP, Lefaucheur C, Loupy A. Archetype Analysis Identifies Distinct Profiles in Renal Transplant Recipients with Transplant Glomerulopathy Associated with Allograft Survival. J Am Soc Nephrol. 2019;30:625-639. [PMID: 30872323 DOI: 10.1681/asn.2018070777] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 7.3] [Reference Citation Analysis]
324 Early HM, Cheang EC, Aguilera JM, Hirschbein JSW, Fananapazir G, Wilson MD, McGahan JP. Utility of Shear Wave Elastography for Assessing Allograft Fibrosis in Renal Transplant Recipients: A Pilot Study. J Ultrasound Med 2018;37:1455-65. [PMID: 29143363 DOI: 10.1002/jum.14487] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
325 Kikić Ž, Kainz A, Kozakowski N, Oberbauer R, Regele H, Bond G, Böhmig GA. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection. Clin J Am Soc Nephrol 2015;10:1435-43. [PMID: 26071493 DOI: 10.2215/CJN.09901014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
326 Furmańczyk-Zawiska A, Urbanowicz A, Perkowska-Ptasińska A, Bączkowska T, Sadowska A, Nazarewski S, Chmura A, Durlik M. Human Pooled Immunoglobulin as Treatment of Active Antibody-Mediated Rejection of Transplanted Kidney. Transplant Proc 2016;48:1446-50. [PMID: 27496425 DOI: 10.1016/j.transproceed.2016.02.054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
327 Hrubá P, Brabcová I, Gueler F, Krejčík Z, Stránecký V, Svobodová E, Malušková J, Gwinner W, Honsová E, Lodererová A, Oberbauer R, Zachoval R, Viklický O. Molecular diagnostics identifies risks for graft dysfunction despite borderline histologic changes. Kidney International 2015;88:785-95. [DOI: 10.1038/ki.2015.211] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
328 Huang G, Wilson NA, Reese SR, Jacobson LM, Zhong W, Djamali A. Characterization of transfusion-elicited acute antibody-mediated rejection in a rat model of kidney transplantation. Am J Transplant 2014;14:1061-72. [PMID: 24708533 DOI: 10.1111/ajt.12674] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
329 Cherukuri A, Mehta R, Sood P, Hariharan S. Early allograft inflammation and scarring associate with graft dysfunction and poor outcomes in renal transplant recipients with delayed graft function: a prospective single center cohort study. Transpl Int 2018;31:1369-79. [DOI: 10.1111/tri.13318] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
330 Thomas KA, Valenzuela NM, Reed EF. The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection. Trends Mol Med 2015;21:319-29. [PMID: 25801125 DOI: 10.1016/j.molmed.2015.02.004] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 10.4] [Reference Citation Analysis]
331 Dean PG, Park WD, Cornell LD, Schinstock CA, Stegall MD. Early subclinical inflammation correlates with outcomes in positive crossmatch kidney allografts. Clin Transplant 2016;30:925-33. [DOI: 10.1111/ctr.12766] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
332 Kanitakis J, Karayannopoulou G, Lanzetta M, Petruzzo P. Graft vasculopathy in the skin of a human hand allograft: implications for diagnosis of rejection of vascularized composite allografts. Transpl Int 2014;27:e118-23. [PMID: 25041139 DOI: 10.1111/tri.12399] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
333 Xu-Dubois YC, Peltier J, Brocheriou I, Suberbielle-Boissel C, Djamali A, Reese S, Mooney N, Keuylian Z, Lion J, Ouali N, Levy PP, Jouanneau C, Rondeau E, Hertig A. Markers of Endothelial-to-Mesenchymal Transition: Evidence for Antibody-Endothelium Interaction during Antibody-Mediated Rejection in Kidney Recipients. J Am Soc Nephrol 2016;27:324-32. [PMID: 25995444 DOI: 10.1681/ASN.2014070679] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 2.9] [Reference Citation Analysis]
334 Meneghini M, Melilli E, Martorell J, Revuelta I, Rigol-Monzó E, Manonelles A, Montero N, Cucchiari D, Diekmann F, Cruzado JM, Gil-Vernet S, Grinyó JM, Bestard O. Combining Sensitive Crossmatch Assays With Donor/Recipient Human Leukocyte Antigen Eplet Matching Predicts Living-Donor Kidney Transplant Outcome. Kidney Int Rep 2018;3:926-38. [PMID: 29989033 DOI: 10.1016/j.ekir.2018.03.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
335 Noppakun K, Kittipanyaworakun T, Ruengorn C, Vongsanim S, Saikam A, Khamlueang N. Plasma volume treated with double filtration plasmapheresis and outcomes of acute antibody-mediated rejection in kidney transplant recipients: A retrospective cohort study. Ther Apher Dial 2021;25:341-9. [PMID: 32666667 DOI: 10.1111/1744-9987.13560] [Reference Citation Analysis]
336 Pérez-Sáez MJ, Yu B, Uffing A, Murakami N, Borges TJ, Azzi J, El Haji S, Gabardi S, Riella LV. Conversion from tacrolimus to belatacept improves renal function in kidney transplant patients with chronic vascular lesions in allograft biopsy. Clin Kidney J 2019;12:586-91. [PMID: 31384452 DOI: 10.1093/ckj/sfy115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
337 Sarihan I, Caliskan Y, Mirioglu S, Ozluk Y, Senates B, Seyahi N, Basturk T, Yildiz A, Kilicaslan I, Sever MS. Amyloid A Amyloidosis After Renal Transplantation: An Important Cause of Mortality. Transplantation 2020;104:1703-11. [PMID: 32732850 DOI: 10.1097/TP.0000000000003043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
338 Parajuli S, Aziz F, Garg N, Panzer SE, Joachim E, Muth B, Mohamed M, Blazel J, Zhong W, Astor BC, Mandelbrot DA, Djamali A. Histopathological characteristics and causes of kidney graft failure in the current era of immunosuppression. World J Transplant 2019; 9(6): 123-133 [PMID: 31750089 DOI: 10.5500/wjt.v9.i6.123] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
339 Davis S, Cooper JE. Acute antibody-mediated rejection in kidney transplant recipients. Transplantation Reviews 2017;31:47-54. [DOI: 10.1016/j.trre.2016.10.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
340 Wehmeier C, Hirt-minkowski P, Amico P, Georgalis A, Hopfer H, Steiger J, Dickenmann M, Schaub S. Successful steroid withdrawal guided by surveillance biopsies-A single-center experience. Clin Transplant 2018;32:e13181. [DOI: 10.1111/ctr.13181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
341 Kim MY, Brennan DC. Therapies for Chronic Allograft Rejection. Front Pharmacol 2021;12:651222. [PMID: 33935762 DOI: 10.3389/fphar.2021.651222] [Reference Citation Analysis]
342 Delville M, Charreau B, Rabant M, Legendre C, Anglicheau D. Pathogenesis of non-HLA antibodies in solid organ transplantation: Where do we stand? Hum Immunol 2016;77:1055-62. [PMID: 27237040 DOI: 10.1016/j.humimm.2016.05.021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
343 Grafals M, Thurman JM. The Role of Complement in Organ Transplantation. Front Immunol 2019;10:2380. [PMID: 31636644 DOI: 10.3389/fimmu.2019.02380] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
344 Mrevlje M, Oblak M, Mlinšek G, Lindič J, Jadranka-Buturović-Ponikvar, Arnol M. First and second morning spot urine protein measurements for the assessment of proteinuria: a diagnostic accuracy study in kidney transplant recipients. BMC Nephrol 2021;22:192. [PMID: 34022831 DOI: 10.1186/s12882-021-02406-x] [Reference Citation Analysis]
345 Jacquemont L, Soulillou JP, Degauque N. Blood biomarkers of kidney transplant rejection, an endless search? Expert Rev Mol Diagn 2017;17:687-97. [PMID: 28571481 DOI: 10.1080/14737159.2017.1337512] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
346 Dobi D, Bodó Z, Kemény É, Bidiga L, Hódi Z, Szenohradszky P, Szederkényi E, Szilvási A, Iványi B. Peritubular capillary basement membrane multilayering in early and advanced transplant glomerulopathy: quantitative parameters and diagnostic aspects. Virchows Arch 2016;469:563-73. [PMID: 27605054 DOI: 10.1007/s00428-016-2010-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
347 Lúcia M, Luque S, Crespo E, Melilli E, Cruzado JM, Martorell J, Jarque M, Gil-Vernet S, Manonelles A, Grinyó JM, Bestard O. Preformed circulating HLA-specific memory B cells predict high risk of humoral rejection in kidney transplantation. Kidney Int 2015;88:874-87. [PMID: 26176829 DOI: 10.1038/ki.2015.205] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 10.0] [Reference Citation Analysis]
348 Levine DJ, Glanville AR, Aboyoun C, Belperio J, Benden C, Berry GJ, Hachem R, Hayes D Jr, Neil D, Reinsmoen NL, Snyder LD, Sweet S, Tyan D, Verleden G, Westall G, Yusen RD, Zamora M, Zeevi A. Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2016;35:397-406. [PMID: 27044531 DOI: 10.1016/j.healun.2016.01.1223] [Cited by in Crossref: 174] [Cited by in F6Publishing: 155] [Article Influence: 29.0] [Reference Citation Analysis]
349 Svachova V, Sekerkova A, Hruba P, Tycova I, Rodova M, Cecrdlova E, Slatinska J, Honsova E, Striz I, Viklicky O. Dynamic changes of B-cell compartments in kidney transplantation: lack of transitional B cells is associated with allograft rejection. Transpl Int 2016;29:540-8. [PMID: 26839984 DOI: 10.1111/tri.12751] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
350 Bouatou Y, Stokman G, Claessen N, Roelofs JJTH, Bemelman F, Kers J, Florquin S. Aryl hydrocarbon receptor expression by macrophages and lymphocytes within infiltrates in BK polyomavirus associated nephropathy. Transpl Immunol 2018;47:18-21. [PMID: 29305091 DOI: 10.1016/j.trim.2017.12.005] [Reference Citation Analysis]
351 Bräsen JH, Khalifa A, Schmitz J, Dai W, Einecke G, Schwarz A, Hallensleben M, Schmidt BMW, Kreipe HH, Haller H, von Vietinghoff S. Macrophage density in early surveillance biopsies predicts future renal transplant function. Kidney Int 2017;92:479-89. [PMID: 28359537 DOI: 10.1016/j.kint.2017.01.029] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
352 Kim IK, Choi J, Vo A, Kang A, Steggerda J, Louie S, Haas M, Mirocha J, Cohen JL, Pizzo H, Kamil ES, Jordan SC, Puliyanda D. Risk factors for the development of antibody-mediated rejection in highly sensitized pediatric kidney transplant recipients. Pediatr Transplantation 2017;21:e13042. [DOI: 10.1111/petr.13042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
353 Hoffman W, Mehta R, Jorgensen DR, Sood P, Randhawa P, Wu CM, Puttarajappa C, Shah NA, Tevar AD, Hariharan S. The Impact of Early Clinical and Subclinical T Cell-mediated Rejection After Kidney Transplantation. Transplantation 2019;103:1457-67. [PMID: 30747837 DOI: 10.1097/TP.0000000000002560] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
354 Lee DR, Kim BC, Kim JP, Kim IG, Jeon MY. C3d-binding Donor-specific HLA Antibody Is Associated With a High Risk of Antibody-mediated Rejection and Graft Loss in Stable Kidney Transplant Recipients: A Single-center Cohort Study. Transplant Proc 2018;50:3452-9. [PMID: 30503524 DOI: 10.1016/j.transproceed.2018.06.037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
355 Kim J, Yuen D, Leung G, Jothy S, Zaltzman J, Ramesh Prasad G, Prabhudesai V, Mnatzakanian G, Kirpalani A. Role of Magnetic Resonance Elastography as a Noninvasive Measurement Tool of Fibrosis in a Renal Allograft: A Case Report. Transplantation Proceedings 2017;49:1555-9. [DOI: 10.1016/j.transproceed.2017.04.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
356 Kim JM, Kwon CH, Joh JW, Sinn DH, Lee S, Choi GS, Lee SK. Conversion of once-daily extended-release tacrolimus is safe in stable liver transplant recipients: A randomized prospective study. Liver Transpl. 2016;22:209-216. [PMID: 26360125 DOI: 10.1002/lt.24336] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
357 Wan SS, Ying TD, Wyburn K, Roberts DM, Wyld M, Chadban SJ. The Treatment of Antibody-Mediated Rejection in Kidney Transplantation: An Updated Systematic Review and Meta-Analysis. Transplantation. 2018;102:557-568. [PMID: 29315141 DOI: 10.1097/tp.0000000000002049] [Cited by in Crossref: 66] [Cited by in F6Publishing: 20] [Article Influence: 16.5] [Reference Citation Analysis]
358 Nasrallah M, Elalfy M, Fakhry S, Rostaing L, Amer I, Elmeseery Y, Mohammed I, El-gamal A, Malvezzi P. Impact of Adopting Routine Luminex-Based Pretransplant Assessment of HLA Antibodies on Clinical Practice and Outcomes in Kidney Transplantation. Transplantation Proceedings 2019;51:2241-4. [DOI: 10.1016/j.transproceed.2019.01.147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
359 Fu Q, Zhang H, Nie W, Deng R, Li J, Xiong Y, Dai Y, Liu L, Yuan X, He X, Wang C. Risk Factors for Acute Rejection After Deceased Donor Kidney Transplantation in China. Transplant Proc 2018;50:2465-8. [PMID: 30316380 DOI: 10.1016/j.transproceed.2018.03.063] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
360 Ozluk Y, Caliskan Y, Sevinc M, Bayram A, Arikan EA, Turkmen A, Akgul S, Savran FO, Sever MS, Kilicaslan I. Re-evaluation of glomerulitis using occlusion criteria based on the Banff 2013 revision: a retrospective study. Transpl Int 2017;30:579-88. [PMID: 28236636 DOI: 10.1111/tri.12943] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
361 Kwon H, Kim YH, Kim JY, Choi JY, Shin S, Jung JH, Park SK, Han DJ. The results of HLA-incompatible kidney transplantation according to pre-transplant crossmatch tests: Donor-specific antibody as a prominent predictor of acute rejection. Clin Transplant 2019;33:e13533. [PMID: 30864255 DOI: 10.1111/ctr.13533] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
362 Gosset C, Lefaucheur C, Glotz D. New insights in antibody-mediated rejection. Curr Opin Nephrol Hypertens 2014;23:597-604. [PMID: 25211610 DOI: 10.1097/MNH.0000000000000069] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
363 Rolak S, Djamali A, Mandelbrot DA, Muth BL, Jorgenson MR, Zhong W, Liu P, Astor BC, Parajuli S. Outcomes of Delayed Graft Function in Kidney Transplant Recipients Stratified by Histologic Biopsy Findings. Transplant Proc 2021;53:1462-9. [PMID: 33579551 DOI: 10.1016/j.transproceed.2021.01.012] [Reference Citation Analysis]
364 Viglietti D, Lefaucheur C, Glotz D. Evidence for an important role of both complement-binding and noncomplement-binding donor-specific antibodies in renal transplantation. Curr Opin Organ Transplant 2016;21:433-40. [PMID: 27348472 DOI: 10.1097/MOT.0000000000000324] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
365 Yaowakulpatana K, Vadcharavivad S, Ingsathit A, Areepium N, Kantachuvesiri S, Phakdeekitcharoen B, Sukasem C, Sra-ium S, Sumethkul V, Kitiyakara C. Impact of CYP3A5 polymorphism on trough concentrations and outcomes of tacrolimus minimization during the early period after kidney transplantation. Eur J Clin Pharmacol 2016;72:277-83. [DOI: 10.1007/s00228-015-1990-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
366 Fuss A, Hope CM, Deayton S, Bennett GD, Holdsworth R, Carroll RP, Coates PT. C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies. Nephrology (Carlton) 2015;20:467-73. [PMID: 25726938 DOI: 10.1111/nep.12441] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 6.2] [Reference Citation Analysis]
367 Lai X, Zheng X, Mathew JM, Gallon L, Leventhal JR, Zhang ZJ. Tackling Chronic Kidney Transplant Rejection: Challenges and Promises. Front Immunol 2021;12:661643. [PMID: 34093552 DOI: 10.3389/fimmu.2021.661643] [Reference Citation Analysis]
368 Bruneval P, Angelini A, Miller D, Potena L, Loupy A, Zeevi A, Reed EF, Dragun D, Reinsmoen N, Smith RN, West L, Tebutt S, Thum T, Haas M, Mengel M, Revelo P, Fedrigo M, Duong Van Huyen JP, Berry GJ. The XIIIth Banff Conference on Allograft Pathology: The Banff 2015 Heart Meeting Report: Improving Antibody-Mediated Rejection Diagnostics: Strengths, Unmet Needs, and Future Directions. Am J Transplant 2017;17:42-53. [PMID: 27862968 DOI: 10.1111/ajt.14112] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
369 Higgins RM, Daga S, Mitchell DA. Antibody-incompatible kidney transplantation in 2015 and beyond. Nephrol Dial Transplant 2015;30:1972-8. [PMID: 25500804 DOI: 10.1093/ndt/gfu375] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
370 Höcker B, Tabatabai J, Schneble L, Oh J, Thiel F, Pape L, Rusai K, Topaloglu R, Kranz B, Klaus G, Printza N, Yavascan O, Fichtner A, Krupka K, Bruckner T, Waldherr R, Pawlita M, Schnitzler P, Hirsch HH, Tönshoff B. JC polyomavirus replication and associated disease in pediatric renal transplantation: an international CERTAIN Registry study. Pediatr Nephrol 2018;33:2343-52. [PMID: 30058047 DOI: 10.1007/s00467-018-4029-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
371 Matas AJ, Helgeson ES, Gaston R, Cosio F, Mannon R, Kasiske BL, Hunsicker L, Gourishankar S, Rush D, Michael Cecka J, Connett J, Grande JP. Inflammation in areas of fibrosis: The DeKAF prospective cohort. Am J Transplant 2020;20:2509-21. [PMID: 32185865 DOI: 10.1111/ajt.15862] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
372 Shiu KY, Dorling A. Optimising long-term graft survival: establishing the benefit of targeting B lymphocytes. Clin Med (Lond) 2014;14 Suppl 6:s84-8. [PMID: 25468927 DOI: 10.7861/clinmedicine.14-6-s84] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
373 Niikura T, Yamamoto I, Nakada Y, Kamejima S, Katsumata H, Yamakawa T, Furuya M, Mafune A, Kobayashi A, Tanno Y, Miki J, Yamada H, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T. Probable C4d-negative accelerated acute antibody-mediated rejection due to non-HLA antibodies. Nephrology (Carlton) 2015;20 Suppl 2:75-8. [PMID: 26031592 DOI: 10.1111/nep.12467] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
374 Kanitakis J, Petruzzo P, Gazarian A, Karayannopoulou G, Buron F, Dubois V, Thaunat O, Badet L, Morelon E. Capillary Thrombosis in the Skin: A Pathologic Hallmark of Severe/Chronic Rejection of Human Vascularized Composite Tissue Allografts? Transplantation 2016;100:954-7. [PMID: 27003099 DOI: 10.1097/TP.0000000000000882] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
375 Couzi L, Pitard V, Moreau JF, Merville P, Déchanet-Merville J. Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation. Front Immunol 2015;6:3. [PMID: 25653652 DOI: 10.3389/fimmu.2015.00003] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
376 Bergler T, Jung B, Bourier F, Kühne L, Banas MC, Rümmele P, Wurm S, Banas B. Infiltration of Macrophages Correlates with Severity of Allograft Rejection and Outcome in Human Kidney Transplantation. PLoS One 2016;11:e0156900. [PMID: 27285579 DOI: 10.1371/journal.pone.0156900] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
377 Hirt-Minkowski P, Rush DN, Gao A, Hopfer H, Wiebe C, Nickerson PW, Schaub S, Ho J. Six-Month Urinary CCL2 and CXCL10 Levels Predict Long-term Renal Allograft Outcome. Transplantation 2016;100:1988-96. [PMID: 27548845 DOI: 10.1097/TP.0000000000001304] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 3.4] [Reference Citation Analysis]
378 Rascio F, Pontrelli P, Accetturo M, Oranger A, Gigante M, Castellano G, Gigante M, Zito A, Zaza G, Lupo A, Ranieri E, Stallone G, Gesualdo L, Grandaliano G. A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation: Type I IFN and chronic antibody-mediated rejection. J Pathol 2015;237:72-84. [DOI: 10.1002/path.4553] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
379 Wilson NA, Bath NM, Verhoven BM, Ding X, Boldt BA, Sukhwal A, Zhong W, Panzer SE, Redfield RR 3rd. APRIL/BLyS Blockade Reduces Donor-specific Antibodies in Allosensitized Mice. Transplantation 2019;103:1372-84. [PMID: 30830041 DOI: 10.1097/TP.0000000000002686] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
380 Ma J, Patel A, Tinckam K. Donor-Specific Antibody Monitoring: Where Is the Beef? Adv Chronic Kidney Dis 2016;23:317-25. [PMID: 27742387 DOI: 10.1053/j.ackd.2016.08.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
381 Jordan SC, Ammerman N, Choi J, Huang E, Peng A, Sethi S, Najjar R, Toyoda M, Lim K, Louie S, Vo A. Novel Therapeutic Approaches to Allosensitization and Antibody-mediated Rejection. Transplantation 2019;103:262-72. [PMID: 30247320 DOI: 10.1097/TP.0000000000002462] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
382 Lefaucheur C, Viglietti D, Mangiola M, Loupy A, Zeevi A. From Humoral Theory to Performant Risk Stratification in Kidney Transplantation. J Immunol Res 2017;2017:5201098. [PMID: 28133619 DOI: 10.1155/2017/5201098] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
383 Halverson LP, Hachem RR. Antibody-Mediated Rejection and Lung Transplantation. Semin Respir Crit Care Med 2021;42:428-35. [PMID: 34030204 DOI: 10.1055/s-0041-1728796] [Reference Citation Analysis]
384 Min JW, Kim KW, Kim BM, Doh KC, Choi MS, Choi BS, Park CW, Yang CW, Kim YS, Oh EJ, Chung BH. Clinical Significance of Pre- and Post-Transplant BAFF Levels in Kidney Transplant Recipients. PLoS One 2016;11:e0162964. [PMID: 27631619 DOI: 10.1371/journal.pone.0162964] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
385 Suhling H, Gottlieb J, Bara C, Taubert R, Jäckel E, Schiffer M, Bräsen J. Chronische Abstoßung: Unterschiede und Ähnlichkeiten bei verschiedenen soliden Organtransplantationen. Internist 2016;57:25-37. [DOI: 10.1007/s00108-015-3806-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
386 Kamburova EG, Hoitsma A, Claas FH, Otten HG; PROCARE Consortium. Results and reflections from the PROfiling Consortium on Antibody Repertoire and Effector functions in kidney transplantation: A mini-review. HLA 2019;94:129-40. [PMID: 31099989 DOI: 10.1111/tan.13581] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
387 Batra RK, Heilman RL, Smith ML, Thomas LF, Khamash HA, Katariya NN, Hewitt WR, Singer AL, Mathur AK, Huskey J, Chakkera HA, Moss A, Reddy KS. Rapid Resolution of Donor-Derived Glomerular Fibrin Thrombi After Deceased Donor Kidney Transplantation: Glomerular Fibrin Thrombi. Am J Transplant 2016;16:1015-20. [DOI: 10.1111/ajt.13561] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
388 Mező B, Reindl-Schwaighofer R, Eskandary F, Heinzel A, Wahrmann M, Doberer K, Heilos A, Bond G, Kläger J, Kozakowski N, Haslacher H, Oberbauer R, Viklický O, Hrubá P, Halloran PF, Rusai K, Prohászka Z, Böhmig GA. High-activity Classical and Alternative Complement Pathway Genotypes-Association With Donor-specific Antibody-triggered Injury and Renal Allograft Survival. Transplant Direct 2020;6:e534. [PMID: 32195325 DOI: 10.1097/TXD.0000000000000978] [Reference Citation Analysis]
389 Haas M. Transplant glomerulopathy: the view from the other side of the basement membrane. J Am Soc Nephrol 2015;26:1235-7. [PMID: 25388221 DOI: 10.1681/ASN.2014090945] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
390 Racusen L, Lefaucheur C. Renal allograft rejection: pieces of the puzzle. J Am Soc Nephrol 2015;26:1004-5. [PMID: 25381428 DOI: 10.1681/ASN.2014090932] [Reference Citation Analysis]
391 Arai T, Oguchi H, Shinoda K, Sakurabayashi K, Mikami T, Itabashi Y, Sakai K. Clinicopathological Analysis of Acute/Active Antibody-Mediated Rejection in Renal Allografts According to the Banff 2013 Classification. Nephron 2020;144 Suppl 1:18-27. [PMID: 33264791 DOI: 10.1159/000512143] [Reference Citation Analysis]
392 Pascual J, Zuckermann A, Djamali A, Hertig A, Naesens M. Rabbit antithymocyte globulin and donor-specific antibodies in kidney transplantation — A review. Transplantation Reviews 2016;30:85-91. [DOI: 10.1016/j.trre.2015.12.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
393 Nissaisorakarn V, Lee JR, Lubetzky M, Suthanthiran M. Urine biomarkers informative of human kidney allograft rejection and tolerance. Human Immunology 2018;79:343-55. [DOI: 10.1016/j.humimm.2018.01.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
394 Nabokow A, Dobronravov VA, Khrabrova M, Gröne H, Gröne E, Hallensleben M, Kieneke D, Weithofer P, Smirnov AV, Kliem V. Long-Term Kidney Allograft Survival in Patients With Transplant Glomerulitis. Transplantation 2015;99:331-9. [DOI: 10.1097/tp.0000000000000606] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
395 O'Regan JA, Canney M, Connaughton DM, O'Kelly P, Williams Y, Collier G, deFreitas DG, O'Seaghdha CM, Conlon PJ. Tacrolimus trough-level variability predicts long-term allograft survival following kidney transplantation. J Nephrol 2016;29:269-76. [PMID: 26374111 DOI: 10.1007/s40620-015-0230-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
396 Chung BH, Kim JH, Choi BS, Park CW, Kim JI, Moon IS, Kim YS, Choi YJ, Oh EJ, Yang CW. Clinical significance of the presence of anti-human leukocyte antigen-donor specific antibody in kidney transplant recipients with allograft dysfunction. Korean J Intern Med 2018;33:157-67. [PMID: 27764540 DOI: 10.3904/kjim.2016.107] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
397 Abreu R, Carvalho F, Viana H, Mesquita I, Possante M, Aires I, Caeiro F, Silva C, Cotovio P, Ferreira A, Remédio F, Nolasco F. Morphologic patterns and treatment of transplant glomerulopathy: A retrospective analysis. Clin Transplant 2017;31. [PMID: 28135784 DOI: 10.1111/ctr.12915] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
398 Kuscu C, Kiran M, Mohammed A, Kuscu C, Satpathy S, Wolen A, Bardhi E, Bajwa A, Eason JD, Maluf D, Mas V, Akalin E. Integrative Analyses of Circulating Small RNAs and Kidney Graft Transcriptome in Transplant Glomerulopathy. Int J Mol Sci 2021;22:6218. [PMID: 34207555 DOI: 10.3390/ijms22126218] [Reference Citation Analysis]
399 Koch M, Wiech T, Marget M, Peine S, Thude H, Achilles EG, Fischer L, Lehnhardt A, Thaiss F, Nashan B. De novo mTOR inhibitor-based immunosuppression in ABO-incompatible kidney transplantation. Clin Transplant 2015;29:1021-8. [DOI: 10.1111/ctr.12624] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
400 Liu A, Woodside KJ, Augustine JJ, Sarabu N. Racial disparity in kidney transplant survival relates to late rejection and is independent of steroid withdrawal. Clin Transplant 2018;32:e13381. [PMID: 30098053 DOI: 10.1111/ctr.13381] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
401 Ebens CL, Smith AR, Verghese PS. Kidney transplant after hematopoietic cell transplant in pediatrics: Infectious and immunosuppressive considerations. Pediatr Transplant 2017;21. [PMID: 28452096 DOI: 10.1111/petr.12929] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
402 Xu X, Han Y, Huang H, Bi L, Kong X, Ma X, Shi B, Xiao L. Circulating NK cell subsets and NKT‑like cells in renal transplant recipients with acute T‑cell‑mediated renal allograft rejection. Mol Med Rep 2019;19:4238-48. [PMID: 30942398 DOI: 10.3892/mmr.2019.10091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
403 Unlu M, Yildiz S, Ellidokuz H, Sarioglu S. Comparison of the renal cortex and the medulla for antibody mediated rejection. Nephrology (Carlton) 2020;25:179-86. [PMID: 31074544 DOI: 10.1111/nep.13598] [Reference Citation Analysis]
404 Garrouste C, Canaud G, Büchler M, Rivalan J, Colosio C, Martinez F, Aniort J, Dudreuilh C, Pereira B, Caillard S, Philipponnet C, Anglicheau D, Heng AE. Rituximab for Recurrence of Primary Focal Segmental Glomerulosclerosis After Kidney Transplantation: Clinical Outcomes. Transplantation 2017;101:649-56. [PMID: 27043407 DOI: 10.1097/TP.0000000000001160] [Cited by in Crossref: 35] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
405 Zecher D, Bach C, Preiss A, Staudner C, Utpatel K, Evert M, Jung B, Bergler T, Böger CA, Spriewald BM, Banas B. Analysis of Luminex-based Algorithms to Define Unacceptable HLA Antibodies in CDC-crossmatch Negative Kidney Transplant Recipients. Transplantation 2018;102:969-77. [DOI: 10.1097/tp.0000000000002129] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
406 Hanssen O, Erpicum P, Lovinfosse P, Meunier P, Weekers L, Tshibanda L, Krzesinski JM, Hustinx R, Jouret F. Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients. Part I. In vivo imaging methods. Clin Kidney J 2017;10:97-105. [PMID: 28643821 DOI: 10.1093/ckj/sfw062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
407 Oguchi H, Sakai K, Yamaguchi Y, Mikami T, Nemoto T, Ohashi Y, Kawamura T, Muramatsu M, Itabashi Y, Shinoda K, Hyodo Y, Takahashi Y, Kawaguchi Y, Onishi H, Hamasaki Y, Shibuya K, Shishido S. Vasa recta hyalinosis reflects severe arteriolopathy in renal allografts. Clin Exp Nephrol 2019;23:799-806. [PMID: 30734165 DOI: 10.1007/s10157-019-01709-6] [Reference Citation Analysis]
408 Arias M, Serón D, Herrero I, Rush DN, Wiebe C, Nickerson PW, Ussetti P, Rodrigo E, de Cos M. Subclinical Antibody-Mediated Rejection. Transplantation 2017;101:S1-S18. [DOI: 10.1097/tp.0000000000001735] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
409 Venner JM, Hidalgo LG, Famulski KS, Chang J, Halloran PF. The Molecular Landscape of Antibody-Mediated Kidney Transplant Rejection: Evidence for NK Involvement Through CD16a Fc Receptors: Molecular Phenotype of ABMR. American Journal of Transplantation 2015;15:1336-48. [DOI: 10.1111/ajt.13115] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 10.7] [Reference Citation Analysis]
410 Geer LI, Kagele S, Townshend S, Watson B, Reed EF, Hickey MJ. Design of a state of the art reporting system and process improvement for reporting of high complexity single antigen bead data for transplant patients to the electronic medical record. BMJ Open Qual 2020;9:e000813. [PMID: 31986117 DOI: 10.1136/bmjoq-2019-000813] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
411 Moris D, Cendales LC. Sensitization and Desensitization in Vascularized Composite Allotransplantation. Front Immunol 2021;12:682180. [PMID: 34456906 DOI: 10.3389/fimmu.2021.682180] [Reference Citation Analysis]
412 O'Neill MA, Hidalgo LG. NK cells in antibody-mediated rejection - Key effector cells in microvascular graft damage. Int J Immunogenet 2021;48:110-9. [PMID: 33586864 DOI: 10.1111/iji.12532] [Reference Citation Analysis]
413 Mafune Hamada A, Yamamoto I, Kawabe M, Katsumata H, Yamakawa T, Katsuma A, Nakada Y, Kobayashi A, Koike Y, Miki J, Yamada H, Kimura T, Tanno Y, Ohkido I, Tsuboi N, Yamamoto H, Urashima M, Yokoo T. Interstitial fibroblasts in donor kidneys predict late posttransplant anemia. Clin Kidney J 2021;14:132-8. [PMID: 33564411 DOI: 10.1093/ckj/sfz122] [Reference Citation Analysis]
414 Schiffer L, Wiehler F, Bräsen JH, Gwinner W, Greite R, Kreimann K, Thorenz A, Derlin K, Teng B, Rong S, von Vietinghoff S, Haller H, Mengel M, Pape L, Lerch C, Schiffer M, Gueler F. Chemokine CXCL13 as a New Systemic Biomarker for B-Cell Involvement in Acute T Cell-Mediated Kidney Allograft Rejection. Int J Mol Sci 2019;20:E2552. [PMID: 31137652 DOI: 10.3390/ijms20102552] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
415 Ho J, Rush DN, Nickerson PW. Urinary biomarkers of renal transplant outcome: . Current Opinion in Organ Transplantation 2015;20:476-81. [DOI: 10.1097/mot.0000000000000208] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
416 Mohamedali B, Pyle J, Bhat G. Acute Cellular Rejection and C4d Positivity in Heart Transplantation: A Manifestation of Asymptomatic Antibody-Mediated Rejection? Am J Clin Pathol 2016;145:238-43. [DOI: 10.1093/ajcp/aqv026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
417 Katsuma A, Yamakawa T, Nakada Y, Yamamoto I, Yokoo T. Histopathological findings in transplanted kidneys. Ren Replace Ther 2017;3. [DOI: 10.1186/s41100-016-0089-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
418 De Serres SA, Noël R, Côté I, Lapointe I, Wagner E, Riopel J, Latulippe E, Agharazii M, Houde I. 2013 Banff Criteria for Chronic Active Antibody-Mediated Rejection: Assessment in a Real-Life Setting. Am J Transplant 2016;16:1516-25. [PMID: 26602055 DOI: 10.1111/ajt.13624] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
419 Masutani K. Viral infections directly involved in kidney allograft function. Nephrology (Carlton) 2018;23 Suppl 2:31-7. [PMID: 29968408 DOI: 10.1111/nep.13285] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
420 Singh T, Kharadjian TB, Astor BC, Panzer SE. Long-term outcomes in kidney transplant recipients with end-stage kidney disease due to anti-glomerular basement membrane disease. Clin Transplant 2021;35:e14179. [PMID: 33259076 DOI: 10.1111/ctr.14179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
421 Halloran PF, Reeve J, Akalin E, Aubert O, Bohmig GA, Brennan D, Bromberg J, Einecke G, Eskandary F, Gosset C, Duong Van Huyen JP, Gupta G, Lefaucheur C, Malone A, Mannon RB, Seron D, Sellares J, Weir M, Loupy A. Real Time Central Assessment of Kidney Transplant Indication Biopsies by Microarrays: The INTERCOMEX Study. Am J Transplant. 2017;17:2851-2862. [PMID: 28449409 DOI: 10.1111/ajt.14329] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 12.8] [Reference Citation Analysis]
422 Oguchi H, Sakai K, Yamaguchi Y, Mikami T, Nemoto T, Ohashi Y, Kawamura T, Muramatsu M, Itabashi Y, Shinoda K, Hyodo Y, Takahashi Y, Kawaguchi Y, Onishi H, Hamasaki Y, Shibuya K, Shishido S. Interlobular hyaline arteriopathy reflects severe arteriolopathy in renal allografts. Nephrology (Carlton) 2018;23 Suppl 2:58-62. [PMID: 29968404 DOI: 10.1111/nep.13275] [Reference Citation Analysis]
423 Bancu I, Hernández-Gallego A, López-Alvárez D, Lozano-Ramos I, Cañas-Sole L, Juega-Mariño J, Pérez-Mir M, Borras-Seres F, Bonet-Sol J, Lauzurica R. Prognostic Value of Modified Banff Score in the Evolution of Renal Function. Transplant Proc 2016;48:2903-5. [PMID: 27932103 DOI: 10.1016/j.transproceed.2016.09.013] [Reference Citation Analysis]
424 Redfield RR, Ellis TM, Zhong W, Scalea JR, Zens TJ, Mandelbrot D, Muth BL, Panzer S, Samaniego M, Kaufman DB, Astor BC, Djamali A. Current outcomes of chronic active antibody mediated rejection - A large single center retrospective review using the updated BANFF 2013 criteria. Hum Immunol 2016;77:346-52. [PMID: 26867813 DOI: 10.1016/j.humimm.2016.01.018] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
425 Mccaughan JA, Tinckam KJ. Donor specific HLA antibodies & allograft injury: mechanisms, methods of detection, manifestations and management. Transpl Int 2018;31:1059-70. [DOI: 10.1111/tri.13324] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
426 Kim K, Moon H, Lee YH, Seo JW, Kim YG, Moon JY, Kim JS, Jeong KH, Lee TW, Ihm CG, Lee SH. Clinical relevance of cell-free mitochondrial DNA during the early postoperative period in kidney transplant recipients. Sci Rep 2019;9:18607. [PMID: 31819080 DOI: 10.1038/s41598-019-54694-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
427 Kläger J, Eskandary F, Böhmig GA, Kozakowski N, Kainz A, Colin Aronovicz Y, Cartron JP, Segerer S, Regele H. Renal allograft DARCness in subclinical acute and chronic active ABMR. Transpl Int 2021;34:1494-505. [PMID: 33983671 DOI: 10.1111/tri.13904] [Reference Citation Analysis]
428 Immenschuh S, Zilian E, Dämmrich ME, Schwarz A, Gwinner W, Becker JU, Blume CA. Indicators of treatment responsiveness to rituximab and plasmapheresis in antibody-mediated rejection after kidney transplantation. Transplantation 2015;99:56-62. [PMID: 25121474 DOI: 10.1097/TP.0000000000000244] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
429 Alsughayyir J, Pettigrew GJ, Motallebzadeh R. Spoiling for a Fight: B Lymphocytes As Initiator and Effector Populations within Tertiary Lymphoid Organs in Autoimmunity and Transplantation. Front Immunol 2017;8:1639. [PMID: 29218052 DOI: 10.3389/fimmu.2017.01639] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
430 Haller J, Wehmeier C, Hönger G, Hirt-Minkowski P, Gürke L, Wolff T, Steiger J, Amico P, Dickenmann M, Schaub S. Differential Impact of Delayed Graft Function in Deceased Donor Renal Transplant Recipients With and Without Donor-specific HLA-antibodies. Transplantation 2019;103:e273-80. [PMID: 31205266 DOI: 10.1097/TP.0000000000002802] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
431 Kincaide E, Hitchman K, Hall R, Yamaguchi I, Ding Y, Crowther B. Impact of active antibody-mediated rejection treatment on donor-specific antibodies in pediatric kidney transplant recipients. Pediatr Transplant 2019;23:e13590. [PMID: 31617318 DOI: 10.1111/petr.13590] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
432 Shuker N, Bouamar R, van Schaik RH, Clahsen-van Groningen MC, Damman J, Baan CC, van de Wetering J, Rowshani AT, Weimar W, van Gelder T, Hesselink DA. A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype-Based With Body-Weight-Based Tacrolimus Dosing After Living Donor Kidney Transplantation. Am J Transplant. 2016;16:2085-2096. [PMID: 26714287 DOI: 10.1111/ajt.13691] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 13.7] [Reference Citation Analysis]
433 Wen J, Xie K, Zhang M, Chen J, Zhang J, Cheng D, Li X, Ji S, Liu Z. HLA-DR, and not PLA2R, is expressed on the podocytes in kidney allografts in de novo membranous nephropathy. Medicine (Baltimore) 2016;95:e4809. [PMID: 27631233 DOI: 10.1097/MD.0000000000004809] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
434 Thomas KA, Valenzuela NM, Gjertson D, Mulder A, Fishbein MC, Parry GC, Panicker S, Reed EF. An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA. Am J Transplant 2015;15:2037-49. [PMID: 25904443 DOI: 10.1111/ajt.13273] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
435 de Graav GN, Hesselink DA, Dieterich M, Kraaijeveld R, Verschoor W, Roelen DL, Litjens NHR, Chong AS, Weimar W, Baan CC. Belatacept Does Not Inhibit Follicular T Cell-Dependent B-Cell Differentiation in Kidney Transplantation. Front Immunol 2017;8:641. [PMID: 28620390 DOI: 10.3389/fimmu.2017.00641] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
436 Nordheim E, Horneland R, Aandahl EM, Grzyb K, Aabakken L, Paulsen V, Midtvedt K, Hartmann A, Jenssen T. Pancreas transplant rejection episodes are not revealed by biopsies of the donor duodenum in a prospective study with paired biopsies. Am J Transplant 2018;18:1256-61. [DOI: 10.1111/ajt.14658] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
437 Kawai T, Sachs DH, Sprangers B, Spitzer TR, Saidman SL, Zorn E, Tolkoff-Rubin N, Preffer F, Crisalli K, Gao B, Wong W, Morris H, LoCascio SA, Sayre P, Shonts B, Williams WW Jr, Smith RN, Colvin RB, Sykes M, Cosimi AB. Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression. Am J Transplant 2014;14:1599-611. [PMID: 24903438 DOI: 10.1111/ajt.12731] [Cited by in Crossref: 186] [Cited by in F6Publishing: 167] [Article Influence: 23.3] [Reference Citation Analysis]
438 Matz M, Heinrich F, Zhang Q, Lorkowski C, Seelow E, Wu K, Lachmann N, Addo RK, Durek P, Mashreghi MF, Budde K. The regulation of interferon type I pathway-related genes RSAD2 and ETV7 specifically indicates antibody-mediated rejection after kidney transplantation. Clin Transplant 2018;32:e13429. [PMID: 30341925 DOI: 10.1111/ctr.13429] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
439 Burghuber CK, Kwun J, Page EJ, Manook M, Gibby AC, Leopardi FV, Song M, Farris AB 3rd, Hong JJ, Villinger F, Adams AB, Iwakoshi NN, Knechtle SJ. Antibody-Mediated Rejection in Sensitized Nonhuman Primates: Modeling Human Biology. Am J Transplant 2016;16:1726-38. [PMID: 26705099 DOI: 10.1111/ajt.13688] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
440 Zeng S, Liang L, Zhang Q, Xu Y, Tang H, Zhang Z, Zhang X, Jiang T, Hu X. Using functional magnetic resonance imaging to evaluate an acute allograft rejection model in rats. Magn Reson Imaging 2019;58:24-31. [PMID: 30630071 DOI: 10.1016/j.mri.2019.01.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
441 van der Zwan M, Baan CC, Colvin RB, Smith RN, White RA, Ndishabandi D, Nigg AL, van den Bosch TPP, de Graav GN, Clahsen-van Groningen MC, Hesselink DA. Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients. Transplant Direct 2019;5:e418. [PMID: 30656216 DOI: 10.1097/TXD.0000000000000857] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
442 Waiser J, Knebel F, Rudolph B, Wu K, Müller E, Sanad W, Budde K, Neumayer HH, Halleck F. Renal allograft loss caused by cardiorenal syndrome: frequency and diagnosis. Transplantation 2015;99:1208-15. [PMID: 25539469 DOI: 10.1097/TP.0000000000000501] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
443 Vo AA, Zeevi A, Choi J, Cisneros K, Toyoda M, Kahwaji J, Peng A, Villicana R, Puliyanda D, Reinsmoen N, Haas M, Jordan SC. A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients. Transplantation 2015;99:299-308. [PMID: 25606785 DOI: 10.1097/TP.0000000000000592] [Cited by in Crossref: 87] [Cited by in F6Publishing: 35] [Article Influence: 12.4] [Reference Citation Analysis]
444 Luo Y, Luo F, Zhang K, Wang S, Zhang H, Yang X, Shang W, Wang J, Wang Z, Pang X, Feng Y, Liu L, Xie H, Feng G, Li J. Elevated Circulating IL-10 Producing Breg, but Not Regulatory B Cell Levels, Restrain Antibody-Mediated Rejection After Kidney Transplantation. Front Immunol 2020;11:627496. [PMID: 33584730 DOI: 10.3389/fimmu.2020.627496] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
445 de Kort H, Willicombe M, Brookes P, Moran LB, Santos-Nunez E, Galliford JW, Taube D, McLean AG, Moss J, Cook HT, Roufosse C. Peritubular Capillary Basement Membrane Multilayering in Renal Allograft Biopsies of Patients With De Novo Donor-Specific Antibodies. Transplantation 2016;100:889-97. [PMID: 26413993 DOI: 10.1097/TP.0000000000000908] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
446 Singh N, Samant H, Hawxby A, Samaniego MD. Biomarkers of rejection in kidney transplantation. Curr Opin Organ Transplant 2019;24:103-10. [PMID: 30540576 DOI: 10.1097/MOT.0000000000000606] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
447 Sablik KA, Clahsen-van Groningen MC, Hesselink DA, van Gelder T, Betjes MGH. Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection. PLoS One 2018;13:e0196552. [PMID: 29746495 DOI: 10.1371/journal.pone.0196552] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
448 McCaughan J, Xu Q, Tinckam K. Detecting donor-specific antibodies: the importance of sorting the wheat from the chaff. Hepatobiliary Surg Nutr 2019;8:37-52. [PMID: 30881964 DOI: 10.21037/hbsn.2019.01.01] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
449 Scalea JR, Redfield RR, Muth BL, Mohamed M, Wilson NA, Ellis TM, Kaufman DB, Djamali A. Older kidney transplant patients experience less antibody-mediated rejection: a retrospective study of patients with mild to moderate sensitization. Clin Transplant 2015;29:1090-7. [DOI: 10.1111/ctr.12632] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
450 den Dulk AC, Shi X, Verhoeven CJ, Dubbeld J, Claas FHJ, Wolterbeek R, Brand-schaaf SH, Verspaget HW, Sarasqueta AF, van der Laan LJW, Metselaar HJ, van Hoek B, Kwekkeboom J, Roelen DL. Donor-specific anti-HLA antibodies are not associated with nonanastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation. Clin Transplant 2018;32:e13163. [DOI: 10.1111/ctr.13163] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
451 Morozumi K, Takeda A, Otsuka Y, Horike K, Gotoh N, Narumi S, Watarai Y, Kobayashi T. Reviewing the pathogenesis of antibody-mediated rejection and renal graft pathology after kidney transplantation. Nephrology (Carlton) 2016;21 Suppl 1:4-8. [PMID: 26971899 DOI: 10.1111/nep.12777] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
452 Grau V, Zeuschner P, Immenschuh S, Bockmeyer CL, Zell S, Wittig J, Säuberlich K, Abbas M, Padberg W, Meyer-schwesinger C, von Brandenstein M, Schlosser M, Dieplinger G, Galliford J, Clarke C, Roufosse C, Becker JU. Immune Complex-Type Deposits in the Fischer-344 to Lewis Rat Model of Renal Transplantation and a Subset of Human Transplant Glomerulopathy. Transplantation 2016;100:1004-14. [DOI: 10.1097/tp.0000000000001068] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
453 Wiebe C, Ho J, Gibson IW, Rush DN, Nickerson PW. Carpe diem-Time to transition from empiric to precision medicine in kidney transplantation. Am J Transplant 2018;18:1615-25. [DOI: 10.1111/ajt.14746] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
454 Lee SK, Kim BK, Jung HY, Cho JH, Park SH, Kim YL, Kim SY, Yoon YR, Chung BH, Lee SH, Kim CD. Metabolomics Study for Identification of Potential Biomarkers of Long-term Survival in Kidney Transplantation Recipients. Transplant Proc 2017;49:1005-11. [PMID: 28583516 DOI: 10.1016/j.transproceed.2017.03.055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
455 Roux A, Bendib Le Lan I, Holifanjaniaina S, Thomas KA, Hamid AM, Picard C, Grenet D, De Miranda S, Douvry B, Beaumont-Azuar L, Sage E, Devaquet J, Cuquemelle E, Le Guen M, Spreafico R, Suberbielle-Boissel C, Stern M, Parquin F;  Foch Lung Transplantation Group. Antibody-Mediated Rejection in Lung Transplantation: Clinical Outcomes and Donor-Specific Antibody Characteristics. Am J Transplant. 2016;16:1216-1228. [PMID: 26845386 DOI: 10.1111/ajt.13589] [Cited by in Crossref: 73] [Cited by in F6Publishing: 70] [Article Influence: 12.2] [Reference Citation Analysis]
456 Mengel M. Renalomics: Molecular Pathology in Kidney Biopsies. Surg Pathol Clin 2014;7:443-55. [PMID: 26837449 DOI: 10.1016/j.path.2014.04.005] [Reference Citation Analysis]
457 Matsuda Y, Sarwal MM. Unraveling the Role of Allo-Antibodies and Transplant Injury. Front Immunol 2016;7:432. [PMID: 27818660 DOI: 10.3389/fimmu.2016.00432] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
458 Yu MY, Kwon S, Moon JJ, Kim YC, Song EY, Lee H, Moon KC, Ha J, Kim DK, Han SW, Kim GH, Kim YS, Yang SH. Role of the IL-33/ST2 pathway in renal allograft rejection. Exp Cell Res 2021;405:112705. [PMID: 34166678 DOI: 10.1016/j.yexcr.2021.112705] [Reference Citation Analysis]
459 Noguchi H, Tsuchimoto A, Ueki K, Kaku K, Okabe Y, Nakamura M. Reduced Recurrence of Primary IgA Nephropathy in Kidney Transplant Recipients Receiving Everolimus With Corticosteroid: A Retrospective, Single-Center Study of 135 Transplant Patients. Transplant Proc 2020;52:3118-24. [PMID: 32600641 DOI: 10.1016/j.transproceed.2020.05.022] [Reference Citation Analysis]
460 de Sandes-freitas TV, Felipe CR, Campos ÉF, de Lima MG, Soares MF, de Franco MF, Aguiar WF, Tedesco-silva H, Medina-pestana JO. Subclinical Lesions and Donor-Specific Antibodies in Kidney Transplant Recipients Receiving Tacrolimus-Based Immunosuppressive Regimen Followed by Early Conversion to Sirolimus. Transplantation 2015;99:2372-81. [DOI: 10.1097/tp.0000000000000748] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
461 Malheiro J, Tafulo S, Dias L, Martins S, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A. Deleterious effect of anti-angiotensin II type 1 receptor antibodies detected pretransplant on kidney graft outcomes is both proper and synergistic with donor-specific anti-HLA antibodies. Nephrology (Carlton) 2019;24:347-56. [PMID: 29451342 DOI: 10.1111/nep.13239] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
462 Weimer ET, Newhall KA. Development of data-driven models for the flow cytometric crossmatch. Hum Immunol 2019;80:983-9. [PMID: 31530432 DOI: 10.1016/j.humimm.2019.09.004] [Reference Citation Analysis]
463 Paquot F, Weekers L, Bonvoisin C, Pottel H, Jouret F. "Acute kidney dysfunction with no rejection" is associated with poor renal outcomes at 2 years post kidney transplantation. BMC Nephrol 2019;20:249. [PMID: 31288762 DOI: 10.1186/s12882-019-1444-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
464 Weissenbacher A, Hautz T, Pierer G, Ninkovic M, Zelger BG, Zelger B, Löscher W, Rieger M, Kumnig M, Rumpold G, Piza-katzer H, Bauer T, Zimmermann R, Gabl M, Arora R, Ninkovic M, Margreiter R, Brandacher G, Schneeberger S, Rti-group Innsbruck. Hand Transplantation in Its Fourteenth Year: The Innsbruck Experience. Vascularized Composite Allotransplantation 2014;1:11-21. [DOI: 10.4161/23723505.2014.973798] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
465 Gwon J, Kim M, Park K, Ko S, Jung C. Clinical Outcomes in Kidney Transplantation from Deceased Donors with Acute Kidney Injury Based on Acute Kidney Injury Network Criteria. Transplantation Proceedings 2018;50:2426-30. [DOI: 10.1016/j.transproceed.2018.03.072] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
466 Mariani LH, Martini S, Barisoni L, Canetta PA, Troost JP, Hodgin JB, Palmer M, Rosenberg AZ, Lemley KV, Chien HP, Zee J, Smith A, Appel GB, Trachtman H, Hewitt SM, Kretzler M, Bagnasco SM. Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies. Nephrol Dial Transplant 2018;33:310-8. [PMID: 28339906 DOI: 10.1093/ndt/gfw443] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 10.3] [Reference Citation Analysis]
467 Chand S, Atkinson D, Collins C, Briggs D, Ball S, Sharif A, Skordilis K, Vydianath B, Neil D, Borrows R. The Spectrum of Renal Allograft Failure. PLoS One 2016;11:e0162278. [PMID: 27649571 DOI: 10.1371/journal.pone.0162278] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
468 Singh HK, Reisner H, Derebail VK, Kozlowski T, Nickeleit V. Polyomavirus nephropathy: quantitative urinary polyomavirus-Haufen testing accurately predicts the degree of intrarenal viral disease. Transplantation. 2015;99:609-615. [PMID: 25136849 DOI: 10.1097/tp0000000000000367] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
469 Klein K, Rübenacker S, Schaefer SM, Kihm LP, Schwenger V, Macher-Goeppinger S, Schemmer P, Süsald C, Zeier M, Morath C, Becker LE. Tissue Expression of Aquaporin 2 Is Correlated to Urine Output and Allograft Function in Sensitized Kidney Transplant Patients. Transplant Proc 2016;48:2629-36. [PMID: 27788793 DOI: 10.1016/j.transproceed.2016.06.056] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
470 Nova-Lamperti E, Fanelli G, Becker PD, Chana P, Elgueta R, Dodd PC, Lord GM, Lombardi G, Hernandez-Fuentes MP. IL-10-produced by human transitional B-cells down-regulates CD86 expression on B-cells leading to inhibition of CD4+T-cell responses. Sci Rep 2016;6:20044. [PMID: 26795594 DOI: 10.1038/srep20044] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 8.7] [Reference Citation Analysis]
471 Delsante M, Maggiore U, Levi J, Kleiner DE, Jackson AM, Arend LJ, Hewitt SM, Carter-Monroe N, Bagnasco SM, Rosenberg AZ. Microvascular inflammation in renal allograft biopsies assessed by endothelial and leukocyte co-immunostain: a retrospective study on reproducibility and clinical/prognostic correlates. Transpl Int 2019;32:300-12. [PMID: 30395360 DOI: 10.1111/tri.13371] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
472 Kwon H, Kim JY, Kim DH, Ko Y, Choi JY, Shin S, Jung JH, Kim YH, Han DJ; Korean Organ Transplantation Registry Study Group. Effect of simultaneous presence of anti-blood group A/B and -HLA antibodies on clinical outcomes in kidney transplantation across positive crossmatch: a nationwide cohort study. Sci Rep 2019;9:18229. [PMID: 31796812 DOI: 10.1038/s41598-019-54397-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
473 Messina M, Ariaudo C, Praticò Barbato L, Beltramo S, Mazzucco G, Amoroso A, Ranghino A, Cantaluppi V, Fop F, Segoloni GP. Relationship among C1q-fixing de novo donor specific antibodies, C4d deposition and renal outcome in transplant glomerulopathy. Transpl Immunol. 2015;33:7-12. [PMID: 26160049 DOI: 10.1016/j.trim.2015.06.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
474 Kolonko A, Słabiak-Błaż N, Karkoszka H, Więcek A, Piecha G. The Preliminary Results of Bortezomib Used as A Primary Treatment for An Early Acute Antibody-Mediated Rejection after Kidney Transplantation-A Single-Center Case Series. J Clin Med 2020;9:E529. [PMID: 32075220 DOI: 10.3390/jcm9020529] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
475 Smith B, Cornell LD, Smith M, Cortese C, Geiger X, Alexander MP, Ryan M, Park W, Morales Alvarez MC, Schinstock C, Kremers W, Stegall M. A method to reduce variability in scoring antibody-mediated rejection in renal allografts: implications for clinical trials - a retrospective study. Transpl Int 2019;32:173-83. [PMID: 30179275 DOI: 10.1111/tri.13340] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
476 Habig DF, Gaspari JL, Lokhandwala PM, Domen RE, Abendroth CS, Kadry Z, Ghahramani N, Shah RA, Jain A, Shike H. Donor-specific antibody to trans-encoded donor HLA-DQ heterodimer. Human Immunology 2015;76:587-90. [DOI: 10.1016/j.humimm.2015.09.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
477 Menon MC, Keung KL, Murphy B, OʼConnell PJ. The Use of Genomics and Pathway Analysis in Our Understanding and Prediction of Clinical Renal Transplant Injury. Transplantation 2016;100:1405-14. [PMID: 26447506 DOI: 10.1097/TP.0000000000000943] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
478 Piotti G, Palmisano A, Maggiore U, Buzio C. Vascular endothelium as a target of immune response in renal transplant rejection. Front Immunol. 2014;5:505. [PMID: 25374567 DOI: 10.3389/fimmu.2014.00505] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
479 Valenzuela NM, Hickey MJ, Reed EF. Antibody Subclass Repertoire and Graft Outcome Following Solid Organ Transplantation. Front Immunol 2016;7:433. [PMID: 27822209 DOI: 10.3389/fimmu.2016.00433] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
480 Manook M, Kwun J, Sacks S, Dorling A, Mamode N, Knechtle S. Innate networking: Thrombotic microangiopathy, the activation of coagulation and complement in the sensitized kidney transplant recipient. Transplant Rev (Orlando) 2018;32:119-26. [PMID: 29935708 DOI: 10.1016/j.trre.2018.01.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
481 Schwaiger E, Eskandary F, Kozakowski N, Bond G, Kikić Ž, Yoo D, Rasoul-Rockenschaub S, Oberbauer R, Böhmig GA. Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection. Nephrol Dial Transplant 2016;31:1342-51. [PMID: 27190362 DOI: 10.1093/ndt/gfw027] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 6.3] [Reference Citation Analysis]
482 Westall GP, Paraskeva MA, Snell GI. Antibody-mediated rejection. Curr Opin Organ Transplant 2015;20:492-7. [PMID: 26262460 DOI: 10.1097/MOT.0000000000000235] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
483 Cioni M, Nocera A, Innocente A, Tagliamacco A, Trivelli A, Basso S, Quartuccio G, Fontana I, Magnasco A, Drago F, Gurrado A, Guido I, Compagno F, Garibotto G, Klersy C, Verrina E, Ghiggeri GM, Cardillo M, Comoli P, Ginevri F. De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients. J Immunol Res 2017;2017:1747030. [PMID: 28367453 DOI: 10.1155/2017/1747030] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
484 Cherukuri A, Mehta R, Sharma A, Sood P, Zeevi A, Tevar AD, Rothstein DM, Hariharan S. Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell-mediated rejection and non-adherence. Kidney Int 2019;96:202-13. [PMID: 31029504 DOI: 10.1016/j.kint.2019.01.033] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
485 Grahammer J, Weissenbacher A, Zelger BG, Zelger B, Boesmueller C, Ninkovic M, Mühlbacher A, Peschel I, Brandacher G, Öfner D, Schneeberger S. Benefits and limitations of belatacept in 4 hand-transplanted patients. Am J Transplant 2017;17:3228-35. [DOI: 10.1111/ajt.14440] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
486 Burton SA, Amir N, Asbury A, Lange A, Hardinger KL. Treatment of antibody-mediated rejection in renal transplant patients: a clinical practice survey. Clin Transplant 2015;29:118-23. [DOI: 10.1111/ctr.12491] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
487 McQuillan RF, Toulany A, Kaufman M, Schiff JR. Benefits of a transfer clinic in adolescent and young adult kidney transplant patients. Can J Kidney Health Dis 2015;2:45. [PMID: 26672951 DOI: 10.1186/s40697-015-0081-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
488 Kanitakis J, Petruzzo P, Badet L, Gazarian A, Thaunat O, Testelin S, Devauchelle B, Dubernard J, Morelon E. Chronic Rejection in Human Vascularized Composite Allotransplantation (Hand and Face Recipients): An Update. Transplantation 2016;100:2053-61. [DOI: 10.1097/tp.0000000000001248] [Cited by in Crossref: 56] [Cited by in F6Publishing: 11] [Article Influence: 9.3] [Reference Citation Analysis]
489 Wozniak LJ, Naini BV, Hickey MJ, Bhattacharyya S, Reed EF, Busuttil RW, Farmer DG, Vargas JH, Venick RS, McDiarmid SV. Acute antibody-mediated rejection in ABO-compatible pediatric liver transplant recipients: case series and review of the literature. Pediatr Transplant. 2017;21. [PMID: 27597379 DOI: 10.1111/petr.12791] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
490 Tsuchimoto A, Masutani K, Omoto K, Okumi M, Okabe Y, Nishiki T, Ota M, Nakano T, Tsuruya K, Kitazono T, Nakamura M, Ishida H, Tanabe K; Japan Academic Consortium of Kidney Transplantation (JACK) Investigators. Kidney transplantation for treatment of end-stage kidney disease after haematopoietic stem cell transplantation: case series and literature review. Clin Exp Nephrol 2019;23:561-8. [PMID: 30584654 DOI: 10.1007/s10157-018-1672-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
491 Nankivell BJ, Renthawa J, Sharma RN, Kable K, O'Connell PJ, Chapman JR. BK Virus Nephropathy: Histological Evolution by Sequential Pathology. Am J Transplant 2017;17:2065-77. [PMID: 28371308 DOI: 10.1111/ajt.14292] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 9.4] [Reference Citation Analysis]
492 Tower CM, Reyes M, Nelson K, Leca N, Kieran N, Muczynski K, Jefferson JA, Blosser C, Kukla A, Maurer D, Chandler W, Najafian B. Plasma C4d+ Endothelial Microvesicles Increase in Acute Antibody-Mediated Rejection. Transplantation 2017;101:2235-43. [PMID: 27846156 DOI: 10.1097/TP.0000000000001572] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
493 Pearl MH, Chen L, ElChaki R, Elashoff D, Gjertson DW, Rossetti M, Weng PL, Zhang Q, Reed EF, Chambers ET. Endothelin Type A Receptor Antibodies Are Associated With Angiotensin II Type 1 Receptor Antibodies, Vascular Inflammation, and Decline in Renal Function in Pediatric Kidney Transplantation. Kidney Int Rep 2020;5:1925-36. [PMID: 33163713 DOI: 10.1016/j.ekir.2020.09.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
494 Schinstock CA, Dadhania DM, Everly MJ, Smith B, Gandhi M, Farkash E, Sharma VK, Samaniego-Picota M, Stegall MD. Factors at de novo donor-specific antibody initial detection associated with allograft loss: a multicenter study. Transpl Int 2019;32:502-15. [PMID: 30597643 DOI: 10.1111/tri.13395] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
495 Cozzi E, Calabrese F, Schiavon M, Feltracco P, Seveso M, Carollo C, Loy M, Cardillo M, Rea F. Immediate and Catastrophic Antibody-Mediated Rejection in a Lung Transplant Recipient With Anti-Angiotensin II Receptor Type 1 and Anti-Endothelin-1 Receptor Type A Antibodies. Am J Transplant 2017;17:557-64. [DOI: 10.1111/ajt.14053] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
496 Caballero A, Palma E, Ruiz-Esteban P, Vazquez T, Sola E, Torio A, Cabello M, Lopez V, Jironda C, Duarte A, Alonso-Titos J, Hernández D. CXCR3+ Monocytes Increase Significantly in Graft Blood Compared to Peripheral Blood in Patients With Stable Kidney Graft Function. Transplant Proc 2018;50:555-9. [PMID: 29579851 DOI: 10.1016/j.transproceed.2017.11.055] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
497 Cunha APL, Fabreti-Oliveira RA, Lasmar MF, Garcia JC, Vilela TP, Nascimento E. Clinical Outcome of Kidney Transplant Patients on the Allograft Function, Loss, Effects of HLA-DQB1-DSA+, and Graft Survival. Transplant Proc 2021;53:2188-96. [PMID: 34420780 DOI: 10.1016/j.transproceed.2021.07.011] [Reference Citation Analysis]
498 Khovanova N, Daga S, Shaikhina T, Krishnan N, Jones J, Zehnder D, Mitchell D, Higgins R, Briggs D, Lowe D. Subclass analysis of donor HLA-specific IgG in antibody-incompatible renal transplantation reveals a significant association of IgG4 with rejection and graft failure. Transpl Int 2015;28:1405-15. [PMID: 26264744 DOI: 10.1111/tri.12648] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
499 South AM, Maestretti L, Kambham N, Grimm PC, Chaudhuri A. Persistent C4d and antibody-mediated rejection in pediatric renal transplant patients. Pediatr Transplant 2017;21. [PMID: 28833936 DOI: 10.1111/petr.13035] [Reference Citation Analysis]
500 Orandi BJ, Chow EH, Hsu A, Gupta N, Van Arendonk KJ, Garonzik-Wang JM, Montgomery JR, Wickliffe C, Lonze BE, Bagnasco SM, Alachkar N, Kraus ES, Jackson AM, Montgomery RA, Segev DL. Quantifying renal allograft loss following early antibody-mediated rejection. Am J Transplant 2015;15:489-98. [PMID: 25611786 DOI: 10.1111/ajt.12982] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 8.9] [Reference Citation Analysis]
501 Mirioglu S, Caliskan Y, Goksoy Y, Gulcicek S, Ozluk Y, Sarihan I, Seyahi N, Kilicaslan I, Turkmen A, Sever MS. Recurrent and de novo glomerulonephritis following renal transplantation: higher rates of rejection and lower graft survival. Int Urol Nephrol 2017;49:2265-72. [DOI: 10.1007/s11255-017-1719-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
502 Sulkowska K, Palczewski P, Wojcik D, Ciszek M, Sanko-resmer J, Wojtowicz J, Leszkiewicz M, Golebiowski M. Intravoxel incoherent motion imaging in monitoring the function of kidney allograft. Acta Radiol 2019;60:925-32. [DOI: 10.1177/0284185118802598] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
503 Halloran PF, Famulski KS, Reeve J. Molecular assessment of disease states in kidney transplant biopsy samples. Nat Rev Nephrol 2016;12:534-48. [DOI: 10.1038/nrneph.2016.85] [Cited by in Crossref: 86] [Cited by in F6Publishing: 76] [Article Influence: 14.3] [Reference Citation Analysis]
504 Eskandary F, Wahrmann M, Mühlbacher J, Böhmig GA. Complement inhibition as potential new therapy for antibody-mediated rejection. Transpl Int 2016;29:392-402. [DOI: 10.1111/tri.12706] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
505 Bangaru V, Uppin M, Yadla M, Gudithi S, Taduri G, Raju S. Isolated Vascular Lesions (IVL) in Early Allograft Biopsies: A Case Series. Indian J Nephrol 2019;29:364-7. [PMID: 31571746 DOI: 10.4103/ijn.IJN_345_18] [Reference Citation Analysis]
506 Taira H, Noguchi H, Ueki K, Kaku K, Tsuchimoto A, Okabe Y, Ohya Y, Nakamura M. Initiation of dialysis for kidney graft failure: A retrospective single-center cohort study. Ther Apher Dial 2021. [PMID: 34779578 DOI: 10.1111/1744-9987.13756] [Reference Citation Analysis]
507 Callemeyn J, Ameye H, Lerut E, Senev A, Coemans M, Van Loon E, Sprangers B, Van Sandt V, Rabeyrin M, Dubois V, Thaunat O, Kuypers D, Emonds MP, Naesens M. Revisiting the changes in the Banff classification for antibody-mediated rejection after kidney transplantation. Am J Transplant 2021;21:2413-23. [PMID: 33382185 DOI: 10.1111/ajt.16474] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
508 Choi J, Aubert O, Vo A, Loupy A, Haas M, Puliyanda D, Kim I, Louie S, Kang A, Peng A, Kahwaji J, Reinsmoen N, Toyoda M, Jordan SC. Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients. Am J Transplant 2017;17:2381-9. [DOI: 10.1111/ajt.14228] [Cited by in Crossref: 163] [Cited by in F6Publishing: 137] [Article Influence: 32.6] [Reference Citation Analysis]
509 Randhawa P. T-cell-mediated rejection of the kidney in the era of donor-specific antibodies: diagnostic challenges and clinical significance. Curr Opin Organ Transplant 2015;20:325-32. [PMID: 25944230 DOI: 10.1097/MOT.0000000000000189] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
510 Mühlbacher J, Jilma B, Wahrmann M, Bartko J, Eskandary F, Schörgenhofer C, Schwameis M, Parry GC, Gilbert JC, Panicker S, Böhmig GA. Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009-Results from a Randomized First-in-Human Phase 1 Trial. Transplantation 2017;101:2410-8. [PMID: 28926521 DOI: 10.1097/TP.0000000000001804] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
511 Jadoul A, Lovinfosse P, Bouquegneau A, Weekers L, Pottel H, Hustinx R, Jouret F. Observer variability in the assessment of renal 18F-FDG uptake in kidney transplant recipients. Sci Rep 2020;10:4617. [PMID: 32165653 DOI: 10.1038/s41598-020-61032-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
512 Cunningham KC, Hager DR, Fischer J, D'alessandro AM, Leverson GE, Kaufman DB, Djamali A. Single-Dose Basiliximab Induction in Low-Risk Renal Transplant Recipients. Pharmacotherapy 2016;36:823-9. [DOI: 10.1002/phar.1774] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
513 Naesens M. Zero-Time Renal Transplant Biopsies: A Comprehensive Review. Transplantation. 2016;100:1425-1439. [PMID: 26599490 DOI: 10.1097/tp.0000000000001018] [Cited by in Crossref: 35] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
514 Pape L, Becker JU, Immenschuh S, Ahlenstiel T. Acute and chronic antibody-mediated rejection in pediatric kidney transplantation. Pediatr Nephrol. 2014;. [PMID: 24865478 DOI: 10.1007/s00467-014-2851-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
515 Okumi M, Unagami K, Kakuta Y, Ochi A, Takagi T, Ishida H, Tanabe K; Japan Academic Consortium of Kidney Transplantation (JACK). Elderly living donor kidney transplantation allows worthwhile outcomes: The Japan Academic Consortium of Kidney Transplantation study. Int J Urol 2017;24:833-40. [PMID: 28913939 DOI: 10.1111/iju.13443] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
516 Yan D, Stokar E, Jacoby A, Gelb BE, Rodriguez ED, Meehan SA. A case of facial composite tissue allograft rejection. JAAD Case Rep 2020;6:845-7. [PMID: 32875035 DOI: 10.1016/j.jdcr.2020.07.004] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
517 Béland S, Désy O, Ung RV, Vallin P, Latulippe E, Riopel J, De Serres SA. Tacrolimus prevents von Willebrand factor secretion by allostimulated human glomerular endothelium. Am J Transplant 2018;18:2314-21. [DOI: 10.1111/ajt.14944] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
518 Guzzi F, Cirillo L, Buti E, Becherucci F, Errichiello C, Roperto RM, Hunter JP, Romagnani P. Urinary Biomarkers for Diagnosis and Prediction of Acute Kidney Allograft Rejection: A Systematic Review. Int J Mol Sci 2020;21:E6889. [PMID: 32961825 DOI: 10.3390/ijms21186889] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
519 Haas M. The Revised (2013) Banff Classification for Antibody-Mediated Rejection of Renal Allografts: Update, Difficulties, and Future Considerations. Am J Transplant 2016;16:1352-7. [PMID: 26696524 DOI: 10.1111/ajt.13661] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 11.5] [Reference Citation Analysis]
520 Stegall MD, Cornell LD, Park WD, Smith BH, Cosio FG. Renal Allograft Histology at 10 Years After Transplantation in the Tacrolimus Era: Evidence of Pervasive Chronic Injury. Am J Transplant 2018;18:180-8. [PMID: 28710896 DOI: 10.1111/ajt.14431] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
521 Uva PD, Papadimitriou JC, Drachenberg CB, Toniolo MF, Quevedo A, Dotta AC, Chuluyan E, Casadei DH. Graft dysfunction in simultaneous pancreas kidney transplantation (SPK): Results of concurrent kidney and pancreas allograft biopsies. Am J Transplant 2019;19:466-74. [DOI: 10.1111/ajt.15012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
522 Viglietti D, Loupy A, Vernerey D, Bentlejewski C, Gosset C, Aubert O, Duong van Huyen JP, Jouven X, Legendre C, Glotz D, Zeevi A, Lefaucheur C. Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss. J Am Soc Nephrol 2017;28:702-15. [PMID: 27493255 DOI: 10.1681/ASN.2016030368] [Cited by in Crossref: 83] [Cited by in F6Publishing: 34] [Article Influence: 13.8] [Reference Citation Analysis]
523 Stokman G, Kers J, Yapici Ü, Hoelbeek JJ, Claessen N, de Boer OJ, Netea MG, Hilbrands L, Bemelman FJ, Ten Berge IJ, Florquin S. Predominant Tubular Interleukin-18 Expression in Polyomavirus-Associated Nephropathy. Transplantation 2016;100:e88-95. [PMID: 26863474 DOI: 10.1097/TP.0000000000001086] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
524 Owoyemi I, Tandukar S, Jorgensen DR, Wu CM, Sood P, Puttarajappa C, Sharma A, Shah NA, Randhawa P, Molinari M, Tevar AD, Mehta RB, Hariharan S. Impact of Subclinical and Clinical Kidney Allograft Rejection Within 1 Year Posttransplantation Among Compatible Transplant With Steroid Withdrawal Protocol. Transplant Direct 2021;7:e706. [PMID: 34124342 DOI: 10.1097/TXD.0000000000001132] [Reference Citation Analysis]
525 Sicard A, Ducreux S, Rabeyrin M, Couzi L, McGregor B, Badet L, Scoazec JY, Bachelet T, Lepreux S, Visentin J, Merville P, Fremeaux-Bacchi V, Morelon E, Taupin JL, Dubois V, Thaunat O. Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. J Am Soc Nephrol 2015;26:457-67. [PMID: 25125383 DOI: 10.1681/ASN.2013101144] [Cited by in Crossref: 170] [Cited by in F6Publishing: 61] [Article Influence: 21.3] [Reference Citation Analysis]
526 Pankewycz O, Soliman K, Laftavi MR. The increasing clinical importance of alloantibodies in kidney transplantation. Immunological Investigations 2014;43:775-89. [DOI: 10.3109/08820139.2014.910016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
527 Becker JU. Current status of pediatric renal transplant pathology. Pediatr Nephrol 2017;32:425-37. [PMID: 27221522 DOI: 10.1007/s00467-016-3381-x] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
528 Ferrari-Lacraz S. Donor-specific antibodies' C1q binding: improvement in kidney graft management? Transpl Int 2017;30:344-6. [PMID: 28166393 DOI: 10.1111/tri.12933] [Reference Citation Analysis]
529 Francke MI, Hesselink DA, Li Y, Koch BCP, de Wit LEA, van Schaik RHN, Yang L, Baan CC, van Gelder T, de Winter BCM. Monitoring the tacrolimus concentration in peripheral blood mononuclear cells of kidney transplant recipients. Br J Clin Pharmacol 2021;87:1918-29. [PMID: 33025649 DOI: 10.1111/bcp.14585] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
530 Hueper K, Gutberlet M, Bräsen JH, Jang MS, Thorenz A, Chen R, Hertel B, Barrmeyer A, Schmidbauer M, Meier M, von Vietinghoff S, Khalifa A, Hartung D, Haller H, Wacker F, Rong S, Gueler F. Multiparametric Functional MRI: Non-Invasive Imaging of Inflammation and Edema Formation after Kidney Transplantation in Mice. PLoS One 2016;11:e0162705. [PMID: 27632553 DOI: 10.1371/journal.pone.0162705] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
531 Nickeleit V, Singh HK, Randhawa P, Drachenberg CB, Bhatnagar R, Bracamonte E, Chang A, Chon WJ, Dadhania D, Davis VG, Hopfer H, Mihatsch MJ, Papadimitriou JC, Schaub S, Stokes MB, Tungekar MF, Seshan SV; Banff Working Group on Polyomavirus Nephropathy. The Banff Working Group Classification of Definitive Polyomavirus Nephropathy: Morphologic Definitions and Clinical Correlations. J Am Soc Nephrol 2018;29:680-93. [PMID: 29279304 DOI: 10.1681/ASN.2017050477] [Cited by in Crossref: 60] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
532 Mubarak M. Plasma cell-rich acute rejection: A morphologic archetype of combined cellular and humoral rejection? Indian J Nephrol 2016;26:157-8. [PMID: 27194828 DOI: 10.4103/0971-4065.161520] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
533 Chen CC, Pouliquen E, Broisat A, Andreata F, Racapé M, Bruneval P, Kessler L, Ahmadi M, Bacot S, Saison-Delaplace C, Marcaud M, Van Huyen JD, Loupy A, Villard J, Demuylder-Mischler S, Berney T, Morelon E, Tsai MK, Kolopp-Sarda MN, Koenig A, Mathias V, Ducreux S, Ghezzi C, Dubois V, Nicoletti A, Defrance T, Thaunat O. Endothelial chimerism and vascular sequestration protect pancreatic islet grafts from antibody-mediated rejection. J Clin Invest 2018;128:219-32. [PMID: 29202467 DOI: 10.1172/JCI93542] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
534 Zheng J, Xue W, Jing X, Hou J, Tian X, Tian P, Ding X, Pan X, Yan H, Feng X, Xiang H, Li Y, Ding C. Influence of de novo donor-specific antibody on early renal allograft function recovery. Ren Fail 2015;37:462-8. [PMID: 25697229 DOI: 10.3109/0886022X.2015.1006066] [Reference Citation Analysis]
535 Hara S. Banff 2013 update: Pearls and pitfalls in transplant renal pathology. Nephrology (Carlton). 2015;20 Suppl 2:2-8. [PMID: 26031578 DOI: 10.1111/nep.12474] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
536 Aguilar PR, Carpenter D, Ritter J, Yusen RD, Witt CA, Byers DE, Mohanakumar T, Kreisel D, Trulock EP, Hachem RR. The role of C4d deposition in the diagnosis of antibody-mediated rejection after lung transplantation. Am J Transplant 2018;18:936-44. [PMID: 28992372 DOI: 10.1111/ajt.14534] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
537 Gosset C, Viglietti D, Rabant M, Vérine J, Aubert O, Glotz D, Legendre C, Taupin J, Duong Van-huyen J, Loupy A, Lefaucheur C. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis. Kidney International 2017;92:729-42. [DOI: 10.1016/j.kint.2017.03.033] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
538 Moon A, Smith GH, Kong J, Rogers TE, Ellis CL, Farris AB“. Development of CD3 cell quantitation algorithms for renal allograft biopsy rejection assessment utilizing open source image analysis software. Virchows Arch 2018;472:259-69. [DOI: 10.1007/s00428-017-2260-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
539 Schutt R, Case J, Kurian SM, Spierling Bagsic SR, Barrick BL, Toll AE, Zhang Q, Reed EF, Quigley MM, Schaffer R, Fisher JS, Rice JC, Marsh CL. Safety and Efficacy of a Steroid Avoidance Immunosuppression Regimen in Renal Transplant Patients With De Novo or Preformed Donor-Specific Antibodies: A Single-Center Study. Transplant Proc 2021;53:950-61. [PMID: 33293041 DOI: 10.1016/j.transproceed.2020.10.021] [Reference Citation Analysis]
540 Madariaga MLL, Shanmugarajah K, Michel SG, Villani V, Muraglia GM 2nd, Torabi R, Leonard DA, Randolph MA, Colvin RB, Yamada K, Madsen JC, Cetrulo CL Jr, Sachs DH. Immunomodulatory Strategies Directed Toward Tolerance of Vascularized Composite Allografts. Transplantation 2015;99:1590-7. [PMID: 25757218 DOI: 10.1097/TP.0000000000000681] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
541 Wu K, Budde K, Schmidt D, Neumayer HH, Rudolph B. The Relationship of the Severity and Category of Acute Rejection With Intimal Arteritis Defined in Banff Classification to Clinical Outcomes. Transplantation 2015;99:e105-14. [PMID: 25719260 DOI: 10.1097/TP.0000000000000640] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
542 Buxeda A, Velis G, Arias-Cabrales C, Zapatero A, Burballa C, Redondo-Pachón D, Mir M, Crespo M, Pascual J, Pérez-Sáez MJ. Kidney transplantation outcomes from elderly donors after circulatory death: a comparison with elderly brain-dead donors. Clin Kidney J 2021;14:1181-9. [PMID: 33841864 DOI: 10.1093/ckj/sfaa114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
543 Morath C, Zeier M. Transplantation: Molecular diagnosis of kidney transplant rejection. Nat Rev Nephrol 2014;10:429-30. [PMID: 24935708 DOI: 10.1038/nrneph.2014.106] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
544 Rosales IA, Foreman RK, Defazio M, Sachs DH, Cetrulo CL, Leonard DA, Colvin RB. Systematic pathological component scores for skin-containing vascularized composite allografts. Vascularized Composite Allotransplantation 2016;3:62-74. [DOI: 10.1080/23723505.2017.1318200] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
545 Ding CG, Jiao LZ, Han F, Xiang HL, Tian PX, Ding XM, Pan XM, Tian XH, Li Y, Zheng J, Xue WJ. Early Immunosuppressive Exposure of Enteric-Coated-Mycophenolate Sodium Plus Tacrolimus Associated with Acute Rejection in Expanded Criteria Donor Kidney Transplantation. Chin Med J (Engl) 2018;131:1302-7. [PMID: 29786042 DOI: 10.4103/0366-6999.232797] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
546 García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Reisaeter AV, Seron D. Kidney allograft subclinical rejection modulates systemic inflammation measured by C-reactive protein at 1 year after transplantation. Clin Transplant 2018;32:e13196. [PMID: 29380890 DOI: 10.1111/ctr.13196] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
547 Preuss S, Rother C, Renders L, Wagenpfeil S, Büttner-Herold M, Slotta-Huspenina J, Holtzmann C, Kuechle C, Heemann U, Stock KF. Sonography of the renal allograft: Correlation between doppler sonographic resistance index (RI) and histopathology. Clin Hemorheol Microcirc 2018;70:413-22. [PMID: 30562894 DOI: 10.3233/CH-189306] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
548 Loupy A, Haas M, Solez K, Racusen L, Glotz D, Seron D, Nankivell BJ, Colvin RB, Afrouzian M, Akalin E, Alachkar N, Bagnasco S, Becker JU, Cornell L, Drachenberg C, Dragun D, de Kort H, Gibson IW, Kraus ES, Lefaucheur C, Legendre C, Liapis H, Muthukumar T, Nickeleit V, Orandi B, Park W, Rabant M, Randhawa P, Reed EF, Roufosse C, Seshan SV, Sis B, Singh HK, Schinstock C, Tambur A, Zeevi A, Mengel M. The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology. Am J Transplant. 2017;17:28-41. [PMID: 27862883 DOI: 10.1111/ajt.14107] [Cited by in Crossref: 375] [Cited by in F6Publishing: 342] [Article Influence: 75.0] [Reference Citation Analysis]
549 Alhamoud I, Huang R, Lacelle C, Burguete D, Hendricks AR, Torrealba JR, Seikaly MG. Allograft outcomes of treated children with kidney transplant who developed plasma cell‐rich acute rejection (PCAR): A single center's experience. Pediatr Transplant 2019;23. [DOI: 10.1111/petr.13500] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
550 Temurhan S, Akgul SU, Caliskan Y, Artan AS, Kekik C, Yazici H, Demir E, Caliskan B, Turkmen A, Oguz FS, Sever MS. A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy. Transplant Proc 2017;49:541-5. [PMID: 28340830 DOI: 10.1016/j.transproceed.2017.02.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
551 Lim B, Kwon H, Bae Y, Jeong H. Immunohistochemical Analysis of Infiltrating Inflammatory Cells in the Isolated V-Lesion of Allograft Kidney. Transplantation Proceedings 2015;47:622-5. [DOI: 10.1016/j.transproceed.2014.12.040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
552 Kamal L, Broin PÓ, Bao Y, Ajaimy M, Lubetzky M, Gupta A, de Boccardo G, Pullman J, Golden A, Akalin E. Clinical, Histological, and Molecular Markers Associated With Allograft Loss in Transplant Glomerulopathy Patients. Transplantation 2015;99:1912-8. [PMID: 25675205 DOI: 10.1097/TP.0000000000000598] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
553 Raza S, Alahmadi I, Broering D, Alherbish A, Ali T. Kidney transplantation in low weight pediatric recipients from adult donors: The short- And the long-term outcomes. Pediatr Transplant 2021;25:e13860. [PMID: 33022859 DOI: 10.1111/petr.13860] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
554 Higuchi H, Kamimura D, Jiang JJ, Atsumi T, Iwami D, Hotta K, Harada H, Takada Y, Kanno-Okada H, Hatanaka KC, Tanaka Y, Shinohara N, Murakami M. Orosomucoid 1 is involved in the development of chronic allograft rejection after kidney transplantation. Int Immunol 2020;32:335-46. [PMID: 31930291 DOI: 10.1093/intimm/dxaa003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
555 Wang HD, Fidder SA, Miller DT, Furtmüller GJ, Ahmadi AR, Nägele F, Lopez J, Quan A, Budihardjo J, Lough DM, Akpinarli B, Etra JW, Vasilic D, Raimondi G, Lee WA, Montgomery RA, Sun Z, Brandacher G. Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation. Transplantation 2018;102:593-600. [DOI: 10.1097/tp.0000000000002070] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
556 Nocera A, Tagliamacco A, Cioni M, Innocente A, Fontana I, Barbano G, Carrea A, Ramondetta M, Sementa A, Basso S, Quartuccio G, Klersy C, Bertocchi M, Verrina E, Garibotto G, Ghiggeri GM, Cardillo M, Comoli P, Ginevri F. Kidney Intragraft Homing of De Novo Donor-Specific HLA Antibodies Is an Essential Step of Antibody-Mediated Damage but Not Per Se Predictive of Graft Loss. Am J Transplant 2017;17:692-702. [DOI: 10.1111/ajt.14000] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
557 Teixeira CM, Tedesco Silva Junior H, Moura LAR, Proença HMS, de Marco R, Gerbase de Lima M, Cristelli MP, Viana LA, Felipe CR, Medina Pestana JO. Clinical and pathological features of thrombotic microangiopathy influencing long-term kidney transplant outcomes. PLoS One 2020;15:e0227445. [PMID: 31923282 DOI: 10.1371/journal.pone.0227445] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
558 Crespo M, Llinàs-Mallol L, Redondo-Pachón D, Butler C, Gimeno J, Pérez-Sáez MJ, Burballa C, Buxeda A, Arias-Cabrales C, Folgueiras M, Sanz-Ureña S, Valenzuela NM, Reed EF, Pascual J. Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection. Front Immunol 2021;12:703457. [PMID: 34305943 DOI: 10.3389/fimmu.2021.703457] [Reference Citation Analysis]
559 Assis BPS, Lasmar MF, Fabreti-Oliveira RA, Araujo SA, Oliveira J, Wanderley DC, Nascimento E. An open-label randomized clinical trial to evaluate the efficacy of everolimus versus tacrolimus in triple maintenance immunosuppressive therapy for kidney transplant patients. Braz J Med Biol Res 2021;54:e9369. [PMID: 33681893 DOI: 10.1590/1414-431X20209369] [Reference Citation Analysis]
560 Takamura T, Yamamoto I, Nakada Y, Katsumata H, Yamakawa T, Furuya M, Mafune A, Kobayashi A, Tanno Y, Miki J, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T. Acute T cell-mediated rejection accompanied by C4d-negative acute antibody-mediated rejection and cell debris in tubulus: A case report: Acute cellular rejection, C4d negative AMR and UTI. Nephrology 2015;20:70-4. [DOI: 10.1111/nep.12466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
561 Kim H, Choe W, Shin S, Kim YH, Han D, Park S, Kwon S, Ko D. ABO‐incompatible kidney transplantation can be successfully conducted by monitoring IgM isoagglutinin titers during desensitization. Transfusion 2020;60:598-606. [DOI: 10.1111/trf.15672] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
562 Maenosono R, Unagami K, Kakuta Y, Furusawa M, Okumi M, Azuma H, Ishida H, Tanabe K. Association between response to rituximab and antibody-mediated rejection in ABO-incompatible living kidney transplantation. Int J Urol 2019;26:1114-20. [PMID: 31522467 DOI: 10.1111/iju.14108] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
563 Ogawa S, Ishimura T, Miyake H, Fujisawa M. Expression profile of mammalian target of rapamycin-related proteins in graft biopsy specimens: Significance for predicting interstitial fibrosis after kidney transplantation. Int J Urol 2017;24:223-9. [PMID: 28173612 DOI: 10.1111/iju.13287] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
564 Mota AP, Menezes CA, Alpoim PN, Cardoso CN, Martins SR, Alves LV, de A Martins-filho O, Gomes KB, Dusse LM. Regulatory and pro-inflammatory cytokines in Brazilian living-related renal transplant recipients according to creatinine plasma levels. Nephrology 2018;23:867-75. [DOI: 10.1111/nep.13114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
565 Loucks-DeVos JM, Eagar TN, Gaber AO, Patel SJ, Teeter LD, Graviss EA, Knight RJ. The detrimental impact of persistent vs an isolated occurrence of de novo donor-specific antibodies on intermediate-term renal transplant outcomes. Clin Transplant 2017;31. [PMID: 28582797 DOI: 10.1111/ctr.13025] [Reference Citation Analysis]
566 Darres A, Ulloa C, Brakemeier S, Garrouste C, Bestard O, Del Bello A, Sberro Soussan R, Dürr M, Budde K, Legendre C, Kamar N. Conversion to Belatacept in Maintenance Kidney Transplant Patients: A Retrospective Multicenter European Study. Transplantation 2018;102:1545-52. [PMID: 29570163 DOI: 10.1097/TP.0000000000002192] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 8.7] [Reference Citation Analysis]
567 Ashraf MI, Schwelberger HG, Brendel KA, Feurle J, Andrassy J, Kotsch K, Regele H, Pratschke J, Maier HT, Aigner F. Exogenous Lipocalin 2 Ameliorates Acute Rejection in a Mouse Model of Renal Transplantation. Am J Transplant 2016;16:808-20. [PMID: 26595644 DOI: 10.1111/ajt.13521] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
568 Laguna-goya R, Utrero-rico A, Cano-romero FL, Gómez-massa E, González E, Andrés A, Mancebo-sierra E, Paz-artal E. Imbalance favoring follicular helper T cells over IL10+ regulatory B cells is detrimental for the kidney allograft. Kidney International 2020;98:732-43. [DOI: 10.1016/j.kint.2020.02.039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
569 Pearl MH, Grotts J, Rossetti M, Zhang Q, Gjertson DW, Weng P, Elashoff D, Reed EF, Tsai Chambers E. Cytokine Profiles Associated With Angiotensin II Type 1 Receptor Antibodies. Kidney Int Rep 2019;4:541-50. [PMID: 30997435 DOI: 10.1016/j.ekir.2018.12.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
570 Huang E, Sethi S, Peng A, Najjar R, Mirocha J, Haas M, Vo A, Jordan SC. Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients. Am J Transplant. 2019;19:1663-1670. [PMID: 30725531 DOI: 10.1111/ajt.15289] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 18.0] [Reference Citation Analysis]
571 Johal S, Jackson-spence F, Gillott H, Tahir S, Mytton J, Evison F, Stephenson B, Nath J, Sharif A. Pre-existing diabetes is a risk factor for increased rates of cellular rejection after kidney transplantation: an observational cohort study. Diabet Med 2017;34:1067-73. [DOI: 10.1111/dme.13383] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
572 Ezekian B, Schroder PM, Mulvihill MS, Barbas A, Collins B, Freischlag K, Yoon J, Yi JS, Smith F, Olaso D, Saccoccio FM, Permar S, Farris AB, Kwun J, Knechtle SJ. Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients. J Am Soc Nephrol 2019;30:2399-411. [PMID: 31658991 DOI: 10.1681/ASN.2019030304] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
573 Masutani K, Tsuchimoto A, Matsukuma Y, Kurihara K, Nishiki T, Kitada H, Tanaka M, Kitazono T, Tsuruya K. Temporal serum creatinine increase and exacerbation of tubulointerstitial inflammation during the first two months in resolving polyomavirus BK nephropathy: Inflammation in resolving BKVN. Nephrology 2015;20:45-50. [DOI: 10.1111/nep.12462] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
574 Malheiro J, Tafulo S, Dias L, Martins S, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A. Impact on mid-term kidney graft outcomes of pretransplant anti-HLA antibodies detected by solid-phase assays: Do donor-specific antibodies tell the whole story? Hum Immunol 2017;78:526-33. [PMID: 28732720 DOI: 10.1016/j.humimm.2017.07.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
575 Kwun J, Matignon M, Manook M, Guendouz S, Audard V, Kheav D, Poullot E, Gautreau C, Ezekian B, Bodez D, Damy T, Faivre L, Menouch D, Yoon J, Park J, Belhadj K, Chen D, Bilewski AM, Yi JS, Collins B, Stegall M, Farris AB, Knechtle S, Grimbert P. Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use. J Am Soc Nephrol 2019;30:1206-19. [PMID: 31227636 DOI: 10.1681/ASN.2018121254] [Cited by in Crossref: 32] [Cited by in F6Publishing: 12] [Article Influence: 10.7] [Reference Citation Analysis]
576 Espinel E, Agraz I, Ibernon M, Ramos N, Fort J, Serón D. Renal Biopsy in Type 2 Diabetic Patients. J Clin Med. 2015;4:998-1009. [PMID: 26239461 DOI: 10.3390/jcm4050998] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
577 Ueki K, Tsuchimoto A, Matsukuma Y, Nakagawa K, Tsujikawa H, Masutani K, Tanaka S, Kaku K, Noguchi H, Okabe Y, Unagami K, Kakuta Y, Okumi M, Nakamura M, Tsuruya K, Nakano T, Tanabe K, Kitazono T; Japan Academic Consortium of Kidney Transplantation investigators. Development and validation of a risk score for the prediction of cardiovascular disease in living donor kidney transplant recipients. Nephrol Dial Transplant 2021;36:365-74. [PMID: 33367750 DOI: 10.1093/ndt/gfaa275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
578 Hara S. Current pathological perspectives on chronic rejection in renal allografts. Clin Exp Nephrol 2017;21:943-51. [PMID: 27848058 DOI: 10.1007/s10157-016-1361-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
579 Ishihara H, Ishida H, Unagami K, Hirai T, Okumi M, Omoto K, Shimizu T, Tanabe K. Evaluation of Microvascular Inflammation in ABO-Incompatible Kidney Transplantation. Transplantation 2017;101:1423-32. [PMID: 27495756 DOI: 10.1097/TP.0000000000001403] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
580 Joachim E, Parajuli S, Swanson KJ, Aziz F, Garg N, Mohamed M, Mandelbrot D, Djamali A. Treatment of Chronic Active Antibody-mediated Rejection With Pulse Steroids, IVIG, With or Without Rituximab is Associated With Increased Risk of Pneumonia. Transplant Direct 2021;7:e644. [PMID: 33335983 DOI: 10.1097/TXD.0000000000001080] [Reference Citation Analysis]
581 Miyairi S, Ueda D, Yagisawa T, Okada D, Keslar KS, Tanabe K, Dvorina N, Valujskikh A, Baldwin WM 3rd, Hazen SL, Fairchild RL. Recipient myeloperoxidase-producing cells regulate antibody-mediated acute versus chronic kidney allograft rejection. JCI Insight 2021;6:148747. [PMID: 34081629 DOI: 10.1172/jci.insight.148747] [Reference Citation Analysis]
582 Zimmerman D, House AA, Kim SJ, Booth RA, Zhang T, Ramsay T, Knoll G. The Risk of Acute Rejection Following Kidney Transplant by 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Status: A Prospective Cohort Study. Can J Kidney Health Dis 2017;4:2054358117699822. [PMID: 28491335 DOI: 10.1177/2054358117699822] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
583 Los-Arcos I, Len O, Perello M, Torres IB, Codina G, Esperalba J, Sellarés J, Moreso F, Seron D, Gavaldà J. Is antibody-mediated rejection in kidney transplant recipients a risk factor for developing cytomegalovirus or BK virus infection? Results from a case-control study. J Clin Virol 2019;110:45-50. [PMID: 30537648 DOI: 10.1016/j.jcv.2018.11.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
584 Seifert ME, Yanik MV, Feig DI, Hauptfeld-Dolejsek V, Mroczek-Musulman EC, Kelly DR, Rosenblum F, Mannon RB. Subclinical inflammation phenotypes and long-term outcomes after pediatric kidney transplantation. Am J Transplant 2018;18:2189-99. [PMID: 29766640 DOI: 10.1111/ajt.14933] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
585 Lee J, Park Y, Kim B, Lee J, Kim H, Kim Y, Huh K. Clinical Implications of Angiotensin II Type 1 Receptor Antibodies in Antibody-mediated Rejection Without Detectable Donor-specific HLA Antibodies After Renal Transplantation. Transplantation Proceedings 2015;47:649-52. [DOI: 10.1016/j.transproceed.2014.11.055] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
586 Legendre C, Loupy A, Rabant M, Aubert O, Rabaté C, Delville M, Tinel C, Amrouche L, Martinez F, Snanoudj R, Bererhi L, Scemla A, Sberro-Soussan R, Duong JP, Suberbielle C, Anglicheau D. [Current aspects of acute humoral rejection]. Nephrol Ther 2014;10:479-83. [PMID: 25440942 DOI: 10.1016/j.nephro.2014.09.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
587 Steiger P, Barbieri S, Kruse A, Ith M, Thoeny HC. Selection for biopsy of kidney transplant patients by diffusion-weighted MRI. Eur Radiol 2017;27:4336-44. [DOI: 10.1007/s00330-017-4814-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
588 Guidicelli G, Guerville F, Lepreux S, Wiebe C, Thaunat O, Dubois V, Visentin J, Bachelet T, Morelon E, Nickerson P, Merville P, Taupin JL, Couzi L. Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival. J Am Soc Nephrol 2016;27:615-25. [PMID: 26047793 DOI: 10.1681/ASN.2014040326] [Cited by in Crossref: 87] [Cited by in F6Publishing: 34] [Article Influence: 12.4] [Reference Citation Analysis]
589 Djamali A, Kaufman DB, Ellis TM, Zhong W, Matas A, Samaniego M. Diagnosis and management of antibody-mediated rejection: current status and novel approaches. Am J Transplant 2014;14:255-71. [PMID: 24401076 DOI: 10.1111/ajt.12589] [Cited by in Crossref: 241] [Cited by in F6Publishing: 201] [Article Influence: 30.1] [Reference Citation Analysis]
590 Davis S, Gralla J, Klem P, Tong S, Wedermyer G, Freed B, Wiseman A, Cooper JE. Lower tacrolimus exposure and time in therapeutic range increase the risk of de novo donor-specific antibodies in the first year of kidney transplantation. Am J Transplant 2018;18:907-15. [PMID: 28925597 DOI: 10.1111/ajt.14504] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 11.4] [Reference Citation Analysis]
591 Cihan Y, Kanzelmeyer N, Drube J, Kreuzer M, Lerch C, Hennies I, Froede K, Verboom M, Ahlenstiel-grunow T, Pape L. Rabbit anti-human thymocyte immunoglobulin for the rescue treatment of chronic antibody-mediated rejection after pediatric kidney transplantation. Pediatr Nephrol 2017;32:2133-42. [DOI: 10.1007/s00467-017-3725-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
592 Becker JU, Chang A, Nickeleit V, Randhawa P, Roufosse C. Banff Borderline Changes Suspicious for Acute T Cell-Mediated Rejection: Where Do We Stand? Am J Transplant 2016;16:2654-60. [PMID: 26988137 DOI: 10.1111/ajt.13784] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 5.5] [Reference Citation Analysis]
593 Rascio F, Pontrelli P, Netti GS, Manno E, Infante B, Simone S, Castellano G, Ranieri E, Seveso M, Cozzi E, Gesualdo L, Stallone G, Grandaliano G. IgE-Mediated Immune Response and Antibody-Mediated Rejection. Clin J Am Soc Nephrol 2020;15:1474-83. [PMID: 32907809 DOI: 10.2215/CJN.02870320] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
594 Salvadori M, Bertoni E. What’s new in clinical solid organ transplantation by 2013. World J Transplant 2014; 4(4): 243-266 [PMID: 25540734 DOI: 10.5500/wjt.v4.i4.243] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
595 Goh LF, Khoo SR, Tung Y, Lee PH, Kee T. Impact of transiting from fluorescent polarisation immunoassay to high-performance liquid chromatography–tandem mass spectrometry for immunosuppressant levels analysis in kidney transplant patients. Proceedings of Singapore Healthcare 2020;29:228-33. [DOI: 10.1177/2010105820974385] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
596 Visentin J, Couzi L, Taupin JL. Clinical relevance of donor-specific antibodies directed at HLA-C: A long road to acceptance. HLA 2021;97:3-14. [PMID: 33052032 DOI: 10.1111/tan.14106] [Reference Citation Analysis]
597 de Kort H, Moran L, Roufosse C. The role of electron microscopy in renal allograft biopsy evaluation. Current Opinion in Organ Transplantation 2015;20:333-42. [DOI: 10.1097/mot.0000000000000183] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
598 Mei T, Noguchi H, Otsu K, Shimada Y, Sato Y, Hisadome Y, Kaku K, Okabe Y, Nakamura M. Risk Factors and Optimal Methods for Incisional Hernias After Kidney Transplantation: A Single-Center Experience From Asia. Transplant Proc 2021;53:1048-54. [PMID: 33726941 DOI: 10.1016/j.transproceed.2021.02.012] [Reference Citation Analysis]
599 Pearl MH, Zhang Q, Palma Diaz MF, Grotts J, Rossetti M, Elashoff D, Gjertson DW, Weng P, Reed EF, Tsai Chambers E. Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation. Kidney Int 2018;93:260-9. [PMID: 28927645 DOI: 10.1016/j.kint.2017.06.034] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 7.2] [Reference Citation Analysis]
600 Arnold ML, Kainz A, Hidalgo LG, Eskandary F, Kozakowski N, Wahrmann M, Haslacher H, Oberbauer R, Heilos A, Spriewald BM, Halloran PF, Böhmig GA. Functional Fc gamma receptor gene polymorphisms and donor-specific antibody-triggered microcirculation inflammation. Am J Transplant 2018;18:2261-73. [DOI: 10.1111/ajt.14710] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
601 Doberer K, Duerr M, Halloran PF, Eskandary F, Budde K, Regele H, Reeve J, Borski A, Kozakowski N, Reindl-Schwaighofer R, Waiser J, Lachmann N, Schranz S, Firbas C, Mühlbacher J, Gelbenegger G, Perkmann T, Wahrmann M, Kainz A, Ristl R, Halleck F, Bond G, Chong E, Jilma B, Böhmig GA. A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection. J Am Soc Nephrol 2021;32:708-22. [PMID: 33443079 DOI: 10.1681/ASN.2020071106] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
602 Troxell ML, Houghton DC. The Basics of Renal Allograft Pathology. Surg Pathol Clin 2014;7:367-87. [PMID: 26837445 DOI: 10.1016/j.path.2014.04.009] [Reference Citation Analysis]
603 Jain V, Dhawan A. Acute antibody-mediated rejection in the liver allograft: A masquerade or new disease? Pediatr Transplant 2017;21. [PMID: 28127881 DOI: 10.1111/petr.12869] [Reference Citation Analysis]
604 Moktefi A, Parisot J, Desvaux D, Canoui-Poitrine F, Brocheriou I, Peltier J, Audard V, Kofman T, Suberbielle C, Lang P, Rondeau E, Grimbert P, Matignon M. C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study. Transpl Int 2017;30:277-87. [PMID: 27992962 DOI: 10.1111/tri.12905] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
605 Lefaucheur C, Viglietti D, Bentlejewski C, Duong van Huyen JP, Vernerey D, Aubert O, Verine J, Jouven X, Legendre C, Glotz D, Loupy A, Zeevi A. IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury. J Am Soc Nephrol 2016;27:293-304. [PMID: 26293822 DOI: 10.1681/ASN.2014111120] [Cited by in Crossref: 175] [Cited by in F6Publishing: 71] [Article Influence: 25.0] [Reference Citation Analysis]
606 Hasegawa J, Honda K, Wakai S, Shirakawa H, Omoto K, Okumi M, Ishida H, Tanabe K. Plasma Cell–Rich Rejection After Kidney Transplantation and the Role of Donor-Specific Antibodies: A Case Report and Review of the Literature. Transplantation Proceedings 2015;47:2533-6. [DOI: 10.1016/j.transproceed.2015.09.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
607 Kim SK, Yang JJ, Hwang SH, Sung H, Shin S, Ko SY, Oh HB. Prediction of HLA-DQ in Deceased Donors and its Clinical Significance in Kidney Transplantation. Ann Lab Med 2021;41:190-7. [PMID: 33063680 DOI: 10.3343/alm.2021.41.2.190] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
608 García-carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Seron D, Reisæter AV. Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific Antibodies. Transplantation 2017;101:1410-5. [DOI: 10.1097/tp.0000000000001216] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 4.4] [Reference Citation Analysis]
609 Haas M. An updated Banff schema for diagnosis of antibody-mediated rejection in renal allografts. Curr Opin Organ Transplant. 2014;19:315-322. [PMID: 24811440 DOI: 10.1097/mot.0000000000000072] [Cited by in Crossref: 54] [Cited by in F6Publishing: 18] [Article Influence: 6.8] [Reference Citation Analysis]
610 Schinstock CA, Askar M, Bagnasco SM, Batal I, Bow L, Budde K, Campbell P, Carroll R, Clahsen-van Groningen MC, Cooper M, Cornell LD, Cozzi E, Dadhania D, Diekmann F, Hesselink DA, Jackson AM, Kikic Z, Lower F, Naesens M, Roelofs JJ, Sapir-Pichhadze R, Kraus ES. A 2020 Banff Antibody-mediatedInjury Working Group examination of international practices for diagnosing antibody-mediated rejection in kidney transplantation - a cohort study. Transpl Int 2021;34:488-98. [PMID: 33423340 DOI: 10.1111/tri.13813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
611 Parajuli S, Bath NM, Hidalgo L, Leverson G, Garg N, R Redfield R 3rd, Mandelbrot DA. Impact of low-level pretransplant donor-specific antibodies on outcomes after kidney transplantation. Immun Inflamm Dis 2021. [PMID: 34407300 DOI: 10.1002/iid3.504] [Reference Citation Analysis]
612 Bath NM, Ding X, Verhoven BM, Wilson NA, Coons L, Sukhwal A, Zhong W, Redfield Iii RR. Autoantibody production significantly decreased with APRIL/BLyS blockade in murine chronic rejection kidney transplant model. PLoS One 2019;14:e0223889. [PMID: 31647850 DOI: 10.1371/journal.pone.0223889] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
613 Bachelet T, Visentin J, Davis P, Taton B, Guidicelli G, Kaminski H, Merville P, Couzi L. The incidence of post-transplant malignancies in kidney transplant recipients treated with Rituximab. Clin Transplant 2021;35:e14171. [PMID: 33247459 DOI: 10.1111/ctr.14171] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
614 Bachmann F, Adam T, Friedersdorff F, Liefeldt L, Slowinski T, Budde K, Waiser J. Perioperative antibiotic prophylaxis in renal transplantation: a single-center comparison between two regimens and a brief survey among the Eurotransplant renal transplantation centers. World J Urol 2019;37:957-67. [PMID: 30109484 DOI: 10.1007/s00345-018-2440-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
615 Reese SR, Wilson NA, Huang G, Redfield RR, Zhong W, Djamali A. Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical Model. Transplantation 2015;99:1785-95. [DOI: 10.1097/tp.0000000000000736] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
616 Mehra NK, Baranwal AK. Clinical and immunological relevance of antibodies in solid organ transplantation. Int J Immunogenet 2016;43:351-68. [DOI: 10.1111/iji.12294] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
617 Reusz GS. Urinary proteomics: fancy gadgetry or a clinically useful diagnostic instrument? The end-user's perspective. Transpl Int 2019;32:25-7. [DOI: 10.1111/tri.13374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
618 Aubert O, Loupy A, Hidalgo L, Duong van Huyen JP, Higgins S, Viglietti D, Jouven X, Glotz D, Legendre C, Lefaucheur C, Halloran PF. Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients. J Am Soc Nephrol 2017;28:1912-23. [PMID: 28255002 DOI: 10.1681/ASN.2016070797] [Cited by in Crossref: 119] [Cited by in F6Publishing: 33] [Article Influence: 23.8] [Reference Citation Analysis]
619 Deger E, Celik A, Dheir H, Turunc V, Yardimci A, Torun M, Cihangiroglu M. Rejection evaluation after renal transplantation using MR diffusion tensor imaging. Acta Radiol 2018;59:876-83. [PMID: 28975804 DOI: 10.1177/0284185117733777] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
620 Broecker V, Bardsley V, Torpey N, Perera R, Montero R, Dorling A, Bentall A, Neil D, Willicombe M, Berry M, Roufosse C. Clinical-pathological correlations in post-transplant thrombotic microangiopathy. Histopathology 2019;75:88-103. [PMID: 30851188 DOI: 10.1111/his.13855] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
621 Roufosse C, Simmonds N, Clahsen-van Groningen M, Haas M, Henriksen KJ, Horsfield C, Loupy A, Mengel M, Perkowska-Ptasińska A, Rabant M, Racusen LC, Solez K, Becker JU. A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology. Transplantation 2018;102:1795-814. [PMID: 30028786 DOI: 10.1097/TP.0000000000002366] [Cited by in Crossref: 174] [Cited by in F6Publishing: 88] [Article Influence: 58.0] [Reference Citation Analysis]
622 Haarberg KMK, Tambur AR. Detection of donor-specific antibodies in kidney transplantation. British Medical Bulletin 2014;110:23-34. [DOI: 10.1093/bmb/ldu005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
623 Goutaudier V, Perrochia H, Mucha S, Bonnet M, Delmas S, Garo F, Garrigue V, Lepreux S, Pernin V, Serre JE, Szwarc I, Merville P, Ramounau-Pigot A, René C, Visentin J, Morgan BP, Frémeaux-Bacchi V, Mourad G, Couzi L, Le Quintrec M. C5b9 Deposition in Glomerular Capillaries Is Associated With Poor Kidney Allograft Survival in Antibody-Mediated Rejection. Front Immunol 2019;10:235. [PMID: 30906289 DOI: 10.3389/fimmu.2019.00235] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
624 Jiang Z, Liang Y, Zhong T, Yang S, Chen Y, Huang G, Wang C, Chen W. Pediatric Donor Glomerulopathy Is a Possible Cause of Abnormal Urinalysis in Adults Receiving Small Pediatric Donor Kidneys. Transplantation 2020;104:1695-702. [PMID: 32732849 DOI: 10.1097/TP.0000000000003038] [Reference Citation Analysis]
625 Benzimra M, Calligaro GL, Glanville AR. Acute rejection. J Thorac Dis 2017;9:5440-57. [PMID: 29312755 DOI: 10.21037/jtd.2017.11.83] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 4.4] [Reference Citation Analysis]
626 Halloran PF, Famulski K, Reeve J. The molecular phenotypes of rejection in kidney transplant biopsies. Current Opinion in Organ Transplantation 2015;20:359-67. [DOI: 10.1097/mot.0000000000000193] [Cited by in Crossref: 39] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
627 Yang Y, Hodgin JB, Afshinnia F, Wang SQ, Wickman L, Chowdhury M, Nishizono R, Kikuchi M, Huang Y, Samaniego M. The two kidney to one kidney transition and transplant glomerulopathy: a podocyte perspective. J Am Soc Nephrol. 2015;26:1450-1465. [PMID: 25388223 DOI: 10.1681/asn.2014030287] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
628 Giannico GA, Arnold S, Langone A, Schaefer H, Helderman JH, Shaffer D, Fogo AB. Non-immunoglobulin A mesangial immune complex glomerulonephritis in kidney transplants. Hum Pathol 2015;46:1521-8. [PMID: 26245687 DOI: 10.1016/j.humpath.2015.06.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
629 Crespo M, Zárraga S, Alonso Á, Beneyto I, Díaz Corte C, Fernandez Rodriguez AM, Franco A, Hernández D, González-roncero FM, Jiménez Martín C, Jimeno L, Lauzurica Valdemoros L, Llorente S, Mazuecos A, Osuna A, Ramos JP, Rodríguez Benot A, Ruiz San Millán JC, Sánchez Fructuoso A, Torregrosa J, Guirado L. Monitoring of Donor-specific Anti-HLA Antibodies and Management of Immunosuppression in Kidney Transplant Recipients: An Evidence-based Expert Paper. Transplantation 2020;104:S1-S12. [DOI: 10.1097/tp.0000000000003270] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
630 Mas VR, Maluf DG. Cellular and molecular profiling of graft injury post renal transplantation. Curr Opin Organ Transplant 2017;22:36-45. [PMID: 27941467 DOI: 10.1097/MOT.0000000000000377] [Reference Citation Analysis]
631 Désy O, Béland S, Vallin P, Riopel J, Latulippe E, Najafian N, Chandraker A, Agharazii M, Batal I, De Serres SA. IL-6 production by monocytes is associated with graft function decline in patients with borderline changes suspicious for acute T-cell-mediated rejection: a pilot study. Transpl Int 2018;31:92-101. [DOI: 10.1111/tri.13070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
632 Wozniak LJ, Venick RS. Donor-specific antibodies following liver and intestinal transplantation: Clinical significance, pathogenesis and recommendations. International Reviews of Immunology 2019;38:106-17. [DOI: 10.1080/08830185.2019.1630404] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
633 Chen XT, Yang SC, Li J, Deng RH, Chen WF, Qiu J, Chen LZ, Wang CX, Huang G. Prognosis of BK polyomavirus nephropathy: 10-year analysis of 133 renal transplant recipients at a single center. Chin Med J (Engl) 2019;132:388-94. [PMID: 30707175 DOI: 10.1097/CM9.0000000000000085] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
634 Holscher CM, Jackson KR, Segev DL. Transplanting the Untransplantable. American Journal of Kidney Diseases 2020;75:114-23. [DOI: 10.1053/j.ajkd.2019.04.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
635 Ville S, Poirier N, Branchereau J, Charpy V, Pengam S, Nerriere-Daguin V, Le Bas-Bernardet S, Coulon F, Mary C, Chenouard A, Hervouet J, Minault D, Nedellec S, Renaudin K, Vanhove B, Blancho G. Anti-CD28 Antibody and Belatacept Exert Differential Effects on Mechanisms of Renal Allograft Rejection. J Am Soc Nephrol 2016;27:3577-88. [PMID: 27160407 DOI: 10.1681/ASN.2015070774] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
636 Cooper JE. Evaluation and Treatment of Acute Rejection in Kidney Allografts. Clin J Am Soc Nephrol 2020;15:430-8. [PMID: 32066593 DOI: 10.2215/CJN.11991019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
637 Gielis EM, Ledeganck KJ, Dendooven A, Meysman P, Beirnaert C, Laukens K, De Schrijver J, Van Laecke S, Van Biesen W, Emonds MP, De Winter BY, Bosmans JL, Del Favero J, Abramowicz D. The use of plasma donor-derived, cell-free DNA to monitor acute rejection after kidney transplantation. Nephrol Dial Transplant 2020;35:714-21. [PMID: 31106364 DOI: 10.1093/ndt/gfz091] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 12.5] [Reference Citation Analysis]
638 Venner JM, Famulski KS, Reeve J, Chang J, Halloran PF. Relationships among injury, fibrosis, and time in human kidney transplants. JCI Insight 2016;1:e85323. [PMID: 27699214 DOI: 10.1172/jci.insight.85323] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 6.8] [Reference Citation Analysis]
639 Ville S, Poirier N, Blancho G, Vanhove B. Co-Stimulatory Blockade of the CD28/CD80-86/CTLA-4 Balance in Transplantation: Impact on Memory T Cells? Front Immunol 2015;6:411. [PMID: 26322044 DOI: 10.3389/fimmu.2015.00411] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
640 Lim MA, Palmer M, Trofe-Clark J, Bloom RD, Jackson A, Philogene MC, Kamoun M. Histopathologic changes in anti-angiotensin II type 1 receptor antibody-positive kidney transplant recipients with acute rejection and no donor specific HLA antibodies. Hum Immunol 2017;78:350-6. [PMID: 28284829 DOI: 10.1016/j.humimm.2017.03.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
641 Chong AS, Rothstein DM, Safa K, Riella LV. Outstanding questions in transplantation: B cells, alloantibodies, and humoral rejection. Am J Transplant 2019;19:2155-63. [PMID: 30803121 DOI: 10.1111/ajt.15323] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
642 Cioni M, Comoli P, Tagliamacco A, Innocente A, Basso S, Fontana I, Magnasco A, Trivelli A, Nocco A, Macchiagodena M, Catenacci L, Klersy C, Verrina E, Garibotto G, Ghiggeri GM, Cardillo M, Ginevri F, Nocera A. Post-transplant de novo non donor-specific HLA antibodies are not associated with poor graft outcome in non-sensitized pediatric recipients of kidney transplantation. Transpl Immunol 2021;65:101375. [PMID: 33610675 DOI: 10.1016/j.trim.2021.101375] [Reference Citation Analysis]
643 Morath C, Opelz G, Zeier M, Süsal C. Clinical relevance of HLA antibody monitoring after kidney transplantation. J Immunol Res 2014;2014:845040. [PMID: 25374891 DOI: 10.1155/2014/845040] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
644 Demetris AJ, Bellamy C, Hübscher SG, O’Leary J, Randhawa PS, Feng S, Neil D, Colvin RB, McCaughan G, Fung JJ. 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection. Am J Transplant. 2016; Epub ahead of print. [PMID: 27273869 DOI: 10.1111/ajt.13909] [Cited by in Crossref: 230] [Cited by in F6Publishing: 187] [Article Influence: 38.3] [Reference Citation Analysis]
645 Barner M, DeKoning J, Kashi Z, Halloran P. Recent Advancements in the Assessment of Renal Transplant Dysfunction with an Emphasis on Microarray Molecular Diagnostics. Clin Lab Med 2018;38:623-35. [PMID: 30420057 DOI: 10.1016/j.cll.2018.07.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
646 Jordan SC, Bunnapradist S, Bromberg JS, Langone AJ, Hiller D, Yee JP, Sninsky JJ, Woodward RN, Matas AJ. Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients. Transplant Direct 2018;4:e379. [PMID: 30234148 DOI: 10.1097/TXD.0000000000000821] [Cited by in Crossref: 44] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
647 Lowe D, Daga S, Briggs D, Khovanova N, Mitchell D, Higgins R, Krishnan N. Meeting report: 3rd international transplant conference: how much risk can you take? Int J Immunogenet 2015;42:59-68. [PMID: 25684274 DOI: 10.1111/iji.12184] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
648 Valenzuela NM, Reed EF. Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies. J Clin Invest 2017;127:2492-504. [PMID: 28604384 DOI: 10.1172/JCI90597] [Cited by in Crossref: 83] [Cited by in F6Publishing: 36] [Article Influence: 16.6] [Reference Citation Analysis]
649 Shimizu T, Ishida H, Hayakawa N, Shibahara R, Tanabe K. Clinical and Pathological Analyses of Cases of Acute Vascular Rejection After Kidney Transplantation. Transplant Proc 2017;49:2251-5. [PMID: 29198655 DOI: 10.1016/j.transproceed.2017.09.046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
650 Venner JM, Famulski KS, Badr D, Hidalgo LG, Chang J, Halloran PF. Molecular landscape of T cell-mediated rejection in human kidney transplants: prominence of CTLA4 and PD ligands. Am J Transplant 2014;14:2565-76. [PMID: 25219326 DOI: 10.1111/ajt.12946] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 7.8] [Reference Citation Analysis]
651 Gierczak V, Jouve T, Malvezzi P, Terrec F, Naciri-Bennani H, Janbon B, Rostaing L, Noble J. Impact of Immunosuppressive Strategies on Post-Kidney Transplantation Thrombocytopenia. Transplant Proc 2021;53:941-9. [PMID: 33121819 DOI: 10.1016/j.transproceed.2020.09.014] [Reference Citation Analysis]
652 Manook M, Kwun J, Burghuber C, Samy K, Mulvihill M, Yoon J, Xu H, MacDonald AL, Freischlag K, Curfman V, Branum E, Howell D, Farris AB, Smith RA, Sacks S, Dorling A, Mamode N, Knechtle SJ. Thrombalexin: Use of a Cytotopic Anticoagulant to Reduce Thrombotic Microangiopathy in a Highly Sensitized Model of Kidney Transplantation. Am J Transplant 2017;17:2055-64. [PMID: 28226413 DOI: 10.1111/ajt.14234] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
653 Bitton L, Vandenbussche C, Wayolle N, Gibier J, Cordonnier C, Verine J, Humez S, Bataille P, Lenain R, Ramdane N, Azar R, Mac Namara E, Hatron P, Maurage C, Perrais M, Frimat M, Vanhille P, Glowacki F, Buob D, Copin M, Quéméneur T, Gnemmi V. Tubulointerstitial damage and interstitial immune cell phenotypes are useful predictors for renal survival and relapse in antineutrophil cytoplasmic antibody-associated vasculitis. J Nephrol 2020;33:771-81. [DOI: 10.1007/s40620-019-00695-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
654 Jasiak NM, Park JM. Immunosuppression in Solid-Organ Transplantation: Essentials and Practical Tips. Crit Care Nurs Q 2016;39:227-40. [PMID: 27254639 DOI: 10.1097/CNQ.0000000000000117] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 3.2] [Reference Citation Analysis]
655 Philogene MC, Bagnasco S, Kraus ES, Montgomery RA, Dragun D, Leffell MS, Zachary AA, Jackson AM. Anti-Angiotensin II Type 1 Receptor and Anti-Endothelial Cell Antibodies: A Cross-Sectional Analysis of Pathological Findings in Allograft Biopsies. Transplantation 2017;101:608-15. [PMID: 27222934 DOI: 10.1097/TP.0000000000001231] [Cited by in Crossref: 35] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
656 Zhang W, Yi Z, Keung KL, Shang H, Wei C, Cravedi P, Sun Z, Xi C, Woytovich C, Farouk S, Huang W, Banu K, Gallon L, Magee CN, Najafian N, Samaniego M, Djamali A, Alexander SI, Rosales IA, Smith RN, Xiang J, Lerut E, Kuypers D, Naesens M, O'Connell PJ, Colvin R, Menon MC, Murphy B. A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection. J Am Soc Nephrol. 2019;30:1481-1494. [PMID: 31278196 DOI: 10.1681/asn.2018111098] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 9.3] [Reference Citation Analysis]
657 Jordan SC, Choi J, Vo A. Achieving incompatible transplantation through desensitization: current perspectives and future directions. Immunotherapy 2015;7:377-98. [DOI: 10.2217/imt.15.10] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
658 Rodelo J, González LA, Ustáriz J, Matera S, Pérez K, Ramírez Z, Arias LF, García Á, Arbeláez M, Henao J. Kidney transplantation outcomes in lupus nephritis: A 37-year single-center experience from Latin America. Lupus 2021;:9612033211028663. [PMID: 34225520 DOI: 10.1177/09612033211028663] [Reference Citation Analysis]
659 Goesch TR, Wilson NA, Zeng W, Verhoven BM, Zhong W, Coumbe Gitter MM, Fahl WE. Suppression of Inflammation-Associated Kidney Damage Post-Transplant Using the New PrC-210 Free Radical Scavenger in Rats. Biomolecules 2021;11:1054. [PMID: 34356678 DOI: 10.3390/biom11071054] [Reference Citation Analysis]
660 Halloran PF, Famulski KS, Chang J. A Probabilistic Approach to Histologic Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Biopsies. Am J Transplant 2017;17:129-39. [PMID: 27340822 DOI: 10.1111/ajt.13934] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
661 Liao T, Zhang Y, Ren J, Zheng H, Zhang H, Li X, Liu X, Yin T, Sun Q. Noninvasive quantification of intrarenal allograft C4d deposition with targeted ultrasound imaging. Am J Transplant 2019;19:259-68. [PMID: 30171802 DOI: 10.1111/ajt.15105] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
662 Roedder S, Sigdel T, Hsieh SC, Cheeseman J, Metes D, Macedo C, Reed EF, Gritsch HA, Zeevi A, Shapiro R, Kirk AD, Sarwal MM. Expression of Mitochondrial-Encoded Genes in Blood Differentiate Acute Renal Allograft Rejection. Front Med (Lausanne) 2017;4:185. [PMID: 29164120 DOI: 10.3389/fmed.2017.00185] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
663 Quintella AHDS, Lasmar MF, Fabreti-Oliveira RA, Nascimento E. Delayed Graft Function, Predictive Factors, and 7-Year Outcome of Deceased Donor Kidney Transplant Recipients With Different Immunologic Profiles. Transplant Proc 2018;50:737-42. [PMID: 29661426 DOI: 10.1016/j.transproceed.2018.02.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
664 Janszky N, Süsal C. Circulating and urinary microRNAs as possible biomarkers in kidney transplantation. Transplant Rev (Orlando) 2018;32:110-8. [PMID: 29366537 DOI: 10.1016/j.trre.2017.12.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
665 Lauro A, Oltean M, Marino IR. Chronic Rejection After Intestinal Transplant: Where Are We in Order to Avert It? Dig Dis Sci 2018;63:551-62. [DOI: 10.1007/s10620-018-4909-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
666 Sá H, Leal R, Rosa MS. Renal transplant immunology in the last 20 years: A revolution towards graft and patient survival improvement. Int Rev Immunol 2017;36:182-203. [PMID: 27682364 DOI: 10.1080/08830185.2016.1225300] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
667 Vo AA, Aubert O, Haas M, Huang E, Zhang X, Choi J, Peng A, Najjar R, Sethi S, Ammerman N, Lim K, Jordan SC. Clinical Relevance of Posttransplant DSAs in Patients Receiving Desensitization for HLA-incompatible Kidney Transplantation. Transplantation 2019;103:2666-74. [DOI: 10.1097/tp.0000000000002691] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
668 Abud J, Pupo BBD, Silva CD, Keitel E, Garcia VD, Manfro RC, Neumann J. Phasing out the pre-transplant cytotoxicity crossmatch: Are we missing something? J Bras Nefrol 2021:S0101-28002021005034301. [PMID: 33899906 DOI: 10.1590/2175-8239-JBN-2019-0222] [Reference Citation Analysis]
669 Teixeira AC, Távora F, de Deus E Silva MLF, Prado RMG, de Matos Esmeraldo R, de Sandes-Freitas TV. The immunohistochemical expression of von Willebrand factor, T-cadherin, and Caveolin-1 is increased in kidney allograft biopsies with antibody-mediated injury. Clin Exp Nephrol 2021;25:305-14. [PMID: 33242156 DOI: 10.1007/s10157-020-01994-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
670 Vaulet T, Divard G, Thaunat O, Lerut E, Senev A, Aubert O, Van Loon E, Callemeyn J, Emonds MP, Van Craenenbroeck A, De Vusser K, Sprangers B, Rabeyrin M, Dubois V, Kuypers D, De Vos M, Loupy A, De Moor B, Naesens M. Data-driven Derivation and Validation of Novel Phenotypes for Acute Kidney Transplant Rejection using Semi-supervised Clustering. J Am Soc Nephrol 2021;32:1084-96. [PMID: 33687976 DOI: 10.1681/ASN.2020101418] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
671 Liu C, Pang S, Phelan D, Brennan DC, Mohanakumar T. Quantitative Evaluation of the Impact of Ethylenediaminetetraacetic Acid Pretreatment on Single-Antigen Bead Assay. Transplant Direct 2017;3:e194. [PMID: 28795145 DOI: 10.1097/TXD.0000000000000709] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
672 Pouliquen E, Koenig A, Chen CC, Sicard A, Rabeyrin M, Morelon E, Dubois V, Thaunat O. Recent advances in renal transplantation: antibody-mediated rejection takes center stage. F1000Prime Rep 2015;7:51. [PMID: 26097724 DOI: 10.12703/P7-51] [Cited by in Crossref: 33] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
673 Dorwal P, Phanish M, Duggal R, Chauhan R, Raina V, Kher V. Chronic active antibody mediated rejection associated with human leukocyte antigen-C*07 antibodies. Indian J Nephrol 2016;26:63-5. [PMID: 26937087 DOI: 10.4103/0971-4065.167282] [Reference Citation Analysis]
674 Cheng EY. The Role of Humoral Alloreactivity in Liver Transplantation: Lessons Learned and New Perspectives. J Immunol Res. 2017;2017:3234906. [PMID: 28164136 DOI: 10.1155/2017/3234906] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
675 Win TS, Murakami N, Borges TJ, Chandraker A, Murphy G, Lian C, Barrera V, Ho Sui S, Schoenfeld D, Teague J, Bueno E, Tullius SG, Pomahac B, Clark RA, Riella LV. Longitudinal immunological characterization of the first presensitized recipient of a face transplant. JCI Insight 2017;2:93894. [PMID: 28679959 DOI: 10.1172/jci.insight.93894] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
676 Mcrae M, Bouchard-boivin F, Béland S, Noël R, Côté I, Lapointe I, Lesage J, Latulippe E, Riopel J, Santoriello D, Husain SA, Désy O, Houde I, Batal I, De Serres SA. Impact of the Current Versus the Previous Diagnostic Threshold on the Outcome of Patients With Borderline Changes Suspicious for T Cell–mediated Rejection Diagnosed on Indication Biopsies. Transplantation 2018;102:2120-5. [DOI: 10.1097/tp.0000000000002327] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
677 Nova-Lamperti E, Romano M, Christakoudi S, Runglall M, McGregor R, Mobillo P, Kamra Y, Tsui TL, Norris S, John S, Boardman DA, Lechler RI, Lombardi G, Hernandez-Fuentes MP; www.GAMBITstudy.co.uk. Reduced TCR Signaling Contributes to Impaired Th17 Responses in Tolerant Kidney Transplant Recipients. Transplantation 2018;102:e10-7. [PMID: 28902773 DOI: 10.1097/TP.0000000000001920] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
678 Novotny M, Hruba P, Vichova P, Maluskova J, Honsova E, Viklicky O, Wohlfahrtova M. Isolated v-lesion represents a benign phenotype of vascular rejection of the kidney allograft - a retrospective study. Transpl Int 2018;31:1153-63. [PMID: 29855106 DOI: 10.1111/tri.13286] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
679 Kono M, Hasegawa J, Ogawa H, Yoshikawa K, Ishiwatari A, Wakai S, Tanabe K, Shirakawa H. False Elevation of the Blood Tacrolimus Concentration, as Assessed by an Affinity Column-mediated Immunoassay (ACMIA), Led to Acute T Cell-mediated Rejection after Kidney Transplantation. Intern Med 2018;57:1265-8. [PMID: 29279473 DOI: 10.2169/internalmedicine.0071-17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
680 Calp-Inal S, Ajaimy M, Melamed ML, Savchik C, Masiakos P, Colovai A, Akalin E. The prevalence and clinical significance of C1q-binding donor-specific anti-HLA antibodies early and late after kidney transplantation. Kidney Int 2016;89:209-16. [PMID: 26535999 DOI: 10.1038/ki.2015.275] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
681 Bruneau S, Wedel J, Fakhouri F, Nakayama H, Boneschansker L, Irimia D, Daly KP, Briscoe DM. Translational implications of endothelial cell dysfunction in association with chronic allograft rejection. Pediatr Nephrol 2016;31:41-51. [PMID: 25903640 DOI: 10.1007/s00467-015-3094-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
682 Sapir-Pichhadze R, Curran SP, John R, Tricco AC, Uleryk E, Laupacis A, Tinckam K, Sis B, Beyene J, Logan AG, Kim SJ. A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection. Kidney Int 2015;87:182-94. [PMID: 24827778 DOI: 10.1038/ki.2014.166] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [